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Abstract
Three-dimensional (3D) segmentation of the prostate in medical images is useful
for prostate cancer diagnosis and therapy guidance. However, manual segmentation of
the prostate is laborious and time-consuming with inter-observer variability at the
prostatic apex, mid-gland, and base. The focus of this thesis was on: (1) accuracy,
reproducibility and procedure time measurement for prostate segmentation on T2weighted endorectal (ER) magnetic resonance (MR) imaging (MRI), and (2) assessment
of the potential of a computer-assisted segmentation technique to be translated to clinical
practice for prostate cancer management.
We collected 42 ER MR images from patients with biopsy-confirmed prostate
cancer. Prostate border delineation was manually performed by one observer on all the
images and by two other observers on a subset of 10 images.
We developed a novel semi-automatic and automatic prostate segmentation
algorithms that identify candidate prostate boundary points using learned local prostate
border appearance characteristics, which were regularized according to learned prostate
shape information to produce the final segmentation. The main novelties of the
algorithms are that the segmentations was based on local appearance similarity of the
prostate border across patients, rather than on the appearance of the entire image. This
makes the appearance-based segmentation more robust to inter-patient variation of
prostate gland internal appearance that could be caused by variable spatial distribution of
cancer in the patients. We evaluated our method against the manual reference
segmentations using mean absolute distance (MAD), Dice similarity coefficient (DSC),
recall rate, precision rate, and volume difference as a complementary boundary-, regioni

and volume-based error metric set to measure the different types of observed
segmentation errors. We applied this evaluation for expert manual segmentation as well
as semi-automatic and automatic segmentation approaches before and after manual
editing by expert physicians. Physicians were instructed to edit the segmentations to their
satisfaction for use in clinical procedures, as would be done with any prostate
segmentation technique integrated into the clinical workflow. We recorded the time
needed for user interaction to initialize the semi-automatic algorithm, algorithm
execution, and manual editing where applicable.
On 42 images, comparing to a single-observer manual segmentation reference, the
measured errors for semi-automatic and automatic algorithm on whole prostate gland
were, respectively, MAD of 2.0 mm and 3.2 mm; DSC of 82% and 71%; recall of 77%
and 69%; precision of 88% and 76%; and ΔV of -4.6 cm3 and -3.6 cm3. These results
compared favourably with observed difference between manual segmentation and a
simultaneous truth and performance level estimation (STAPLE) reference for a subset of
10 images (whole gland differences as high as MAD = 3.1 mm, DSC = 78%, recall =
66%, precision = 77%, and ΔV = 15.5 cm3). For each 3D image, the semi-automatic
algorithm required about 30 seconds, on average, to be initialized. Using an unoptimized
Matlab research platform on a single CPU core, the average execution times for semiautomatic and automatic algorithm were 85 seconds and 54 seconds, respectively, to
segment a prostate MRI in 3D. We also measured average editing times of 330 and 390
seconds for the semi-automatic and automatic segmentation results, respectively, whereas
an expert spent 210 seconds on average editing manual segmentations performed by
another expert. Inter-operator variability resulting from using our computer-assisted
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algorithms to generate starting segmentations for manual editing was not substantially
higher than that resulting from using expert manual segmentations as starting
segmentations, suggesting a role for our (semi-)automated segmentation algorithm in this
context.
The presented algorithms used learned local appearance characteristics and
prostate shape separately to segment the prostate and regularize the segmentation,
respectively. The semi-automatic algorithm needed minimal user interaction of
approximately 30 seconds to be initialized; this was replaced by about 3 seconds of
computational time using the automatic segmentation. Both algorithms are highly
parallelizable.
The main conclusions of this thesis were that: (1) computer-assisted segmentation
approaches reduced the inter-observer segmentation variability compared to manual
segmentation, (2) the accuracy of the computer-assisted approaches was near to or within
the range of observed variability in manual prostate segmentation performed by experts,
(3) manual editing of semi-automated and automated segmentation approaches improved
the accuracy and inter-operator variability, (4) the recorded procedure time for prostate
segmentation was reduced using computer-assisted segmentation approaches followed by
manual editing compared to fully manual segmentation, and (5) starting the manual
segmentation from an initial computer-assisted segmentation label could yield lower
variability in the final segmentations and the choice of automatic vs. semi-automatic
segmentation comes down to operator preference.

iii

Keywords
Magnetic resonance imaging, MRI, prostate cancer, segmentation, validation, T2weighted, endorectal coil.

iv

Co-Authorship Statement
This thesis is presented in an integrated article format, the chapters of which are based on
the following publications that are either published or in preparation for submission:
Chapter 2: M. Shahedi, D. W. Cool, C. Romagnoli, G. S. Bauman, M. BastianJordan, E. Gibson, G. Rodrigues, B. Ahmad, M. Lock, A. Fenster, and A. D. Ward,
"Spatially varying accuracy and reproducibility of prostate segmentation in magnetic
resonance images using manual and semi-automated methods," Medical Physics 41 (11),
113503 (2014).
My contributions to this work included defining the research questions; designing
and implementing the segmentation method; data preparation; designing, implementing
and analyzing the experiments; operating the segmentation algorithm; and drafting the
manuscript. D. W. Cool, C. Romagnoli, G. S. Bauman, and M. Bastian-Jordan
contributed to collectiion and preparation of the data set, manual segmentation of the MR
images, and operating the semi-automatic segmentation algorithm. E. Gibson, G.
Rodrigues, B. Ahmad, and M. Lock contributed to operating the semi-automatic
segmentation algorithm. A. D. Ward contributed to defining the research questions,
designing and analyizing the experiments, operating the semi-automatic segmentation
algorithm, interpreting the results, and drafting the manuscript. A. Fenster motivated the
initial research direction. All authors helped in reviewing and editing the manuscript. The
work was performed under supervision of A. D. Ward and A. Fenster.
Chapter 3: M. Shahedi, D. W. Cool, C. Romagnoli, G. S. Bauman, M. BastianJordan, A. Fenster, and A. D. Ward, "Accuracy and acceptability of an automated method
for prostate segmentation in magnetic resonance imaging.".
v

My contributions to this work included defining the research questions; designing
and implementing the segmentation method; data preparation; designing, implementing
and analyzing the experiments; and drafting the manuscript. D. W. Cool, C. Romagnoli,
G. S. Bauman, and M. Bastian-Jordan contributed to collection and preparation of the
data set and manual segmentation of the MR images. A. D. Ward contributed to defining
the research questions, designing and analyizing the experiments, interpreting the results,
and drafting the manuscript. All authors helped in reviewing and editing the manuscript.
The work was performed under supervision of A. D. Ward and A. Fenster.
Chapter 4: M. Shahedi, D. W. Cool, C. Romagnoli, G. S. Bauman, M. BastianJordan, G. Rodrigues, B. Ahmad, M. Lock, A. Fenster, and A. D. Ward, "Impact of
physician editing on repeatability and time for manual and computer-assisted prostate
segmentation on magnetic resonance imaging.".
My contributions to this work included defining the research questions; data preparation;
designing, implementing and analyzing the experiments; and drafting the manuscript. D.
W. Cool and G. S. Bauman contributed to collecting and preparation of the data set,
manual segmentation of the MRI images, and editing the segmentations. C. Romagnoli
and M. Bastian-Jordan contributed to collection and preparation of the data set and
manual segmentation of the MR images. G. Rodrigues, B. Ahmad, and M. Lock
contributed to editing the segmentations. A. D. Ward contributed to defining the research
questions, designing and analyizing the experiments, interpreting the results, and drafting
the manuscript. All authors helped in reviewing and editing the manuscript. The work
was performed under supervision of A. D. Ward and A. Fenster.

vi

Dedication

To my mother and father,
and to all those who have taught me throughout my life’s journey

vii

Acknowledgements
The support, participation and assistance of so many people were contributory to
the completion of the work presented in this thesis.
First, I would like to thank Prof. Aaron Fenster for giving me this opportunity to
work in his laboratory. I acknowledge his supervision, guidance and support throughout
my graduate studies. He taught me a lot by asking critical questions that showed me
hidden aspects of problems and led me to better solutions. I also learned a lot from him
by watching him managing the projects and the research group.
I would also like to thank Prof. Aaron Ward who was not only a supervisor to me
but also a wise mentor, a great teacher, and a nice friend. It was really a good opportunity
for me to join his lab and work with him closely. He deeply cares about his students and
always loves to teach them something new. I can definitely say that in all of the meetings
with him, even the informal and non-scientific ones, I learned something valuable from
him. It was a great chance and an absolute pleasure for me to work in his group and I
cannot forget what he has done for me throughout the years of my PhD program.
I would like to thank my advisors Prof. Eugene Wong and the late Prof. Cesare
Romagnoli for their advice, guidance and support. They provided me with invaluable
insights and suggestions that improved my knowledge and elevated my understanding of
the problems in the technical and clinical domains. Prof. Romagnoli’s passing in the last
year of my PhD program was a big loss for me. Even during his illness, he was always
willing to help and spent a lot of time assisting with data preparation and answering my
questions. May he rest in peace.

viii

I am hugely indebted to Dr. Derek Cool for his unconditional help and support at
each step of the project. He spent hours reviewing my segmentation labels and editing
them. His experience and knowledge in both technical and clinical aspects made him an
incredible collaborator on this project.
This project gave me the opportunity to collaborate with an excellent group of
clinicians: Drs. Glenn Bauman, George Rodrigues, Michael Lock, Belal Ahmad and
Matthew Bastian-Jordan. I would like to thank all of them for their assistance and
invaluable advice. I would also like to thank Dr. David Palma who always seemed more
than happy to help and answer my questions related to the clinical side of the project.
I would also thank all my colleagues at Baines Imaging Laboratory and Robarts
Research Institute for their help and support, especially Dr. Eli Gibson, Dr. Tharindu De
Silva, Hamid Sadeghi Neshat and Dr. Ali Tavallaei, Sarah Mattonen, Carol Johnson,
Yiwen Xu, Peter Martin, Andrew Warner, Mehrnoush Salarian, Wenchao Han, Dr.
Timothy Yeung, Derek Soetemans, Sachi Elkerton, Dr. David Tessier, Dr. Chandima
Edirisinghe, Dr. Mohammad Kayvanrad, Dr. Lena Gorelick, Dr. Eranga Ukwatta and so
many other colleagues in different labs at Western University that I cannot enumerate
them all.
My

sincere

gratitude

also

goes

to

Ashley

Kewayosh

Samuel,

the

Internationalization Programming Coordinator of The International and Exchange
Student Centre, for her unconditional support and encouragement from the very
beginning of my trip to Canada and also to Maria Jardine, housekeeping staff at the
Baines Imaging Laboratory, who always reminded and encouraged me to look at life
positively.

ix

I am grateful to my friends in London who helped and supported me during recent
years. Special thanks to Omid Farhangi, Arman Abtahi, Sahar Samimi, Naeeme Modir,
Elmira Rezanavaz, Maryam Mojalal, Vahid Dehnavi, Nasrin Farhangi, Malihe
Mehdizadeh, Maysam Mirahmadi, Ehsan Omidi, Pooriya Khorshidi, Lida Radan, Amir
Owrangi and Samaneh Kazemi. I would also thank my friends all over the world for their
supports, especially Alireza Aghasi, Omeed Momeni, Hasan Mashayekh, Afshin Safari,
Amir Mir Mohammad Sadeghi, Ehsan Mahmoodi, Mohammad Ansari, Hoda Moazzen,
Behrouz Golzarpour, Samaneh Shadmehr, Mahdi Saniei and Bahare Aminian.
Finally, I would like to wholeheartedly thank my parents, Akram Panahandeh and
Mohammad Shahedi, my siblings, Ehsan, Yasser and Sama, and other extended family
for their love and incredible support in every step of my life’s journey.

x

Table of Contents
Abstract

i

Co-Authorship Statement

v

Dedication

vii

Acknowledgements

viii

Table of Contents

xi

List of Tables

xv

List of Figures

xvi

List of Abbreviations

xvii

Chapter 1. Introduction
1
1.1 Anatomy of the prostate gland ................................................................................. 3
1.2 Prostate cancer and its prevalence............................................................................ 5
1.3 Prostate cancer screening and diagnosis .................................................................. 5
1.3.1 Digital rectal examination .............................................................................. 7
1.3.2 Prostate specific antigen test .......................................................................... 7
1.3.3 Prostate biopsy ............................................................................................... 8
1.3.4 Grading and staging of prostate cancer .......................................................... 9
1.3.5 Other diagnosis methods .............................................................................. 11
1.3.6 Risk groups .................................................................................................. 12
1.3.7 Early diagnosis clinical workflow ............................................................... 13
1.4 Prostate cancer treatment ....................................................................................... 14
1.4.1 Radical treatments ........................................................................................ 14
1.4.2 Lesion-directed treatments ........................................................................... 17
1.5 Prostate cancer imaging ......................................................................................... 17
1.5.1 Ultrasound imaging ...................................................................................... 18
1.5.2 Computed tomography imaging .................................................................. 19
1.5.3 Magnetic resonance imaging ....................................................................... 19
1.5.4 Nuclear imaging ........................................................................................... 26
1.6 The role of MRI in diagnosis and treatment of prostate cancer ............................. 26
1.6.1 MRI-targeted TRUS-guided biopsy............................................................. 26
1.6.2 MRI-CT fusion radiotherapy planning ........................................................ 27
1.6.3 MRI-guided biopsy and focal therapy ......................................................... 28
1.7 Prostate contouring on MRI ................................................................................... 28
1.7.1 Challenges in manual prostate contouring in MRI ...................................... 29
1.7.2 Computer-assisted prostate segmentation on MRI ...................................... 30
1.7.3 Validation challenges ................................................................................... 34
1.8 Hypothesis .............................................................................................................. 36
xi

1.9 Objectives ............................................................................................................... 37
1.10 Thesis outline ....................................................................................................... 37
1.10.1 Chapter 2 - Spatially varying accuracy and reproducibility of prostate
segmentation in magnetic resonance images using manual and semiautomated methods ................................................................................... 37
1.10.2 Chapter 3 - Accuracy and acceptability of an automated method for
prostate segmentation in magnetic resonance imaging ............................. 39
1.10.3 Chapter 4 - Impact of physician editing on repeatability and time for
manual and computer-assisted prostate segmentation on magnetic
resonance imaging .................................................................................... 40
1.11 References ............................................................................................................ 42
Chapter 2. Spatially varying accuracy and reproducibility of prostate
segmentation in magnetic resonance images using manual and semiautomated methods
53
2.1 Introduction ............................................................................................................ 53
2.2 Materials and Methods ........................................................................................... 57
2.2.1 Materials ...................................................................................................... 57
2.2.2 Semi-automated segmentation ..................................................................... 58
2.2.3 Validation metrics ........................................................................................ 65
2.3 Experiments............................................................................................................ 69
2.3.1 Inter-operator variability: Manual segmentation ......................................... 69
2.3.2 Accuracy and Inter-operator variability: Semi-automatic segmentation ..... 70
2.3.3 Sensitivity to initialization: Semi-automatic segmentation ......................... 71
2.3.4 Source of Variability: Semi-automatic segmentation .................................. 72
2.4 Results .................................................................................................................... 73
2.4.1 Inter-operator variability: Manual segmentation ......................................... 73
2.4.2 Accuracy and inter-operator variability: Semi-automatic segmentation ..... 74
2.4.3 Sensitivity to initialization: Semi-automatic segmentation ......................... 80
2.4.4 Source of variability: Semi-automatic segmentation ................................... 81
2.5 Discussion .............................................................................................................. 81
2.5.1 Inter-operator variability: manual segmentation .......................................... 82
2.5.2 Accuracy and inter-operator variability: Semi-automatic segmentation ..... 83
2.5.3 Sensitivity to initialization: Semi-automatic segmentation ......................... 86
2.5.4 Source of variability: Semi-automatic segmentation ................................... 86
2.5.5 Limitations ................................................................................................... 87
2.5.6 Conclusions .................................................................................................. 88
2.6 References .............................................................................................................. 89
Chapter 3. Accuracy and acceptability of an automated method for prostate
segmentation in magnetic resonance imaging
92
3.1 Introduction ............................................................................................................ 92
3.2 Materials and Methods ........................................................................................... 97
3.2.1 Materials ...................................................................................................... 97
3.2.2 Automated segmentation ............................................................................. 98
3.2.3 Validation ................................................................................................... 102
xii

3.3 Experiments.......................................................................................................... 104
3.3.1 Comparison of automatic and semi-automatic segmentation: accuracy
and time ................................................................................................... 104
3.3.2 Comparison of automatic and semi-automatic segmentation versus interoperator variability in manual segmentation........................................... 105
3.4 Results .................................................................................................................. 107
3.4.1 Comparison of automatic and semi-automatic segmentation: accuracy
and time ................................................................................................... 107
3.4.2 Comparison of automatic and semi-automatic segmentation versus interoperator variability in manual segmentation........................................... 108
3.5 Discussion ............................................................................................................ 112
3.5.1 Comparison of automatic and semi-automatic segmentation: accuracy
and time ................................................................................................... 112
3.5.2 Comparison of automatic and semi-automatic segmentation versus interoperator variability in manual segmentation........................................... 114
3.5.3 Limitations ................................................................................................. 116
3.5.4 Conclusions ................................................................................................ 117
3.6 References ............................................................................................................ 119
Chapter 4. Impact of physician editing on repeatability and time for manual and
computer-assisted prostate segmentation on magnetic resonance imaging
121
4.1 Introduction .......................................................................................................... 121
4.2 Materials and Methods ......................................................................................... 125
4.2.1 Materials .................................................................................................... 125
4.2.2 Study design ............................................................................................... 126
4.2.3 Spatial editing magnitude and inter-operator variability ........................... 127
4.2.4 Required editing time and correlation with spatial error metrics .............. 130
4.3 Results .................................................................................................................. 132
4.3.1 Spatial editing magnitude and inter-operator variability ........................... 132
4.3.2 Required editing time and correlation with spatial error metrics .............. 134
4.3.3 Correlation of editing time with the metric values .................................... 135
4.4 Discussion ............................................................................................................ 139
4.4.1 Spatial editing magnitude and inter-operator variability ........................... 139
4.4.2 Required editing time and correlation with spatial error metrics .............. 141
4.4.3 Limitations ................................................................................................. 144
4.4.4 Conclusions ................................................................................................ 145
4.5 References ............................................................................................................ 147
Chapter 5. Conclusions and directions for future work
150
5.1 Conclusions .......................................................................................................... 150
5.2 Applications and future directions ....................................................................... 153
5.2.1 Applications in ongoing clinical research studies ...................................... 153
5.2.2 Suggestions for future work ....................................................................... 154
5.3 References ............................................................................................................ 156
Appendix A

158
xiii

Curriculum Vitae

159

xiv

List of Tables
Table 1.1: Prostate cancer staging using the TNM system. ............................................. 11
Table 1.2: Prostate cancer risk groups. ............................................................................ 13
Table 1.3: A survey of prostate MRI segmentation algorithms. ...................................... 35
Table 2.1: Inter-operator variability in manual segmentation: Range of mean MAD,
DSC, recall, precision, and ΔV (bilateral MAD and |ΔV| was used for “Operator vs
Operator” section). ............................................................................................................ 74
Table 2.2: Accuracy and variability for semi-automatic segmentation: mean±standard
deviation of MAD, DSC, recall, precision, and ΔV. Corresponding letters show
statisticaly significant differences between each error value of our method and the
corresponding error value of another method where applicable. (p < 0.05). .................... 75
Table 2.3: The average results across the nine operators and 10 images compared to
the single operator results across 42 images: mean±standard deviation of MAD, DSC,
recall, precision, and ΔV. Corresponding letters indicate statistically significant
differences between two modes (p < 0.05). ...................................................................... 77
Table 2.4: Consistency of the manual and the semi-automatic segmentations: average
of means (average of standard deviations) of MAD, DSC, recall, precision, and ΔV
across 3 manual and 3 semi-automatic segmentations of the prostate by 3 expert
operators. ........................................................................................................................... 78
Table 2.5: Sensitivity of the semi-automatic algorithm to initialization (center points
and anteroposterior symmetry axes): mean±standard deviation of MAD, DSC, recall,
precision, and ΔV offsets from reference measurements across 1000 repetitions × 42
patients. ............................................................................................................................. 81
Table 3.1: Accuracy of automatic segmentation: mean ± standard deviation of MAD,
DSC, recall, precision, and ΔV. ...................................................................................... 108
Table 4.1: Reported segmentation errors for prostate segmentation algorithms
intended for use on T2w ER MRI. .................................................................................. 125
Table 4.2: User manual interaction time for ready to use prostate segmentation in
T2w MRI. ........................................................................................................................ 134
Table 4.3: Correlation between editing time and spatial editing magnitude measured
using five metrics. ........................................................................................................... 136

xv

List of Figures
Figure 1.1: Prostate location in the reproductive system of the male human body. .......... 4
Figure 1.2: Prostate gland zonal anatomy. ......................................................................... 4
Figure 1.3: Digital rectal examination (DRE) .................................................................... 7
Figure 1.4: Diagram depicting transrectal prostate biopsy. ............................................... 9
Figure 1.5: Three standard imaging planes in radiology. ................................................ 20
Figure 1.6: Axial view of T2w prostate MRI acquired (a) without, and (b) with ER
coil..................................................................................................................................... 21
Figure 1.7: ER coil distortion on MRI ............................................................................. 25
Figure 2.1: Algorithm block diagram. ............................................................................. 59
Figure 2.2: Training. ........................................................................................................ 61
Figure 2.3: Segmentation. ................................................................................................ 65
Figure 2.4: Inter-observer variability. .............................................................................. 74
Figure 2.5: Qualitative and quantitative results for three sample prostates. .................... 76
Figure 2.6: Inter-observer variability. .............................................................................. 79
Figure 3.1: Automatic coarse localization of the prostate. ............................................ 102
Figure 3.2: Elements used to calculated the DSC, recall, and precision validation
metrics. ............................................................................................................................ 104
Figure 3.3: Accuracy of the computer-based segmentations vs. inter-operator
variability of manual segmentation. ................................................................................ 110
Figure 3.4: Accuracy of the computer-based segmentations vs. inter-operator
variability of manual segmentation. ................................................................................ 111
Figure 4.1: Study design showing the workflow for a particular operator #i. ............... 126
Figure 4.2: User manual interaction time on manual, semi-automatic (S.A.) and
automatic segmentations. ................................................................................................ 134
Figure 4.3: Inter-operator variability. ............................................................................ 137
Figure 4.4: Editing magnitude, showing the differences between the segmentations
pre- and post-editing for each of the three conditions. ................................................... 138

xvi

List of Abbreviations
2D

Two-dimensional

3D

Three-dimensional

ADC

Apparent diffusion coefficient (mm2/sec.)

ADT

Androgen deprivation therapy

ANOVA

Analysis of variance

AP

Anteroposterior

APSA

Anteroposterior symmetry axis

CT

Computed tomography

CZ

Central zone

DCE

Dynamic contrast-enhanced

DRE

Digital rectal examination

DSC

Dice similarity coefficient (%)

DWI

Diffusion-weighted imaging

EBRT

External beam radiotherapy

ER

Endorectal receiver

FDG

Fluorodeoxyglucose

FN

False negative (cm3)

FP

False positive (cm3)

HD

Hausdorff distance (mm)

HDR

High dose-rate

HIFU

High intensity focused ultrasound

HRQOL

Health-related quality of life

IGRT

Image-guided radiotherapy

IMRT

Intensity modulated radiotherapy

IS

Inferior-superior

LINAC

Linear accelerator

LDR

Low dose-rate

MAD

Mean absolute distance (mm)

MG

Mid-gland
xvii

MICCAI

Medical Image Computing and Computer Assisted Intervention

MR

Magnetic resonance

MRI

Magnetic resonance imaging

MRS

Magnetic resonance spectroscopy

NCC

Normalized cross correlation (unitless)

NCCN

National Comprehensive Cancer Network

NVB

Neurovascular bundle

PCa

Prostate cancer

PDM

Point distribution model

PET

Positron emission tomography

PROMISE

Prostate MR image segmentation

PSA

Prostate-specific antigen

PZ

Peripheral zone

RF

Radio frequency

RMS

Root-mean-square

ROI

Regions of interest

RT

Radiation therapy

SA

Semi-automatic

SD

Standard deviation

SNR

Signal-to-noise ratio (unitless)

STAPLE

Simultaneous truth and performance level estimation

T2w

T2-weighted

TNM

Tumor Node Metastasis

TP

True positive (cm3)

TRUS

Transrectal ultrasound

TZ

Transition zone

WG

Whole gland

ΔV

Volume difference (cm3)

xviii

Chapter 1.
Introduction
Three-dimensional (3D) segmentation of the prostate in medical images is useful
for diagnosis and treatment planning of prostate cancer (PCa) [1, 2]. Magnetic resonance
imaging (MRI) is increasingly being utilitized for PCa diagnosis and staging [3]. More
specifically, T2-weighted (T2w) MRI is superior to other MRI sequences in anatomy
visualization and is most commonly used for contouring the prostate boundary [3].
Endorectal receiver (ER) coil MRI provides improved image quality by increasing the
contrast and signal-to-noise ratio [4-6]. However, the ER coil causes substantial
deformation of the prostate tissue [7, 8] and also renders fine details and edges more
salient in the magnetic resonance (MR) images, presenting an additional challenge to
segmentation algorithms developed for use on MR images acquired without an ER coil.
Manual contouring of the prostate on MRI is a time-consuming task with substantial
inter-observer variability [9]. This is an important issue in clinical trials involving
multiple investigators performing radiation therapy planning, in which inter-operator
variation in contouring could materially impact the trial results. The impact of interoperator contouring variability on clinical outcomes is unknown and has not yet been
extensively studied [1].
Manual contouring of the prostate is a labourious and time-consuming task [10,
11]. Employing a computer-assisted algorithm for prostate segmentation could facilitate
the contouring task by making it faster with minimal required user interaction. It also
could help in the establishment of clinical methods that require the prostate to be
1

segmented more than once during the course of the treatment. For example, recontouring
the prostate over the course of radiation therapy (RT) could help radiotherapists to adjust
the plan based on the evolving condition of the patient [12].
Several algorithms have been presented in the literature for 3D segmentation of
the prostate on T2W MRI acquired with an ER coil [13-16]. Predominantly, in the
published studies the accuracy of the segmentation results was evaluated by comparison
to a single-observer reference standard manual segmentation of each image in the data
set. However, due to high inter-observer variation in manual contouring of the prostate by
experts, there is no gold standard for prostate contouring on MRI [1] and this challenges
the comparison of error metric values obtained from different segmentation algorithms on
different data sets. Furthermore, in most studies, the choice of segmentation error metrics
is somewhat arbitrary and not determined based on clinical demands [1]. The use of a set
of complementary error metrics to capture most types of medically relevant segmentation
errors is beneficial to assessing an algorithm’s suitability for clinical translation.
Comparing two commonly-used metrics, surface-based error metrics such as the mean
absolute distance (MAD) between segmentation boundaries are usually more sensitive to
local misalignments of the shape surfaces. Region-based metrics such as the Dice
similarity coefficient (DSC), are measured based on the overlap area or volume and they
are less sensitive to error types like sharp local surface misalignments. The
appropriateness of a particular method depends on the intended use of the segementation.
For example, a local surface misalignment in radiation therapy could be neglected using a
region-based error metric but this error might cause an overdose of healthy tissues or an
underdose of the tumour volume.

2

The focus of this thesis is to comprehensively evaluate the prostate segmentation
accuracy and inter-operator variability and to compare novel semi-automatic and fully
automatic computer-assisted segmentation algorithms with manual segmentation in terms
of accuracy, reproducibility and required operator interaction time. The remainder of this
chapter describes PCa prevalence and its clinical diagnosis and treatment methods; the
role of medical imaging, specifically MRI, in diagnosis and treatment planning of the
PCa; and the role of prostate contouring in MRI-guided or MRI-targeted procedures.

1.1 Anatomy of the prostate gland
The prostate is a part of the reproductive and urinary system of the male human
body. A normal and healthy prostate is usually a walnut-sized gland that is located just
below the bladder, anterior to the rectum and posterior to the pubic symphysis. It has an
inverted pyramid shape with the base abutting the bladder and the apex abutting the
urogenital diaphragm (Figure 1.1). It surrounds the bladder neck and the urethra.
Additional structures such as seminal vesicles, neurovascular bundles (NVBs) and
muscles also surround the prostate gland. Figure 1.1 shows the prostate location in the
male reproductive system.
The prostate gland is divided into three different zones with different embryologic
origins: the peripheral zone, transition zone, and central zone. In a healthy prostate, the
peripheral zone forms about 70% of the prostate gland volume. It surrounds the urethra at
the prostate apex and extends posterolaterally to the prostate base. The central zone
contains the ejaculatory ducts and accounts for about 25% of the prostate tissue. The
transition zone comprises only 5% to 10% of the gland volume and is located between
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the peripheral and the central zones. Figure 1.2 shows the anatomy of the prostate gland
and its zones.
Superior
Bladder
Seminal
vesicle
Pubic bone

Rectum

Posterior

Prostate

Ejaculatory
duct

Anterior

Urethra
Urogenital
diaphragm
Penis

Testis

Inferior

Figure 1.1: Prostate location in the reproductive system of the male human body.
Adapted from [17].
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Figure 1.2: Prostate gland zonal anatomy. CZ: central zone, TZ: transition zone, and PZ:
peripheral zone
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1.2 Prostate cancer and its prevalence
PCa is the most commonly diagnosed cancer in men in North America, excluding
skin cancer [18, 19]. The American Cancer Society predicts that in 2015 over 220,000
new cases of PCa will be diagnosed; this represents approximately one quarter of all
cancers among men. The American Cancer Society also predicts over 27,000 deaths from
PCa in the United States in 2015 [18]. In Canada, one out of eight men will be diagnosed
with PCa within his lifetime. Approximately 24,000 new cases of PCa are predicted to be
diagnosed in Canada in 2015. PCa is also the second cause of death by cancer among
Canadian men [19]. About 98% of PCa cases occur in men aged 50 years and older [20].
Prostate tumour cells develop in widely different patterns, at different growth
rates, and with different aggressiveness and metastatic ability. There also exist benign
prostate tumours that are not cancerous. Benign tumours can cause problems, such as
pain and urination difficulties, but usually they are not life threatening and they do not
spread to other organs of the body. Due to the wide variation in prostate tumour types,
accurate and reliable diagnosis of PCa is vital for planning effective treatment that is
appropriate to the aggressiveness level of the disease. Tumour size, location and extent,
and the type of carcinoma are considered by clinicians during treatment selection.

1.3 Prostate cancer screening and diagnosis
In general, screening means testing for a disease in healthy and asymptomatic
populations to identify and treat the disease at earlier stages, whereas diagnosis refers to
detecting disease among individuals having symptoms and signs. Since PCa is usually
asymptomatic in the early stages, there are some screening tests such as digital rectal
examination (DRE), prostate-specific antigen (PSA) blood testing and transrectal
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ultrasound (TRUS) imaging [21] to help in identifying the PCa in its early stages. It has
been shown that about 75% of PCa would not be diagnosed early without PSA screening
in the population [22] and there is no doubt that early diagnosis of aggressive PCa is
helpful to preventing cancer spread to other organs. An early and accurate diagnosis helps
to treat the patient more efficiently and effectively. However, screening in PCa is still a
controversial subject [23-26]. On one hand, there is evidence that PCa screening could
reduce the rate of advanced and metastatic PCa [25, 26]. On the other hand, there is a
higher probability of missing a fast-growing tumour in the interval between PCa
screening tests [24], implying that screening is a less effective approach for diagnosis of
fast-growing PCa tumours compared to slow-growing tumours that are usually less lifethreatening. Moreover, early diagnosis of PCa through screening tests could be also
harmful due to potential overdiagnosis and overtreatment of the disease [23].
Overtreatment of PCa is especially concerning in patients for whom treatment is
associated with minimal benefit compared to active surveillance (e.g. patients older than
65 years [27]).
The success of screening processes depends on two principal conditions: (1) there
are available tests to detect the disease at the early stages, and (2) there are effective
treatments for the disease at the early stages [24]. Therefore, to improve the benefits of
screening it is necessary to improve the accuracy, sensitivity and specificity of the cancer
detection methods as well as the efficiency of the treatment procedures.
In the following subsections, we briefly introduce the standard tests that are
typically used for PCa screening and diagnosis.
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1.3.1 Digital rectal examination
DRE is a PCa screening test. During the test, the physician uses a gloved
lubricated finger to palpate the prostate gland through rectum to examine the prostate for
any irregularities in shape, size and texture (Figure 1.3). The detection rate of DRE by
itself is low [28]. Sensitivities of 40% to 55% has been reported in the literature for DRE
[28-30]. However, there are cancers that are detected by DRE alone or could be
diagnosed through DRE earlier than with PSA blood testing and ultrasound imaging [31].
Therefore, considering also the simplicity and availability of the test, DRE is routinely
used for screening.

Figure 1.3: Digital rectal examination (DRE) Adapted from [17].

1.3.2 Prostate specific antigen test
PSA is a protein that is produced by the prostate gland and released into the
bloodstream. Most of the time, when an abnormality such as PCa occurs in the prostate,
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more PSA is released into the blood stream. During a PSA test, a small amount of blood
is taken and the level of PSA in the blood is measured. A high level of PSA in the blood
or a rapid elavation of the PSA level over time are considered as signs of suspicion for
PCa.
There is not any level of PSA in the blood defined as normal. However,
traditionally, PSA levels of 4 ng/mL are considered as a cutoff point to distinguished
normal from abnormal. PSA levels above 10 ng/mL are usually considered as high PSA
level that is suspicious for advanced or metastatic PCa. According to American Cancer
Society guidlines for early detection of PCa, if the PSA level is lower than 2.5 ng/mL,
screening could be conducted every two years, and for PSA levels of 2.5 ng/mL and
above the screening interval should be one year. It also suggests biopsy for men at
average risk for PCa whose PSA level is 4.0 ng/mL or greater. For individuals at high
risk for cancer when the PSA level is within the range of 2.5 ng/mL to 4.0 ng/mL
individualized diagnosis planning is suggested [32].

1.3.3 Prostate biopsy
Patients with abnormal DRE or high or elevated PSA levels are referred for
prostate biopsy [32]. Currently, prostate needle biopsy is the clinical standard for
diagnosis of PCa. This is an outpatient procedure which is done under local anesthesia.
During the biopsy process a thin needle is inserted through either the rectal wall
(transrectal biopsy) or the perineum and usually 6 to 24 (typically about 12) small
samples of the prostate are taken from different parts of the gland [33]. Transrectal
prostate biopsy is most common. This process is usually done under two-dimensional
(2D) TRUS imaging guidance. Figure 1.4 shows a schematic depicting transrectal
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prostate biopsy. The biopsy samples are sent to a pathology laboratory, where a
pathologist looks at the specimens under a microscope and reports on the presence and
grade of PCa. The pathologist categorizes cancerous foci using a standard grading system
called the Gleason grading system [34]. The number of biopsy samples that are cancerous
and the percentage of cancer in each biopsy core are also reported. Since about 30% of
cancers are missed during the first TRUS-guided prostate biopsy [35, 36], for individuals
with persistently elevated PSA or positive DRE whose initial biopsy did not detect
cancer, repeat biopsy is required [36].

Prostate

Biopsy needle

Bladder

Ultrasound
transducer

Urethra

Rectum

Figure 1.4: Diagram depicting transrectal prostate biopsy. Adapted from [17].

1.3.4 Grading and staging of prostate cancer
PCa grading: The Gleason system is one of the most commonly used systems for
gradig PCa in pathological samples. The Gleason system was first presented in 1966 by
Donald F. Gleason [37] and it became more popular in North America in the late 1980s
and early 1990s. The grading system is based on tissue architecture at the cellular level
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and refers to identification of aggressiveness of the cancer cells based on their histologic
pattern of arrangement [34]. In the Gleason grading system, nine fundamental tumour cell
patterns are defined under 5 grades; grade 1 to grade 5, with lower grades being closer to
normal tissue and higher grades being more aggressive. Within the prostate, the first and
second most predominant Gleason grades are added together and reported as Gleason
score or Gleason sum. The higher the Gleason score, the higher chance of harbouring
PCa tumours with potential to grow and spread quickly.
PCa staging: PCa is also characterized based on how much cancer has spread
within or beyond the prostate border; this is referred to as PCa staging. There is a strong
relationship between PCa stage and the probability of curative treatment. The tumournode-metastasis (TNM) staging system presented by the American Joint Committee on
Cancer is one of the most commonly used cancer staging methods worldwide [38]. It
categorizes PCa into four main stages; taking the size of the tumour, the extent to which
lymph nodes are involved, and the presence of metastases into account. Gleason grading
of the tumour is also considered in the staging process. In stage I, cancer foci are usually
microscopic and cannot be detected during DRE, the PSA level is lower than 10 ng/mL,
and the Gleason score is less than or equal to 6. In this stage, cancer is usually detected
through biopsy and few of the obtained samples are cancerous. In stage II, cancer is
confined to the prostate gland and may be detected by DRE. In this stage, PSA could rise
up to 20 ng/mL or higher. In stage III, the tumour has extended beyond the prostate
capsule, but no regional lymph node metastasis or distant metastasis is detected. In stage
IV, cancer has invaded adjacent tissues and organs. In this stage, metastasis in regional
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lymph node(s) and/or other organs might be found [38]. Table 1.1 presents a brief and
general overview of the TNM staging system for PCa.
Table 1.1: Prostate cancer staging using the TNM system. This table is adapted and
summarized from [38]. N0 means no regional lymph node metastasis and N1 means
regional lymph node metastasis. M0 means no distant metastasis and M1 means
metastasis in other organs beyond the prostate gland.
Stage

I

IIA

IIB

III
IV

Tumour
Microscopic nonpalpable
tumour confined to prostate
capsule
Tumour confined to
prostate capsule and
involving 50% or less of
one lobe
Tumour confined to
prostate capsule and
involving either more than
50% of one lobe, or both
lobes
Tumour expansion beyond
the prostate
Tumour invasion of
adjacent structures beyond
the prostate

Regional
Distant
lymph node
metastasis
metastasis

PSA level*
(ng/mL)

Gleason
score*

N0

M0

< 10

≤6

N0

M0

<20

≤7

N0

M0

any

any

N0

M0

any

any

N0/N1

M0/M1

any

any

* Where available

1.3.5 Other diagnosis methods
Medical imaging: Ultrasound imaging is one of the imaging methods currently
performed as a clinical follow up method to the DRE and PSA blood tests to measure the
prostate gland size, as well as the PCa tumour size, location and extent. Ultrasound
imaging is also used for guidance of clinical procedures such as prostate biopsy or
brachytherapy. 2D TRUS imaging is the most common method used for PCa diagnosis or
guidance of some of the clinical procedures. Between 25% and 40% of PCa tumours have
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been reported as isoechoic [39-41], meaning that they are not detected through ultrasound
imaging.
Bone scan: Bones are usually the first target of metastasis in prostate cancer.
Therefore a bone scan or bone scintigraphy is usually used as a follow up test for highgrade and/or high-stage PCa. The bone scan is a nuclear imaging method in which a lowlevel radioactive material (called a radiotracer) is injected into a vein and this material is
absorbed by bones. A gamma camera, which is a radiation-sensitive device, scans the
body and detects the radiation emitted by the radiotracer. The more active the bone, the
more radiotracer will be absorbed and detected by the camera. Some tumours, infections,
bone abnormalities and bone damage show up as sites of increased radiotracer uptake
and are demonstrated as hot spot areas on imaging. The hot spots might suggest cancer
metastasis to the bone or they might be detected because of some other bone
abnormalities.

1.3.6 Risk groups
PCa patients are categorized into six different risk groups based on the initial
clinical assessment: very low-, low-, intermediate-, high-, very high-risk, or metastatic
cancer. These risk groups are used to choose the appropriate treatment option for the
patients. If a patient’s risk group changes over a period of time, this is strongly suggestive
of cancer progression and indicates radical treatments such as surgery or radiotherapy
[42]. Table 1.2 shows the six risk factors and their characteristics. In the next subsection
(1.3.7) we describe the clinical treatment plan that is suggested for each risk group.
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1.3.7 Early diagnosis clinical workflow
The National Comprehensive Cancer Network (NCCN) has published a guideline
that suggests a clinical workflow for PCa diagnosis and treatment planning [42]. In this
guideline for early detection of the PCa, initial risk assessment based on DRE and PSA is
suggested. Biopsy is usually offered based on DRE and PSA results. For individuals of
45 to 75 years of age with normal DRE and PSA level lower than 1 ng/mL, repeating
DRE and PSA at 2-4 years intervals is suggested. If the PSA level is equal to or higher
than 1ng/mL, or the individual’s age is above 75 years with a PSA level lower than 3
ng/mL, DRE and PSA testing are offered every 1–2 years. For individuals with PSA level
above 3.0 ng/mL, the NCCN guidline suggests workup for benign disease; i.e., either
TRUS-guided biopsy or PSA and DRE testing every 6–12 months [43].
Table 1.2: Prostate cancer risk groups. This table is adapted from [44].
Gleason
score

Staging

PSA level
(ng/mL)

Risk group

PCa extent

Very low

Clinically
localized

Stage I
≤ 5% tissue involvement
< 3 positive biopsy cores
(< 50% cancer in each)

and

≤6

and

< 10

Low

Clinically
localized

Stage I or II
≤ 50% of one lobe is involved

and

2 to 6

and

< 10

Intermediate

Clinically
localized

Stage II
> 50% of one lobe or both lobes are
involved

or

7

or

10-20

High

Clinically
localized

Stage III
Extracapsular extension

or

8-10

or

> 20

Very high

Locally
advanced

Stage III or IV
Seminal vesicle(s) invasion

any

any

Metastatic

Metastatic

Regional lymph and/or distant
metastasis

any

any

For treatment planning, NCCN guidelines suggest a specific strategy for each risk
group. The recommended strategies are usually based on the estimated life expectancy of
the patient and PCa growth and progression over time. The suggested treatment options
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could be selected from active surveillance (i.e. active monitoring of disease progression),
radiotherapy (brachytherapy or external beam radiotherapy; EBRT) and surgery (radical
prostatectomy with or without pelvic lymph node dissection). In some cases, androgen
deprivation therapy or ADT is also recommended, usually combined with the radical
treatments such as EBRT or radical prostatectomy [44].

1.4 Prostate cancer treatment
1.4.1 Radical treatments
Surgery: Currently, one of the clinical standard PCa treatments is to surgically
remove the whole prostate gland and the attached seminal vesicles, also known as radical
prostatectomy. This surgery is usually done for patients with clinically localized PCa that
is progressive and aggressive. Some times the local lymph nodes are also removed during
the same surgery [44]. Radical prostatectomy is sometimes followed by other treatment
or monitoring options such as radiotherapy, chemotherapy, ADT or active surveillance to
avoid the risk of PCa recurrence [45].
Since the prostate is surrounded by the sphincter urethrae muscle, as well as
nerves and blood vessels that are critical for erections, and is attached to many organs
such as rectum and bladder, radical prostatectomy can have severe side effects such as
urinary incontinence and erectile dysfunction [46-48]. Prostatectomy has minimal postsurgery bowel function-related symptoms [49]. The NCCN guidelines recommend radical
prostatectomy for patients with 10 or more years of estimated life expectancy who do not
have any serious health conditions that would contraindicate the surgery [44].
External beam radiation therapy: EBRT is another common radical treatment
option for PCa, where ionizing radiation (e.g. X-ray) is generated and delivered to the
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target by a computer-controlled linear accelerator (LINAC). The LINAC targets the
prostate and directs the radiation from outside of the body at the prostate gland to kill the
cancerous cells. Intensity modulated radiotherapy (IMRT) is one of the state-of-art
radiathion therapy methods in radiation oncology used for PCa treatment. With IMRT,
compared to traditional radiation therapy, oncologists can plan the radiation therapy with
the aim of delivering a higher dose to the tumour and minimizing radiation exposure to
the healthy surrounding tissues. For accurate radiation delivery to the target, prostate
localization is performed by image-guided radiotherapy (IGRT) [44]. In IGRT, for each
radiation delivery secssion the target is tracked by an intra-operative imaging system such
as ultrasound imaging, X-ray imaging or cone-beam computed tomography (CT) to
increase the accuracy of the targeting and compensate tissue movment.
Prostate EBRT dose planning is usually done under CT image guidance because
CT provides 3D anatomical localization of the pelvis and also provides the electron
density information of the tissues that is required for radiation dose calculation. Radiation
oncologists usually use inverse planning for radiation dose planning in IMRT. In inverse
planning the oncologists first delineate the prostate border as well as the surfaces of all
organs at risk in 3D. They then use advanced software to prioritize the dose delivery and
limitations for the organs at risk and run the software to design the dose plan. The dose
plan is used in a computer-controlled LINAC for radiation therapy delivery.
The limitation with CT based planning is the low soft tissue contrast in CT
images. Therefore, CT cannot provide accurate and repeatable contour delineation for the
prostate and some of the surrounding organs at risk such as the rectum, bladder and
NVBs [50, 51].

15

In terms of health-related quality of life (HRQOL), in general, patients who
undergo EBRT have less urinary incontinence but worse bowel function compared to
prostatectomy patients [52, 53]. HRQOL improves over time post-treatment for PCa
patients treated with EBRT [54]. EBRT also avoids surgery-associated risks and
complications such as bleeding and transfusion-related risks, and anesthesia-associated
side effects [44].
Brachytherapy: Brachytherapy, as an internal radiotherapy, is another radical
treatment method usually used for lower-risk PCa cases [44]. In this method, radioactive
sources are placed within the prostate tissue to kill the cancerous cells. Prostate
brachytherapy is an outpatient procedure that is performed under either general or spinal
anesthesia. The treatment is usually planned using ultrasound and/or MR imaging. The
radioactive sources are usually placed in the prostate through transperineal insertion
under the guidance of an imaging technique like TRUS [55].
Low dose-rate (LDR) and high dose-rate (HDR) brachytherapy are the two main
types of brachytherapy treatment approaches for PCa. In HDR brachytherapy a catheter is
inserted into the prostate and a high-dose radiation is delivered to the cancerous tissue. In
LDR brachytherapy a number of small radioactive seeds are permanently implanted in
the prostate gland to deliver low dose radiation to the tumour cells within a longer period
of time compared to HDR brachytherapy. Brachytherapy as monotherapy is
recommended to patients with low-risk PCa. For intermediate-risk PCa, brachytherapy is
combined with EBRT with or without ADT. Brachytherapy rarely is a useful option for
high-risk PCa treatment [44].
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Brachytherapy is usually performed within a day and the patient can return to
normal activities in a short time [44]. Less erectile dysfunction is reported after
brachytherapy compared to EBRT and prostatectomy [49]. The incidence of urinary
continence is lower after brachytherapy compared to prostatectomy, and bowel
dysfunction is comparable to EBRT [49, 52].

1.4.2 Lesion-directed treatments
In a subset of prostate cancer patients with organ-confined cancer, PCa consists of
a dominant high-grade tumour surrounded by primarily non-cancerous tissue. Therefore,
a number of emerging therapy methods such as cryotherapy and high intensity focused
ultrasound (HIFU) suggest preserving as much healthy parenchyma as possible and
delivering the treatment to the tumour site [44]. In these local therapy methods (also
known as focal therapies) the treatment is focused on the tumour cells to spare healthy
tissues from destruction. This leads to minimally invasive treatments with fewer and lesssevere risks and side effects compared to radical treatments like prostatectomy and
radiotherapy.

1.5 Prostate cancer imaging
There are many different imaging modalities that are being used for PCa
diagnostic and therapeutic procedures. For each clinical procedure, the imaging modality
to be utilitzed is chosen according to the features required for that type of procedure.
Sometimes it is required or more effective to use combination of two or more imaging
methods. Ultrasound, CT, MRI and positron emission tomography (PET) are the most
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popular imaging modalities that are currently being used for PCa diagnosis or treatment
in clinical procedures.

1.5.1 Ultrasound imaging
As is also mentioned in section 1.3.5, ultrasound imaging and more specifically
TRUS imaging is the most common imaging modality used for PCa diagnosis and
treatment. It is an inexpensive and safe imaging modality that is available in most clinical
centres. In TRUS imaging, a transrectal ultrasound transducer is inserted into the rectum
and acquires images from the prostate gland through the rectal wall. TRUS is capable of
displaying the anatomy of the prostate and provides real time imaging with rates of up to
30 frames per second. There are two types of TRUS probe available that provide different
views; end-firing and side-firing probes. Both probe types are currently used in clinical
procedures such as TRUS-guided biopsy but the preference of one over the other is still a
matter of debate [56-59]. However, for prostate biopsy, end-firing probes are
recommended because they provide greater freedom of biopsy plane manipulation and
they enable better access to the peripheral zone, where PCa tumours are most likely to be
found [57, 59]. Side-firing probes are mostly used in transperineal biopsy or
brachytherapy.
TRUS is one of the imaging modalities used for accurate estimation of the
prostate gland volume [60]. It is also used for PCa detection and tumour volume
estimation, however ultrasound imaging is not able to detect all prostate tumours; about
25 to 40 percent of PCa tumours have been reported as isoechoic [39-41].
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1.5.2 Computed tomography imaging
CT is an imaging modality based on X-ray irradiation of the body from different
angles and processing the acquired data by a computer to generate the images. CT
provides each 3D image in the form of a set of cross-sectional images. The CT image
intensities are directly correlated with the electron density of the tissues. This is an
exclusive feature of CT imaging that is required for radiation dose calculation during the
radiotherapy planning process. However, X-rays forms the CT images, image contrast is
lower for soft tissues compared to the image contrast for hard tissues (e.g. bones). For
prostate imaging, although CT imaging provides a useful 3D anatomical image of the
pelvis, prostate contouring on CT images is challenging and subject to high interobserver variability compared to other imaging modalities such as ultrasound and MRI
[9, 61, 62].

1.5.3 Magnetic resonance imaging
MRI is known as a noninvasive medical imaging method. MRI uses a strong
magnetic field (usually 0.5 to 3.0 Tesla) and radio frequency (RF) pulses (with frequency
of ~42.5 MHz/Tesla) to generate the cross-sectional images of the body. MRI yields
high-contrast, detailed images of soft tissues. However, for air and bone imaging the
quality of MR images is poor, and additional techniques such as using contrast agents are
required.
MRI is capable of producing 3D images in the form of a set of cross-sectional 2D
images. There are three orthogonal standard imaging planes defined in radiology to
present cross-sectional views: the axial, sagittal, and coronal imaging planes. The axial
plane (also known as the transverse plane) divides the body into superior and inferior
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parts (Figure 1.5 (a)). The sagittal imaging plane (also known as the lateral plane) is
perpendicular to the axial plane and divides body into left and right parts (Figure 1.5 (b)).
The coronal imaging plane (also known as the frontal plane) is perpendicular to the axial
and sagittal planes and divides the body into anterior (ventral) and posterior (dorsal) parts
(Figure 1.5 (c)).

(a)

(b)

(c)

Axial

Sagittal

Coronal

Figure 1.5: Three standard imaging planes in radiology. (a) Axial plane, (b) sagittal
plane, and (c) coronal plane.
1.5.3.1 Prostate MRI
Although MRI is not used as a clinical standard test for PCa [63-65], MRI has
demonstrated its potential and important role as an imaging modality for PCa
management [63-68]. Over the past two decades, in many centres MR imaging has been
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used for PCa diagnosis, staging, treatment planning and therapy guidance [65-67, 69].
Most commonly, prostate MRI is performed at 1.5 or 3.0 Tesla magnetic field strength. In
some centres, an ER coil and/or pelvic phased array coil (also known as a body coil) are
used for prostate MRI to increase the signal-to-noise ratio (SNR) and improve the spatial
resolution of the images [7, 70]. Although the optimal use of the ER coil for prostate MRI
is still under study, there is some evidence of improvement in diagnosis and staging of
PCa using ER MRI [7, 70, 71]. Figure 1.6 shows the same axial cross-section of the
prostate on T2w MRI acquired with and without ER coil from the same patient.

Prostate
Prostate
Rectum
Rectum

A

A
R

R

L

L
P

P

(a)

(b)

Figure 1.6: Axial view of T2w prostate MRI acquired (a) without, and (b) with ER coil.
Both images are midgland slices of the same patient
There are several different MR imaging pulse sequences available for prostate
that form multiparametric MRI; e.g. T1-weighted MRI, T2w MRI, dynamic contrast
enhanced (DCE) MRI, diffusion weighted imaging (DWI), and MR spectroscopy (MRS)
[65].
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1.5.3.2 Multiparametric MRI
T1- and T2-weighted MRI: T1- and T2-weighted MRI are both used for PCa
detection [72]. T1-weighted MRI is also used for detection of hemorrhage after prostate
biopsy [72]. The zonal anatomy of the prostate is appreciated better on T2w MRI
compared to T1-weighted MRI, and therefore usually T2w MRI is used as a main
imaging approach for anatomy description of the prostate and adjacent tissues [73-75]. In
T2w MRI of the healthy prostate, the peripheral zone appears brighter than the central
and transitional zones, which are mixed dark to semi-bright regions on the image [76]. In
T2w MRI, a hypointense area within the peripheral zone is considered to be PCa unless a
hyperintense area (i.e. usually associated with the post-biopsy hemorrhage) is observed at
the same location on T1-weighted MRI [77]. However, in some cases, PCa is challenging
to detect on T2w MRI, because PCa can occur within an isointense region or even a
hyperintense area compared to the background [70]. Sensitivity and specificity for T2w
MRI in PCa detection have been reported as 52% to 83%, and 46% to 83%, respectively
[78].
Contouring of the prostate on MRI is used for localizing the prostate border with
surrounding tissues to help clinicians deliver the treatment to the prostate gland, and more
specifically, to the PCa tumour sites while preserving healthy surrounding tissues from
harm. Due to its better anatomical definition, the contouring task is often performed on
T2w MR images. Furthermore, T2w MRI is useful in assessing the PCa extent and its
spread beyond the prostate border. Hence, prostate border localisation on this MRI
sequence could be helpful to staging.
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Dynamic contrast enhanced MRI: For acquisition of DCE MRI, an MRI contrast
agent is injected into the body and the changes in contrast agent uptake and washout by
the prostate tissue are measured through acquisition of a time series of T1-weighted MR
images. DCE MRI is useful for detecting, localising, and staging of PCa [79, 80]. It has
shown high sensitivity and specificity for early detection of PCa [79].
Diffusion weighted imaging: DWI is another type of MRI in which the mobility of
water molecules at the microscopic level is measured. DWI measures the apparent
diffusion coefficient (ADC) value that reflects the water diffusion pattern in the tissue.
The idea behind clinical DWI is that, in general, the water motion in healthy human body
tissues with intact cell microstructures is oriented and anisotropic. In a pathological
change in tissue these microstructures are destroyed, therefore, the pattern of water
diffusion in the tissue is more isotropic [81]. DWI has a short acquisition time and
usually provides high-contrast between PCa and normal tissue and is useful in PCa
diagnosis. However, because of low SNR, the spatial resolution of DWI is low [82].
MR spectroscopy: MRS is used in combination with MRI to provide more
information about tissue characteristics [83]. Similar to MRI, MRS is also based on the
nuclear magnetic resonance phenomenon. It provides information about the metabolic
activity of the prostate by measuring the quantities of some metabolites (e.g. choline,
citrates, creatine and polyamines) within the prostate gland. The metabolite quantities or
the ratio between them indicate different abnormalities of the prostate [82]. One of the
most important metabolite change in PCa is related to the level of citrate [84].
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1.5.3.3 Endorectal receiver coil
In MRI and MRS, the smaller the receiver RF coil and the closer the coil is
located to the target, the lower the noise level. Body and ER coils are two common RF
receiver coils that are used in prostate MRI to enhance the quality of MR images in terms
of spatial resolution and SNR [70]. The most common ER coil used in prostate MRI is
an inflatable ER coil that consists of a probe with a inflatable latex cover, also called a
balloon. The balloon is filled by either air, perfluorocarbon, or barium after insertion into
rectum for better positioning and coverage, and less coil motion [85]. Typically, the
inflated ER coil has a cylindrical shape with about 8.5 cm length and about 4.5 cm
diameter after inflation [7, 70].
Despite improvement in image quality via the ER coil, the ER coil complicates
some aspects of imaging. For example, the ER coil substantially displaces and deforms
the prostate [7]. On average, it compresses the prostate gland about 15%
anteroposteriorly, and expands it about 8% in the left-right direction [7]. In MRI-targeted
image-guided procedures, MRI information is often combined with another imaging
modality (such as intra-procedural TRUS). Therefore, the deformation of the prostate
shape challenges image alignment between MRI and the other imaging modality. In
EBRT, CT imaging (the standard imaging modality for dose calculation) is acquired with
no prostate gland deformation and in TRUS-guided procedures, although the endorectal
transducer is used, the shape of the transducer and the way it is located inside the rectum
is different and therefore the prostate shape is deformed in a different way [7]. Another
limitation related to the use of the ER coil is the presence of some image distortion and
artifacts such as magnetic susceptibility, coil flare, and rectum movement artifacts [86].
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Figure 1.7 shows some types of imaging artifacts that occur on ER MRI. Some
distortions, e.g. magnetic susceptibility, occur because of the air-inflated ER coil and can
be reduced by replacing air with other ER coil balloon filling materials [85].
Furthermore, since the ER coil is placed posterior to the prostate, it generates an
inhomogeneity in the received signal and, accordingly, in the image intensities [87]. In
MRI, the voxel intensities are higher close to the coil.

(a)

(b)

(c)

(d)

Figure 1.7: ER coil distortion on MRI [86]: (a) gland distortion, (b) near-field coil flare
artifact, (c) coil-related artifact because of air-inflated balloon, and (d) rectal movement
distortion.
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Although the ER coil improves image quality overall and some studies have
shown a positive impact of using ER coil on MRI-based PCa diagnosis [6, 69, 71, 88-90],
the use of the ER coil for prostate MRI is still debated because the coil is not comfortable
for the patients and generates image distortions. One study suggested that the ER coil
does not significantly improve MRI power in diagnosis of PCa [86]. Another study [91]
has shown that in terms of staging accuracy, non-ER 3.0 Tesla MRI is equivalent to ER
1.5 Tesla MRI.

1.5.4 Nuclear imaging
Some types of nuclear imaging methods such as PET are also used for prostate
imaging. PET scanning cannot provide accurate anatomical information; however, it can
detect tumours based on the metabolic functionality of the tissues. Sometimes a
combination of PET and another imaging modality such as CT (called PET/CT) is used to
generate high-resolution anatomic images fused with functional images [92]. Since the
metabolic glucose activity of PCa is low, fluorodeoxyglucose (FDG)-PET scanning is
less useful for PCa diagnosis particularly in the early stages, but is usually used in
metastasis detection [92]. There are studies that show the role of other radiotracers in
PET imaging for early detection of PCa [93].

1.6 The role of MRI in diagnosis and treatment of prostate cancer
1.6.1 MRI-targeted TRUS-guided biopsy
Due to lack of visibility of many PCa tumours on TRUS, the standard TRUSguided prostate biopsy is usually performed based on a systematic sampling approach
from different regions of the prostate gland [33]. About 35% of PCa is not detected
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during the first attempt at TRUS-guided biopsy [36]. Since MRI yields improved ability
for detecting and localizing of PCa [63-69], there are some recently developed biopsy
systems that utilize MR images to define biopsy targets, and map those targets to the realtime intra-operative TRUS images to help clinicians direct the biopsy needles to the predefined suspicious regions. It has been shown that this has increased the detection rate of
biopsy and decreased the rate of repeat biopsy [94-96].

1.6.2 MRI-CT fusion radiotherapy planning
The CT scan is very important for dose calculation in radiation therapy planning
because it provides the electron density distribution of body tissues as well as useful
anatomical information. For dose planning, it is also important to identify the boundaries
of the prostate and surrounding sensitive tissues and organs. Since the soft tissue contrast
on CT images is lower than on MRI, contouring the prostate on CT could result in lower
accuracy and higher intra- and inter-observer variability [9, 50]. It is also nearly
impossible to detect or localize prostate tumours in CT images. One way to account for
inter-observer variability in radiotherapy planning is to use an expanded safety margin
around the boundary, but this can cause undesirable irradiation of surrounding healthy
tissues. Another way is to improve the accuracy and consistency of the border delineation
using MR imaging. However, in MRI, there is not a unique correspondence between
pixel intensity and electron density. Poor imaging of bones and image distortions are the
other disadvantages of using MRI for dose planning. To address these challenges, one
approach is to use MRI-to-CT image fusion that enables using MRI-based delineated
borders on CT images for radiotherapy planning. It has been shown in the literature that
using MRI guidance for prostate EBRT planning could increase the accuracy and
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repeatability of the planning [62, 97, 98]. There are also studies on MRI-only
radiotherapy planning methods in which CT imaging has been omitted [99]. To estimate
the electron density information of the tissues, the MR image is segmented and different
values are assigned to different regions based on the characteristics of the tissues. The
MRI-only methods overcome the image registration and fusion errors. However, the
accuracy of dosimetry is affected due to lack of accurate electron density information
within the tissues.

1.6.3 MRI-guided biopsy and focal therapy
The increasing potential of MRI for diagnosis, localisation, and staging of PCa
has driven the development of diagnostic and therapeutic devices that are compatible
with the MRI magnetic field and imaging approach and can be used inside the MRI bore.
MRI-guided biopsy [75] and MRI-guided focal therapy [100] are two examples of MRIguided procedures in which MRI-compatible devices are used. In these procedures, the
traditional intra-procedure imaging modality is replaced by MRI to increase the accuracy
of the procedures by avoiding image fusion and registration errors. This comes with the
compromise of increased cost of the procedure and awkward patient positioning issues
due to the confines of the MRI bore.

1.7 Prostate contouring on MRI
Delineation of the prostate gland on MRI plays an important role in some
diagnostic and therapeutic procedures. It helps to define the anatomy of the organ and to
measure its volume. Measurement of the volume is useful for diagnosis and treatment
planning. For example, the PSA level is usually interpreted in the context of prostate
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volume [101]. Contouring of the prostate on MRI could be also helpful either in planning
and delivering an MRI-guided therapy, or in the fusion of MR images to other imaging
modalities (e.g. CT or ultrasound) for running an MRI-targeted image-guided process.
However, there are uncertainties and challenges around manual contouring of the
prostate on MRI, described below.

1.7.1 Challenges in manual prostate contouring in MRI
Accuracy and reproducibility: The prostate is a soft tissue organ that is
surrounded by other soft tissue structures such as the bladder, seminal vesicles, muscles,
NVBs, and penile bulb. It has been shown using histology that the prostate is not a fully
encapsulated gland, and the adjacent tissues in some parts are blended with the
periprostatic tissues [102]. Thus, for some portions of the prostate, there does not exist a
discrete, “true” boundary, even when viewed under the microscope. This poses
challenges to prostate boundary delineation on medical imaging, rendering manual
contouring a challenging task that is subject to relatively high intra- and inter-observer
variability [9, 103]. This variability is even higher within some parts of the prostate such
as base and apex regions [103]. This contouring variability could potentially influence the
outcomes of clinical procedures, and also could cause a lack of performance consistency
of a similar procedure between different clinical centres in multi-centre trials [1].
Therefore, any approach that helps to reduce this variability and improve the
reproducibility of the task could be helpful from clinical point of view.
Timing: Contouring time is another issue with manual contouring of the prostate
on MRI. There are several reports that report manual prostate contouring times, with the
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average contouring time for the whole prostate in 3D varying between five minutes [10]
up to approximately 20 minutes [11].

1.7.2 Computer-assisted prostate segmentation on MRI
In some clinical applications, computer-assisted contouring of the images (also
called image segmentation) can provide more accurate and reproducible results in a
shorter time. Segmentation is an image processing method in which the image usually is
divided into two non-overlapped homogeneous regions with respect to some image
characteristics such as intensity or texture [104]. One region is the region of interest
(ROI) or object and the other is the background.
There are different types of approaches available for image segmentation in
medical imaging. Segmentation algorithms work based on the features that are extracted
from the image; e.g. image intensities, textures, intensity gradients or edges [105]. Some
methods like thresholding and pixel clustering are based on pixel classificaltion and some
others could be based on edge, boundary or shape detection. Sometimes a combination of
multiple image-derived features is used to segment an image. There is also a group of
segmentation methods that segment an image based on prior knowledge about image
structure and characteristics obtained from a training image set.
Segmentation algorithms are usually designed or modified to optimize the result
for specific applications. There are several presented image segmentation algorithms
available in the literature for prostate segmentation in MRI, as described in a recent
survey [106]. These algorithms have been developed to make the image contouring either
faster, more accurate and/or more repeatable.
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1.7.2.1 User interaction
There are two types of segmentation algorithm; semi-automatic and automatic. In
semi-automatic segmentation, some operator interaction is required. Interaction allows
for incorporation of the operator’s domain knowledge into the process of the image
segmentation. Usually, operator interaction improves the accuracyof the algorithm and
makes the algorithm more robust, but it could make the algorithm laborious and timeconsuming to use. In automatic segmentation, the computer segments the image with no
operator interaction required. However, automatic segmentation algorithms usually
require parameter tuning by a user for initialization [104].
1.7.2.2 Prostate MRI segmentation challenges
As explained earlier, using the ER coil improves MR image quality from a
clinical point of view, but can render computer-assisted segmentation more challenging
due to the higher contrast within the prostate that reveals many details and edges that are
not pertinent to the prostate boundary itself. Segmentation on ER MRI is also challenged
by intensity inhomogeneity artifacts [85] and other artifacts as described in subsection
1.5.3.3. Thus, prostate segmentation on ER MRI is a substantially different problem,
compared to prostate segmentation on MRI acquired with a body coil.
1.7.2.3 Prostate ER MRI segmentation techniques
There are several techniques have been presented in the literature for
segmentation of the prostate on T2w MRI acquired with an ER coil. Martin et al. [13]
presented a semi-automatic atlas-based method using intensity information combined
with few landmarks to register an atlas to a test image. They evaluated their algorithm
within different ROIs, including the midgland, base and apex, using a distance-based
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error metric, and for the whole gland using region-based metrics. They reported some
difficulties using atlas registration for small prostates with volume less than 25 cm3 that
resulted in higher segmentation errors. Vikal et al. [14] utilized shape modeling for a
slice-by-slice 3D segmentation of the prostate on T2w MRI. Their semi-automatic
method needed one centre point for initialisation and each slice segmentation was used as
the initialisation for the segmentation of the next slice. They evaluated their method on
three T2w ER MR images acquired at 3.0 Tesla using the MAD and DSC metrics to
measure performance. Toth and Madabhushi [15] presented a semi-automatic
segmentation method using a landmark-free active appearance model. They used a level
set-based shape representation for their method. The method has been evaluated using the
MAD and DSC error metrics selectively for different ROIs. Liao et al. [16] presented a
hierarchical automatic segmentation using a multi-atlas-based method for coarse
segmentation of the target image followed by a semisupervised regularization for the
final fine segmentation. They evaluated their method on 66 T2w MR images using MAD,
DSC, and Hausdorff distance (HD) metrics for the whole gland. Cheng et al. [107]
presented an automatic atlas-based approach for T2w prostate MRI segmentation. Their
algorithm is a slice-by-slice segmentation in which first an adaptive active appearance
model is used to provide an initial coarse segmentation and then a support vector
machine-based approach is used to refine the segmentation. Their evaluated their method
using region based metrics on the whole gland.
In 2012, the Medical Image Computing and Computer Assisted Intervention
(MICCAI) conference held a prostate MR image segmentation (PROMISE12) challenge
in which 11 teams were involved. The challenge evaluated the prostate T2w algorithms
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presented by the teams and compared their performance in two parts; an online challenge
and a live challenge. The data set contained both ER and non-ER MR images. DSC,
MAD, 95% HD, and the percentage of the relative volume difference metrics were used
to evaluate the algorithms. The metrics were applied to the whole gland, as well as the
base and apex regions separately. PROMISE12 is a valuable study that measured and
compared the segmentation errors of different state-of-the-art methods using the same
data set to test and a single reference to evaluate [108].
Alvarez et al. [109] presented an automatic segmentation method for T2w
prostate and tested their algorithm on 50 images from the PROMISE12 data set,
including 24 ER MR images. In their method, for each test image a subset of similar
training images are selected using a multi-scale analysis, and then the segmentation labels
from the training images are registered to the test image and locally combined using a
patch-based approach. Their results were sensitive to the number of atlases used and the
size of the patches. They used the DSC measured on the whole gland to evaluate their
method against a manual reference segmentation. Table 1.3 provides a high-level
comparison of all of these approaches.
Table 1.3 gives a brief overview on all the mentioned segmentation methods.
Although there are several segmentation algorithms available in the literature for which
the segmentation accuracy is asymptotically approaching the observed range of
differences between experts in manual segmentation, there remain some important
limitations. For example, for some of the techniques the complexity of the algorithms is
high. This complexity resulted in longer computational time ([15, 16]) compared to the
methods with less complexity, but did not make a meaningful difference in segmentation
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accuracy. Furthermore, some methods are not readily amenable to speed-up through
parallel computing implementation.

1.7.3 Validation challenges
1.7.3.1 Lack of gold standard
The high inter-observer variability in manual contouring of the prostate MRI
challenges the preparation a single gold-standard reference segmentation for each image.
The absence of a reference to define the true extent of an object makes it difficult to
validate the absolute accuracy of the contouring results [1]. The use of a single observer’s
manual contours as a reference standard thus complicates the interpretation of the results.
Where different observers’ reference standard segmentations were used in different
studies, this poses a challenge to comparing different algorithms since differing results
could be attributed to inter-observer variability in manual contouring rather than in true
differences between algorithm performance. Combining a set of different contours from a
group of experts as a consensus of opinion to make one reference standard is an approach
to mitigate this issue and simplify validation. Simultaneous truth and performance level
estimation (STAPLE) [110] is one of the most common approaches for combining a set
of segmentation using a weighted voting scheme.
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Table 1.3: A survey of prostate MRI segmentation algorithms.
Authors

Techniques

Field
ER
strength
coil
(Tesla)

Martin et al. [13]

Atlas-based

X

Vikal et al. [14]

Shape modeling
(slice-by-slice)

Toth and
Madabhushi [15]

Landmark-free
active appearance
model

3.0

yes

Liao et al. [16]

Multi-atlas-based

X

Cheng et al. [107]

Atlas-based

Alvarez et al. [109] Atlas-based

3.0

Validation
regions
WG, A, MG, B

MAD

WG

Recall,
Precision

yes

yes

Validation
metrics

Data set
size

Number
of
references

18

one

3

one based
on two
experts’s
agreement

108

one for 108
images and
two for a
subset of
17 images

A, MG, B

MAD, DSC

WG, A, MG, B

DSC

WG

MAD, DSC

X

WG

MAD, DSC,
HD

66 (test)
9 (atlas)

one

3.0

X

WG

TP, FN, FP,
DSC, ΔV%

100
(training)
40 (test)

one

X

24 out
of 50

WG

DSC

50

one

WG: whole gland, A: apex, MG: mid-gland, B: base

1.7.3.2 Lack of a standard validation methodology
Despite the lack of a straightforward gold standard, computer-assisted
segmentation algorithms require validation to support clinical translation. This evaluation
needs (1) a set of error metrics that are sensitive to different, clinically relevant types of
contouring errors and (2) a method for evaluation of the contouring in different anatomic
regions of interest within the prostate. The validation approach must take inter-observer
variability in manual reference contours into account. To the best of our knowledge, there
is no accepted standard set of error metrics use for evaluation of prostate contouring on
medical imaging. Currently, most research groups have used one or two error metrics,
and these choices have not generally been connected to any specific clinical procedures
[1]. There are several classes of error metrics that have been used. In one class of metrics,
the distances between corresponding points on the automatic and reference segmentations
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are calculated and aggregated (e.g. the MAD). In another class of metrics, the overlap
region of two shapes or volumes is measured in various ways (e.g. the DSC). However,
each metric is able to detect one or few types of errors but not all different types of errors;
e.g. local surface misalignment, partial regional overlap, and volume difference.
Therefore, comprehensive segmentation algorithm evaluation requires a set of
complementary error metrics that covers the range of errors types that are relevant to
clinical procedures of interest.
Furthermore, since the contouring is generally more challenging to perform (for
both manual and automatic methods) at the inferior (apex) and superior (base) ends of the
prostate, as compared to the midgland region, reporting the overall segmentation error for
the whole prostate gland does not provide enough information about the local accuracy of
the segmentation method under evaluation. Large errors in the base and apex can be
compensated by small errors in the midgland, with an apparently favourable overall error
reported that is discordant with large errors in the apex and base. Measuring segmentation
errors separately within these different anatomic regions mitigates this issue. This helps
the clinician to evaluate the readiness of an algorithm for clinical translation.

1.8 Hypothesis
The central hypothesis of this thesis is as follows: computer-assisted 3D prostate
segmentation on T2w ER MRI will (1) decrease the time required for an expert physician
to achieve a clinically acceptable segmentation, and (2) reduce inter-observer variability
in segmentation, as compared to manual segmentation.
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1.9 Objectives
To test the central hypothesis, the three major objectives of this thesis are:
I.

(Chapter 2) To develop a semi-automatic prostate segmentation

algorithm for T2w prostate ER MRI, and evaluate it against multi-observer manual
reference standard segmentations.
II.

(Chapter 3) To develop and evaluate a fully automated prostate

segmentation algorithm for T2w prostate ER MRI, and evaluate it against multi-observer
manual reference standard segmentation.
III.

(Chapter 4) To measure the inter-observer variability and total

segmentation time resulting from the use of the semi-automatic (Objective I) and
automatic (Objective II) segmentation methods, followed by expert manual editing to
yield clinically acceptable segmentations.

1.10 Thesis outline
1.10.1 Chapter 2 - Spatially varying accuracy and reproducibility of prostate
segmentation in magnetic resonance images using manual and semiautomated methods
The purpose of this work was to develop an approach for evaluation of a semiautomatic prostate segmentation algorithm for T2w MRI acquired with an ER coil and
compare it to manual segmentation in terms of accuracy and repeatability within the
whole gland, and separately within the apex, mid-gland, and base regions. We collected
MR images from 42 prostate cancer patients. The prostate border was delineated
manually by one observer on all images and by two other observers on a subset of 10
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images. We used complementary boundary-, region-, and volume-based metrics to
elucidate the different types of segmentation errors that we observed. Compared to
manual segmentation, our semi-automatic approach reduced the necessary user
interaction by only requiring an indication of the anteroposterior orientation of the
prostate and the selection of prostate center points on the apex, base, and midgland slices.
Based on these inputs, the algorithm identified the prostate boundary using learned
boundary appearance characteristics and performed regularization based on learned
prostate shape information.
In contrast with the active appearance model, our segmentation algorithm was
based on local appearance characteristics. Furthermore, our algorithm optimized the
segmentation first based on the appearance features and then further optimized based on
shape features, rendering it more amenable to parallel computing implementation.
The algorithm required an average of 30 seconds of user interaction time for each
3D segmentation. Comparing the semi-automatic segmentations against a single-operator
manual segmentation, the results of this chapter showed a MAD of 2.0 mm, DSC of 82%,
recall of 77%, precision of 88%, and ΔV of = −4.6 cm3 for the whole gland on average.
We found that overall, midgland segmentation was more accurate and repeatable than the
segmentation of the apex and base, with the base posing the greatest challenge. The semiautomatic approach reduced interobserver segmentation variability. Its accuracy, as well
as the accuracies of recently published methods from other groups, were within the range
of observed expert variability in manual segmentation. Further efforts in the development
of computer-assisted segmentation would be most productive if focused on improvement
of segmentation accuracy and reduction of variability within the prostatic apex and base.
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1.10.2 Chapter 3 - Accuracy and acceptability of an automated method for
prostate segmentation in magnetic resonance imaging
In this chapter, we developed a fully automatic segmentation algorithm and
evaluated its accuracy within different regions of interest (i.e. whole gland, apex,
midgland, and base regions) using a complementary set of error metrics. We compared it
to the semi-automatic approach (Chapter 2) and the inter-observer variability in manual
segmentation. We used the same data set used in Chapter 2. In our automatic approach,
we coarsely localized the prostate in the image using the prior measured dimensions of
the gland that are readily available from the clinical TRUS examination before MRI
acquisition. This localization is used to define the search space and to initialize the
segmentation algorithm. Consequently, no user interaction is required for running the
algorithm.
We evaluated the algorithm using a set of region- bouandary- and volume-based
metrics; i.e., MAD, DSC, recall, precision and ΔV. We compared the accuracy of the
automatic segmentation approach to the semi-automatic approach. We also compared the
accuracy of both computer-assisted approaches to the range of inter-observer variation in
manual segmentation.
The automatic algorithm needed less than a minute to segment the prostate in 3D.
Comparing the segmentation results to single-observer manual segmentation, for the
whole gland we measured a MAD of 3.2 mm, DSC of 71%, recall of 69%, precision of
76%, and ΔV of -3.6 cm3. In a multi-observer study, we measured a MAD of 3 mm, DSC
of 72%, recall of 74%, precision of 74%, and ΔV of -0.3 cm3, whereas the difference
between two observers’ manual segmentations were as high as MAD of 2.8 mm, DSC of
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74%, recall of 87%, precision of 60%, and |ΔV| of 18.3 cm3. The results of the
comparison of semi-automatic and automatic segmentation algorithm performance were
mixed. Overall, the previously presented semi-automatic approach outperformed the
automatic approach in terms of most of the metrics within some of prostatic regions.
However, there were some metrics such as recall and ΔV that revealed superior
performance from the automatic approach on some prostatic regions, compared to semiautomatic segmentation.
The results of this chapter show that (1) concordant with results from other
published algorithms, accuracy was highest in the mid-gland and lower in the apex and
base regions of the prostate, (2) the fully automatic approach requires no user interaction
and needs 3 seconds of computation time, (3) the differences between the automatic and
semi-automatic segmentation error metrics were consistently smaller than the differences
observed between manual contours performed by expert observers, (4) The segmentation
error metric values were near to or within the range of expert manual segmentation
variability for most of the metrics at most of the prostatic regions.

1.10.3 Chapter 4 - Impact of physician editing on repeatability and time for
manual and computer-assisted prostate segmentation on magnetic resonance
imaging
Segmentation of the prostate gland on T2w MRI is an important part of several
diagnostic and therapeutic procedures for PCa. Since manual segmentation is timeconsuming and subject to high inter-expert operator variability, it has been widely
recognized that these clinical procedures could benefit from a rapid and repeatable
computer-assisted prostate segmentation technique. Many such algorithms have been
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proposed in the literature [13-16, 107, 109], usually evaluated against manual reference
segmentations performed by a single operator, with reported error metric values for
recently published methods asymptotically approaching inter-operator variability in
manual segmentation. Despite the tremendous volume of work performed in this area, the
translation of computer-assisted segmentation algorithms to clinical care is rare, and
manual segmentation is still routinely performed in clinic. As a step toward addressing
this issue, in this chapter we focused on measuring the suitability of computer-assisted
segmentation algorithms for clinical translation, based on measurements of inter-operator
segmentation variability (which contributes to consistency of patient care) and
measurements of the segmentation editing time required to yield clinically acceptable
segmentations (which contributes to physician affinity to uptake of new segmentation
tools, and patient throughput). We performed a pilot study with five expert operators
under three pre- and post-editing conditions: manual segmentation, semi-automatic
segmentation, and fully automatic segmentation. As expected, the results of this chapter
showed that the amount of editing performed by the operators was directly related to the
amount of automation involved in producing the starting segmentations. The provision of
a starting segmentation using computer-assisted techniques reduced editing time and
post-editing inter-operator variability, compared to manual segmentation. The amount of
editing time was not correlated with the values of typically used segmentation error
metrics such as the MAD between boundaries or the DSC, implying that the necessary
post-segmentation editing time needs to be measured directly for multiple operators in
order to evaluate an algorithm’s suitability for clinical translation.
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Chapter 5 will conclude with a summary of the advances in knowledge stemming
from this thesis work. This chapter also discusses the practical applications of this work
and potential directions for future research.
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Chapter 2.
Spatially varying accuracy and reproducibility of
prostate segmentation in magnetic resonance images
using manual and semi-automated methods †

2.1 Introduction
PCa is the most common non-cutaneous cancer and was the second leading cause
of cancer death among North American men in 2012 [1]. Three-dimensional (3D)
prostate segmentation in medical images is useful to the planning of diagnosis and
therapy procedures [2, 3]. Recent developments in magnetic resonance imaging (MRI)
have demonstrated its usefulness for PCa detection and staging[4-6] with T2 weighted
(T2w) MRI most commonly used for prostate boundary delineation due to its superior
anatomic visualization [6]. Endorectal (ER) coil imaging provides improved image
quality[4, 5, 7], but this coil induces substantial tissue deformation [8, 9] and the resulting
higher contrast images contain more details and edges, presenting an increased challenge
to segmentation algorithms designed for use on non-ER coil imaging. Manual
segmentation of the prostate on MRI is a time-consuming task and is subject to

†A version of this chapter has been published: M. Shahedi, D. W. Cool, C. Romagnoli, G. S. Bauman, M.
Bastian-Jordan, E. Gibson, G. Rodrigues, B. Ahmad, M. Lock, A. Fenster, A. D. Ward, “Spatially varying
accuracy and reproducibility of prostate segmentation in magnetic resonance images using manual and
semiautomated methods.” Medical Physics 41:11 (2014).
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substantial inter-observer variation [10], motivating the need for a fast and reproducible
segmentation algorithm for 3D segmentation of the prostate on T2W ER MRI.
Several methods have been published in the literature for 3D segmentation of the
prostate on T2W ER MRI. Martin et al. [11] presented a semi-automatic method based on
the registration of an atlas to a test image using a combination of intensity-based and
landmark-based methods, and evaluated it within different regions of interest including
mid-gland, base and apex using a distance-based metric. They also used region-based
evaluation for the whole gland. Vikal et al. [12] presented a semi-automatic slice-by-slice
3D method using a shape model, evaluated on 3 images using the mean absolute distance
(MAD) and Dice similarity coefficient [13] (DSC). Toth et al. [14] used a semi-automatic
multi-feature landmark-free active appearance model, and selectively used the MAD and
DSC for evaluation of different anatomic regions. Liao et al. [15] presented an automatic
multi-atlas-based segmentation method followed by a semi-supervised regularization.
They evaluated their method using DSC, MAD and Hausdorff distance metrics on the
whole gland. In 2012, a prostate MR image segmentation (PROMISE12) challenge was
held as part of the Medical Image Computing and Computer Assisted Intervention
(MICCAI) conference and involved 11 teams. This challenge compared the performance
of the teams’ submitted prostate T2W MRI segmentation algorithms. It consisted of two
main parts: an online challenge and a live challenge. The image data set in the challenge
contained both ER and non-ER MR images, some acquired at 1.5 Tesla and some at 3.0
Tesla magnetic field strengths. Four experts each manually segmented 25 images out of
100 (i.e. each image was segmented by one expert and not more than one expert
segmented each image). Next, an additional expert reviewed all the manual
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segmentations and edited them for consistency as deemed necessary, yielding a single
manual reference segmentation for accuracy measurement in each of the 100 cases (a
second manual segmentation by an inexperienced non-clinical observer with two years’
experience in prostate MRI research was used for a ranking score calculation based on
the error metrics, but was not used in any inter-operator variability measurements). The
algorithms’ segmentations were compared with the manual reference using DSC, MAD,
95% Hausdorff distance, and the percentage of the relative volume difference as the
metrics. These metrics were reported on the whole gland, as well as the base and apex
regions separately. The results of the live challenge on 20 images showed a range of 2.0
mm to 4.2 mm for MAD, 65% to 89% for DSC, and 1.5% to 43.1% for absolute relative
volume difference on whole gland [16].
The PROMISE study measured the performance of different segmentation
methods on the same set of images with the same manual reference. By holding the
images and reference segmentations constant and measuring the performance of different
algorithms, this study provided highly valuable measurements of variability in
segmentation errors arising from the use of different state-of-the-art algorithms. By
contrast, our study holds the algorithm constant (i.e. we tested a single algorithm) and
used a reference standard based on multiple operators, addressing the question of the
accuracy and variability of a segmentation algorithm’s results compared to inter-operator
variability in the manual segmentation, such as one could observe in routine clinical
practice. Thus, our study and the PROMISE study achieved complementary aims; in the
future, a grand challenge-style study comparing different segmentation algorithms against
a multiple-operator reference standard would be highly valuable.
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In all of the reviewed published studies, the segmentation results were evaluated
by comparison to a single-observer reference, with the inter-operator variability in
manual segmentation and its effect on accuracy measurement not measured or taken into
account in interpreting the segmentation results. In these studies, the accuracy was
usually measured using one or at most two types of error metrics and none used a
complementary set of error metrics capturing different types of errors such as
surface/boundary misalignments, regional overlap errors, and volume differences. The
use of a complementary set of error metrics is supportive of a comprehensive
segmentation accuracy measurement, permitting the end user to focus on the metrics
capturing performance aspects of importance to the user’s intended application of the
technique. In addition, several previous studies report on segmentation accuracy only for
the prostate gland as a whole, without reporting on spatial variations in the error through
gland sub regions such as the apex, mid-gland and base. It is well-known that for both
human experts and contemporary algorithms, mid-gland segmentation is usually
performed with lower error and variability compared to segmentation of the apex and
base, which are considered to be more challenging tasks. Thus, reporting of segmentation
error on a whole-gland basis alone challenges the interpretation of the segmentation
results in the interventional context, where accurate apex and base segmentations are
critical to sparing harm to surrounding critical structures.
To address the need for a 3D method, fully evaluated using a comprehensive set
of metrics, we present here an interactive algorithm for 3D prostate segmentation on
T2W ER MRI, based on learned local appearance of the prostate border and learned
variability of prostate shape. We used a set of complementary boundary-based, overlap-
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based, and volume-based metrics to evaluate the segmentation over the whole gland and
separately within each anatomic region of interest (prostate apex, mid-gland, and base).
The method has two main steps, training and segmentation. During training, we captured
the local image appearance of the prostate at the boundary on cross-sections from
superior to inferior by computing a set of circular mean intensity image patches on each
slice. The prostate shape variability on each axial slice was measured using a point
distribution model (PDM) [17]. The segmentation algorithm requires minimal user input
to initialize a radial-based search for candidate boundary points that are regularized using
the PDM to produce the final result. The algorithm segmentations were validated against
manual segmentations using complementary boundary-based (MAD), regional overlap
(DSC, recall rate, and precision rate) and volume difference (ΔV) metrics, and interoperator variability was measured.

2.2 Materials and Methods
2.2.1 Materials
We used 42 axial T2W fast spin echo ER MR images acquired as follows: 23
images with TR = 4000–13000 msec, TE = 156–164 msec, NEX = 2 and 19 images with
TR = 3500–7320 msec, TE = 102–116 msec, NEX = 1–2. Some images were acquired at
1.5 Tesla (9 images) and some at 3.0 Tesla (33 images), with voxel sizes from
0.27×0.27×2.2 mm to 0.44×0.44×6 mm (covering a range of voxel sizes typically seen in
clinical prostate MRI). The images were acquired using four different scanners: Signa
Excite, Discovery MR 750 (General Electric Healthcare, Waukesha, WI, USA),
MAGNETOM Avanto, and MAGNETOM Verio (Siemens Medical Solutions, Malvern,
PA, USA). All of the images were acquired from patients diagnosed with PCa based on
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needle biopsy. The study was approved by the research ethics board of our institution,
and written informed consent was obtained from all patients prior to enrolment. Each of
the 42 images was segmented manually by one observer, with the segmentation
subsequently reviewed and adjusted as deemed necessary by an expert radiology resident
with experience in reading >100 prostate MRI cases. The initial manual segmentations
were performed either by a radiologist or by a graduate student under the advisement of a
radiologist. For inter-operator comparison, two additional observers (a radiologist and a
radiation oncologist) each performed manual segmentations on a subset of 10 images to
provide a total of three independent manual segmentations per patient. To select this
subset of 10 images, we qualitatively assigned easy-, moderate- and difficult-to-segment
labels to a set of images acquired at our institution, and randomly selected 10 images
from all three categories. The prostate volumes were calculated based on the available
manual segmentations for the whole image set and ranged from 15 cm3 to 89 cm3 with
mean ± standard deviation (SD) of 35±14 cm3.

2.2.2 Semi-automated segmentation
Our algorithm consists of two main parts: training and segmentation. Figure 2.1
shows the algorithm’s block diagram, illustrating the training and segmentation
components, described in detail in sections 2.2.2.1 and 2.2.2.2 below.
2.2.2.1 Training
2.2.2.1.1 Spatial normalization. As a spatial normalization step, we parameterized the
slice locations in the training images according to slices identified by the operator at
specific anatomic locations. Our inferior-superior parameterization was from 0 (apex) to
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1 (base) and was used to define inter-subject axial slice correspondence. Therefore, for
each (𝑥, 𝑦, 𝑧) point in the MR Cartesian space, we have an (𝑥, 𝑦, 𝑧̂ ) point in the
normalized coordinate system, where 𝑧̂ is a real unitless value in the range of [0,1]. We
map 𝑧̂ values to corresponding slice numbers in the MR space by using a nearest
neighbor inter-slice interpolation. We also chose the smallest physical pixel size along xand y-axes (0.273 mm × 0.273 mm) in the data set as the reference pixel size and
resampled all the training images with different pixel sizes to that reference pixel size,
using bicubic interpolation.
Training
Local appearance
model
computation

…

Point distribution
model
computation

Training image Set

Local appearance

Pre-processing

Prostate shape
variability

Border
delineation
(Figure 2.3)

2D border
correction

3D regularization

Segmented image

Test image

Segmentation

Figure 2.1: Algorithm block diagram. The training images are manually delineated. The
candidate boundary points are shown on the test image after “border delineation” step.
The final segmentation result is shown on the test image after the “3D regularization”
step.
2.2.2.1.2 Prostate border landmark selection. For each training image slice, we manually
defined 4 corresponding landmark points on the prostate border: the anterior-most point,
the opposite posterior point on the rectal wall, and two points approximately the
midpoints of the portions of the prostate boundary touching the neurovascular bundles
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(NVBs); see Figure 2.2. We used equal angle interpolation between each neighboring
landmark pair, using the mid-point of the line segment defined by anterior and posterior
landmarks as the central point, to define 32 additional landmarks, for a total of 36. For a
slice with a parameterized axial position of 𝑧̂ , the 𝑖 th landmark is 𝒍𝑖,𝑧̂ = (𝑥𝑖,𝑧̂ , 𝑦𝑖,𝑧̂ , 𝑧̂ ) and
𝑖 ∈ {1,2, … ,36}. 𝑥𝑖,𝑧̂ and 𝑦𝑖,𝑧̂ are the x- and y-coordinates of the 𝑖 th landmark on the slice.
We observed that in general, the anterior and NVB landmarks are separated by ~120
degrees, and the NVB and posterior landmarks are separated by ~60 degrees. We
therefore interpolated ~2/3 of the 32 additional landmarks between the NVB and anterior
landmarks (11 interpolated landmarks on the left and right), and ~1/3 of the 32 additional
landmarks between the NVB and posterior landmarks (5 interpolated landmarks on the
left and right), as shown in Figure 2.2.
2.2.2.1.3 Image patch. A circular image patch 𝒑(𝑚), centered at (𝑥𝜙 , 𝑦𝜙 , 𝑧̂ ) on the slice
at axial position 𝑧̂ , is defined as a vector of 𝑀 consistently ordered image intensities
𝒑 = Φ(𝑥𝜙 , 𝑦𝜙 , 𝑧̂ ) = {𝐼(𝑥, 𝑦, 𝑧̂ )|𝐷((𝑥, 𝑦, 𝑧̂ ), (𝑥𝜙 , 𝑦𝜙 , 𝑧̂ )) ≤ 𝑟𝜙 },

(2.1)

where 𝑟𝜙 is the patch radius, and 𝐷 is the Euclidean distance function.
2.2.2.1.4 Training image patches. We defined a circular image patch 𝒑𝑖,𝑧̂ = Φ(𝒍𝑖,𝑧̂ ) =
Φ(𝑥𝑖,𝑧̂ , 𝑦𝑖,𝑧̂ , 𝑧̂ ), centered on 𝑖 th landmark of the 36 landmarks (𝒍𝑖,𝑧̂ ) in the training images.
The intensity-normalized patch corresponding to the 𝑖 th landmark on the 𝑘th training
image (𝐼 𝑘 ) is defined as
̂𝑘𝑖,𝑧̂ =
𝒑

𝒑𝑖,𝑧̂ − 𝝁𝝓
,
𝜎𝜙
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(2.2)

where 𝜇𝜙 and 𝜎𝜙 are the mean and standard deviation of 𝒑𝑖,𝑧̂ , respectively. For each set
of corresponding slices in the training set, we calculated the mean intensity of each
corresponding set of patch pixels, yielding a set of 36 mean intensity patches. The mean
intensity patch corresponding to the 𝑖 th landmark at slice position 𝑧̂ across the 𝑁 training
images is defined as
𝑁

̅ 𝑖,𝑧̂
𝒑

1
̂𝑘𝑖,𝑧̂ .
= ∑𝒑
𝑁

(2.3)

𝑘=1

~120°

~120°

~60°

~60°

Figure 2.2: Training. determination of 36 prostate border landmarks. The four white dots
are user-selected landmarks, the gray dots are interpolated landmarks, and the white cross
is the origin.
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2.2.2.1.5 Point distribution model. For each set of corresponding slices at slice position 𝑧̂ ,
we also used the 36 landmarks to compute a PDM capturing prostate shape variability at
each inferior-superior anatomic position. We used generalized Procrustes analysis[18] to
align (translating, rotating and scaling) all the segmentations by minimizing the least
squares error between the points. Principal component analysis was then used to compute
the eigenvectors and eigenvalues of the covariance matrix for all of the training landmark
coordinates[17].
2.2.2.2 Segmentation
The segmentation algorithm incorporates a small set of inputs from the operator to
define the inferior-superior extents of the prostate, as well as its center and orientation.
These inputs are: (1) the apex-most and base-most slice numbers (𝑧); (2) the points at the
center of the prostate on the apex- and base-most slices, and on the slice within the midgland equidistant to these two slices; and (3) the anteroposterior (AP) orientation of the
prostate as seen on this mid-gland slice. We developed a customized graphical user
interface to efficiently collect these operator inputs.
Using these operator inputs, we parameterized the axial slice positions of the test
image as in training, permitting the extraction of the corresponding mean intensity
patches and PDM corresponding to each axial slice from the training stage. The center
points for all prostate slices were estimated by interpolating the three operator-provided
center points on the base, mid-gland and apex slices. Therefore, a center point
(𝑥𝐶 (𝑧̂ ), 𝑦𝐶 (𝑧̂ ), 𝑧̂ ) was available for each slice at position 𝑧̂ . We approximated the
orientation of the prostate in all axial slices from base to apex using the mid-gland AP
symmetry axis (APSA). The segmentation was performed on each prostate axial slice
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within the image volume, resulting in a 3D segmentation of the prostate from the base,
through the mid-gland, to the apex.
2.2.2.2.1 Preprocessing. Before delineating the prostate border, first we applied a median
filter (using a 5 × 5 pixel sliding window) as an edge-preserving low-pass filter to each
axial slice, in order to reduce image noise.
2.2.2.2.2 Appearance-based boundary point selection. For each axial slice 𝑧̂ in the 3D
volume, we used the prostatic center point (𝑥𝐶 (𝑧̂ ), 𝑦𝐶 (𝑧̂ ), 𝑧̂ ) and the APSA to define 36
rays emanating from the center point, intended to be homologous to the orientations of
the training landmarks. We used a radial search strategy to choose a set of 36 candidate
points for the prostate border on each slice. As the search space was small, we used an
exhaustive search to maximize the normalized cross correlation (NCC) of each mean
intensity patch with the image region under the patch along the corresponding ray (Figure
2.3), i.e.:
̅𝑖,𝑧̂ , Φ(𝑥, 𝑦, 𝑧̂ )] ,
(𝑥̇ 𝑖,𝑧̂ , 𝑦̇ 𝑖,𝑧̂ ) = arg max 𝑁𝐶𝐶[𝒑
(𝑥,𝑦)

(𝑥, 𝑦) ∈ {(𝑥, 𝑦)|(𝑥, 𝑦, 𝑧̂ ) ∈ 𝑅𝑖 , 𝑟𝑚𝑖𝑛 < 𝐷[(𝑥, 𝑦, 𝑧̂ ), (𝑥𝐶 (𝑧̂ ), 𝑦𝐶 (𝑧̂ ), 𝑧̂ )] < 𝑟𝑚𝑎𝑥 } ,

(2.4)
(2.5)

where (𝑥̇ 𝑖,𝑧̂ , 𝑦̇ 𝑖,𝑧̂ ) is the optimal point with the highest NCC along 𝑖 th ray (𝑅𝑖 ), 𝑟𝑚𝑖𝑛 and
𝑟𝑚𝑎𝑥 indicate the search start point and stop point on each ray, respectively, and
𝑀

𝒑1 (𝑚) − 𝜇ϕ1 𝒑2 (𝑚) − 𝜇ϕ2
1
𝑁𝐶𝐶(𝒑1 , 𝒑2 ) = ∑
×
,
𝑀
𝜎ϕ1
𝜎ϕ2
𝑚=1

(2.6)

where 𝑀 is the number of pixels in patches 𝒑1 and 𝒑2 , and 𝜇ϕ1 and 𝜇ϕ2 are mean voxel
intensities, and 𝜎ϕ1 and 𝜎ϕ1 are the standard deviations of pixel intensities of patches 𝒑1
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and 𝒑2 , respectively. This process yielded 36 candidate border points on each slice, with
one on each ray.
2.2.2.2.3 Shape-based boundary regularization [two-dimensional (2D)]. We aligned the
mean shape in the PDM to each set of 36 candidate points using Procrustes analysis and
extracted the parameters from the model that represented the shape of the candidate
points. Then we calculated the parameters of the nearest shape in the PDM to the 36
candidate points by restriction of each extracted parameter in the model to the range of
[−1.5𝜆, 1.5𝜆] where 𝜆 is the corresponding eigenvalue. We defined those points with
absolute distances greater than 1.5 standard deviation to the nearest shape in the model as
outlier boundary points, and corrected them by replacing them with the corresponding
points of the model shape. This procedure was iterated until all outliers were eliminated
or a specified maximum number of iterations was reached. This resulted in a set of shaperegularized boundary points, yielding a plausible prostate shape.
2.2.2.2.4 3D regularization. After applying two-dimensional (2D) shape regularization to
all of the prostate slices, for ray i, a second order curve was fitted to all the boundary
points from base to apex in order to regularize the prostate shape in 3D. By interpolating
the points with a spline from apex to base, we obtained a smooth, continuous 3D
segmentation of the prostate.
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Figure 2.3: Segmentation. 36 rays and patch translation along one ray (the dotted manual
segmentation is overlaid for reference but is not provided to the segmentation algorithm).

2.2.3 Validation metrics
We evaluated our method against manual segmentations with complementary
boundary-based (MAD), regional overlap (DSC, recall and precision) and volume
difference (ΔV) metrics. The metrics are explained later in this section. To develop a
reference against which to compare the metrics resulting from our segmentation
algorithm, we measured the inter-operator variability in expert manual prostate border
delineation on a subset of 10 of our 42 3D images. Each of these images was manually
segmented in 3D by three observers: one radiologist, one radiation oncologist, and one
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radiology resident, all specializing in prostate MRI. We calculated the metrics (1) in 2D
for each slice, (2) in 3D for the whole gland, (3) in 3D for the superior-most third of the
prostate (corresponding approximately to the base), (4) in 3D for the middle third (midgland), and (5) in 3D for the inferior-most third (apex). In cases where the operator’s
selected apex and base slices differed from those of the reference segmentation, we
calculated the 2D metrics on the slices that were common to both segmentations. To
apply our 3D metrics to the defined base, mid-gland and apex regions, the middle third of
the slices common to both the operator’s and the reference segmentations were defined as
the mid-gland region, and the remaining inferior and superior parts were considered to be
the apex-most and base-most components, respectively. The operator interaction time
was measured as well as inter-operator time and accuracy differences.
2.2.3.1 Mean absolute distance
The mean absolute distance (MAD) is a metric that measures the disagreement
between two curves (in 2D) or surfaces (in 3D) as an aggregate of Euclidean distances
between corresponding sets of points on these surfaces. We defined two modes for
computing the MAD: unilateral and bilateral. In unilateral MAD, one surface is the
reference surface and points are corresponded by finding the closest point on the
reference surface to each point on the other surface. The MAD is then the average of the
distances between corresponding points, defined as
𝑀𝐴𝐷(𝑋, 𝑌) =

1
∑ min 𝐷(𝑝, 𝑞) ,
𝑞∈𝑌
𝐾
𝑝∈𝑋

(2.7)

where X and Y are the point sets (Y is the reference set), K is the number of points of X,
𝑝 = (𝑥𝑝 , 𝑦𝑝 , 𝑧𝑝 ) is a point in X and 𝑞 = (𝑥𝑞 , 𝑦𝑞 , 𝑧𝑞 ) is a point in Y, and 𝐷(𝑝, 𝑞) is the 3D
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Euclidean distance between p and q. The bilateral MAD is defined as the mean of two
unilateral MADs, calculated with each of the two surfaces as the reference. We reported
𝑀𝐴𝐷 in mm, with 𝑀𝐴𝐷 = 0 mm indicative of perfect alignment between shapes, and
larger 𝑀𝐴𝐷 values indicating increasing levels of shape disagreement.
2.2.3.2 Dice similarity coefficient
The Dice similarity coefficient (DSC) [13] measures the misalignment between
two shapes in terms of their overlap region. The DSC of two 3D shapes is
𝐷𝑆𝐶(𝑋, 𝑌) =

2(𝑋 ∩ 𝑌)
2𝑇𝑃
=
,
𝑋+𝑌
𝐹𝑃 + 2𝑇𝑃 + 𝐹𝑁

(2.8)

where TP is the true positive (correctly identified) region, and FN is the false negative
(incorrectly ignored) region. We reported 𝐷𝑆𝐶 as a percentage. A 𝐷𝑆𝐶 value of 100%
indicates perfect alignment, and a 𝐷𝑆𝐶 value of 0% indicates no overlap of the two
shapes.
2.2.3.3 Recall rate
The recall rate, or sensitivity, is the proportion of the reference, which is
identified correctly, defined as
𝑅𝑒𝑐𝑎𝑙𝑙(𝑋, 𝑌) =

𝑇𝑃
.
𝑇𝑃 + 𝐹𝑁

(2.9)

In this chapter, 𝑅𝑒𝑐𝑎𝑙𝑙 is the proportion of the reference prostate segmentation that is
within the segmentation provided by the algorithm and is reported as a percentage. An
ideal 𝑅𝑒𝑐𝑎𝑙𝑙 value of 100% indicates that the segmentation provided by the algorithm
covers the entire reference segmentation, plus potentially some additional regions outside
of the reference segmentation.
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2.2.3.4 Precision rate
The precision rate is the proportion of the segmentation which is true positive, and
is defined as
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛(𝑋, 𝑌) =

𝑇𝑃
.
𝑇𝑃 + 𝐹𝑃

(2.10)

where FP is the false positive (incorrectly identified) region. In this chapter, 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 is
the proportion of the segmentation provided by the algorithm that is within the reference
prostate segmentation. An ideal 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 value of 100% indicates that the segmentation
provided by the algorithm lies entirely within the reference segmentation, but may or may
not completely overlap the reference segmentation. An ideal segmentation algorithm
would yield 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 of 100% and 𝑅𝑒𝑐𝑎𝑙𝑙 of 100%. Computing and interpreting these
metrics both separately and together provides a means for understanding both the
magnitude and the meaning of the types of regional overlap errors made by a
segmentation algorithm, complementing the information provided by 𝐷𝑆𝐶.
2.2.3.5 Volume difference (ΔV)
The signed volume difference (ΔV) is the subtraction of the volume of the
reference segmentation from the volume given by the segmentation algorithm:
∆𝑉 = 𝑉𝑎𝑙𝑔𝑜𝑟𝑖𝑡ℎ𝑚 − 𝑉𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 ,

(2.11)

where 𝑉𝑎𝑙𝑔𝑜𝑟𝑖𝑡ℎ𝑚 is the volume of segmentation result, and 𝑉𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 is the volume of
the prostate in the manual segmentation. ΔV is a signed metric and was reported in cm3 in
this chapter. A negative value of ΔV indicates under-segmentation and a positive value
indicates over-segmentation in terms of the volume of the prostate.
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2.3 Experiments
For all of the experiments in this chapter, we used a single value for the patch
radius 𝑟𝜙 , chosen by systematic search. We selected a representative subset of 6 images
from the data set. We applied our algorithm using patch radii in the range of 3 𝑚𝑚 ≤
𝑟𝜙 ≤ 17 𝑚𝑚, using leave-one-out cross-validation to define training and test images. For
each image, we measured the MAD, DSC, ΔV, as well as the average of recall and
precision values (as one metric) for each patch radius. Then, we calculated the average of
the four metrics across the 6 images, yielding four mean values, one for each metric. We
ranked the radii based on each metric, resulting in 4 rankings; thus, each radius had four
rank values. We calculated the average of the 4 rank values for each radius and chose the
radius (𝑟𝜙 = 5) having the lowest average rank.
The radial search started on each ray from a distance of 2 mm from the center
point (𝑟𝑚𝑖𝑛 = 2 𝑚𝑚) and ended at 35 mm (𝑟𝑚𝑎𝑥 = 35 𝑚𝑚). This range was chosen
based on our observed prostate size and imaging field of view in the data set. The
maximum number of iterations for shape-based 2D regularization was set to be 25.

2.3.1 Inter-operator variability: Manual segmentation
We compared the observers’ segmentations in a pairwise fashion using our 3D
validation metrics. We also compared each observer’s segmentation to the simultaneous
truth and performance level estimation (STAPLE) [19] segmentation derived from all
three observers’ segmentations. STAPLE is a method that is intended to estimate a single
reference segmentation from a set of reference segmentations using a weighted voting
scheme.
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2.3.2 Accuracy and Inter-operator variability: Semi-automatic segmentation
We performed a single-operator evaluation of the semi-automated segmentation
algorithm on all 42 3D images in our data set, and compared the results to a single
manual reference segmentation. We used a leave-one-out cross-validation methodology
to split the 42 images into training (41 images) and test (one image) sets in each of 42
rounds of testing, with metrics averaged over all rounds.
We performed a multiple-operator evaluation of the semi-automated segmentation
algorithm in terms of accuracy, inter-operator variability, and operator interaction time.
We partitioned our data set into non-overlapping training and test sets of 32 and 10
images, respectively. The 10-image test set was the same as the data set used in Section
2.3.1. Nine operators, including 4 radiation oncologists, one radiologist, one radiology
resident, one imaging scientist and two graduate students, all with research and/or clinical
experience with prostate imaging, used our semi-automated segmentation algorithm to
segment each of the 10 images. We computed aggregate 3D segmentation metrics by
averaging across all operators, and we also compared the metrics for each operator with
all other operator results to measure the inter-operator variability. Since operators’
judgments regarding anteroposterior prostate orientation and the locations of the apexmost and base-most slices differed, we measured the inter-operator variability in base and
apex slice selection and prostate orientation definition. We calculated the mean standard
deviation of the operators’ selected apex and base slice numbers, as well as the APSA
angle with respect to anterior-posterior axis of the MRI coordinate system. To measure
the inter-operator variability in apex, base and mid-gland center point selection, we first
determined the superior-most (base) and inferior-most (apex) slices that were common to
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the segmentations of all observers, as well as the mid-gland slice equidistant to both. We
then calculated the means of the 9 actual or interpolated center points at each of these
slice locations. On each slice, we then measured the Euclidean distance of each of the 9
center points to the mean point.
We had three manual segmentations available on the same 10-image test set as
was used in Section 2.3.1. To perform a direct comparison of our segmentation error
metrics for manual and semi-automatic segmentation, we used those three manual
segmentations to compute a STAPLE reference standard segmentation from each of the
10 images. Our error metrics were calculated with respect to the STAPLE reference for
the manual segmentations, as well as for semi-automatic segmentations performed by the
same experts on the same 10 images. The mean and standard deviation of these metrics
for the manual and semi-automatic scenarios were calculated to measure differences in
accuracy and observer variability arising from using manual vs. semi-automatic
segmentation.

2.3.3 Sensitivity to initialization: Semi-automatic segmentation
To examine the sensitivity of the semi-automated segmentations to the operator’s
center point selection, we performed a simulation study wherein our 42 images were
repeatedly segmented 1000 times using perturbed (in accordance with the previously
observed inter-operator variability) prostate center points at each iteration. We calculated
perturbed center point positions within the prostate by randomly sampling from 2D
Gaussian distributions (three in total: one for each of the apex, mid-gland, and base
slices) with means defined at “ideal” center points defined on the midpoint of the line
segment between the most-anterior and the most-posterior prostate border landmarks
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used in the training. The standard deviations of these Gaussian distributions were
estimated based as the root mean square (RMS) distances to the means of the center
points collected from the nine operators in Section 2.3.2. In this test, the sensitivity for
each image was measured as the difference of the metrics based on the perturbed center
points and the metrics based on the “ideal” center points. Therefore, for N images and
1000 repetitions, we have 1000N measured differences. We reported the mean and the
standard deviation of these 1000N values for each metric.
To measure the sensitivity of the results to the selection of the anteroposterior
symmetry axes, we performed another simulation study wherein our 42 images were
repeatedly segmented 1000 times using randomly modified axis angles. For that purpose,
at each iteration, we randomly selected a set of 42 angles from a Gaussian distribution
with zero mean and the same standard deviation as the standard deviation of the observed
angle across the nine operators in Section 2.3.2, and added them to the symmetry axis
angles used in the single-operator experiment. We measured the sensitivity as the
differences between metrics based on the randomly generated angles and the metrics
based on the reference angles used in the single-operator experiment. We reported the
mean and standard deviation of these differences across all patients and 1000 repetitions.

2.3.4 Source of Variability: Semi-automatic segmentation
To measure the relative contributions of different sources of variability for our
semi-automatic segmentation algorithm, we designed a three-way analysis of variance
(ANOVA) test, with reference, trainer, and operator factors. We used the same subset of
10 images as used in the three-operator experiment, and two observers (denoted Observer
#1 and Observer #2) who were selected due to the discordance of their manual
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segmentations of these 10 images observed in the results of experiment described in
Section 2.3.1. These two observers also executed the semi-automated segmentation on
each of these 10 images. For these two observers, all possible configurations of manual
segmentations used for reference (used to calculate the validation metrics), manual
segmentations used as the trainers for the semi-automated tool, and semi-automated
segmentation operators were tested. This yielded a set of segmentation error metrics for
each configuration. We performed an ANOVA test for each of our five metrics and each
region of interest including whole gland, mid-gland, base and apex to test the following
null hypotheses:
H01: The trainer has no significant impact on the error.
H02: The operator has no significant impact on the error.
H03: The reference has no significant impact on the error.

2.4 Results
2.4.1 Inter-operator variability: Manual segmentation
The key result of this experiment was a substantially high inter-operator
variability in manual segmentation. Table 2.1 shows the range of 3D metrics in pair-wise
comparison between operators and also between each operator and STAPLE reference.
Since in this experiment, the segmentations in each pair-wise comparison were both
performed manually, the MAD values were calculated in bilateral mode and the absolute
volume difference (|∆𝑉|) was calculated. MAD values were calculated in unilateral mode
with STAPLE as the reference, and the signed volume difference (∆𝑉) was reported.
Figure 2.4 qualitatively shows the inter-observer variability in prostate segmentation.
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Table 2.1: Inter-operator variability in manual segmentation: Range of mean MAD,
DSC, recall, precision, and ΔV (bilateral MAD and |ΔV| was used for “Operator vs
Operator” section).
Region of interest
Whole gland
Mid-gland
Apex
Base
Whole gland
Mid-gland
Apex
Base

Operator vs
Operator

Operator vs
STAPLE

MAD (mm)
[1.0,2.8]
[0.7,1.8]
[1.1,3.0]
[1.3,3.5]

DSC (%)
[74,90]
[88,96]
[65,88]
[66,86]

[0.2,3.1]
[0.2,1.9]
[0.2,3.4]
[0.2,3.7]

[78,98]
[89,98]
[70,99]
[72,98]

Range of mean metric values
Recall (%)
Precision (%)
[87,99]
[96,99]
[83,98]
[79,99]

[60,94]
[81,95]
[51,94]
[52,93]

ΔV (cm3)
[1.9,18.3]
[0.1,3.3]
[0.5,6.1]
[1.5,7.7]

[66,100]
[82,100]
[58,100]
[60,100]

[87,98]
[96,99]
[84,98]
[80,98]

[-2.8,15.5]
[-0.5,3.2]
[-0.8,5.3]
[-1.8,7.0]

S

S

L

L

R

R
I

I

S

S
P

P

A

A
I

I

Reference 1

Reference 2

Reference 3

Reference 1

Algorithm
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Reference 2

Reference 3

Algorithm

A
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L

L
P

P
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Mid-gland
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Base

Mid-gland

Base

Figure 2.4: Inter-observer variability. The 3D surfaces show the three manual
segmentations and the algorithm results. The three solid contours show the three
observers’ manually drawn contours. The dashed contours show the algorithm’s results.

2.4.2 Accuracy and inter-operator variability: Semi-automatic segmentation
The key results of this experiment were that (1) the accuracy measured for our
algorithm based on one reference, similar to the accuracies of most of the other
segmentation algorithms presented in the literature, are within the inter-operator
variability range for manual segmentation on our data set; (2) the variability observed
between different operators in the measured errors using a multi-operator study was not
significant based on most of the metrics and for most regions of interest. The results of
the single-operator evaluation of the semi-automated segmentation algorithm on all 42
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3D images in our data set are shown in Table 2.2 and compared to previous work. For the
whole gland, we measured a mean±standard deviation MAD (unilateral) of 2.0±0.5 mm,
DSC of 82±4%, recall of 77±9%, precision of 88±6% and ΔV of -4.6±7.2 cm3. The
measured mean±standard deviation execution time using an unoptimized Matlab research
platform on a single CPU core was 85±20 sec. Under the assumption of normal
distribution of the error metric values, we conducted one-tailed heteroscedastic t-tests
[20] to compare our results to previous work, in each case testing the null hypothesis
regarding the relative performance of the methods. With α=0.05, corresponding letters
show where the null hypothesis was rejected in Table 2.2. Figure 2.5 shows qualitative
and quantitative results for three sample prostates.
Table 2.2: Accuracy and variability for semi-automatic segmentation: mean±standard
deviation of MAD, DSC, recall, precision, and ΔV. Corresponding letters show
statisticaly significant differences between each error value of our method and the
corresponding error value of another method where applicable. (p < 0.05).
Methods

N

Our method

42

Liao et al [15]

66

Toth et al [14]

108

Vikal et al [12]

3

Martin et al
[11]

17

Region of interest
Whole gland
Mid-gland (1/3)
Apex (1/3)
Base (1/3)
Whole gland
Whole gland
Mid-gland (1/3)
Apex (1/3)
Base (1/3)
Mid-gland (9/13)
Apex (2/13)
Base (2/13)
Whole gland
Mid-gland
Apex
Base

MAD (mm)
2.0±0.5 bi
1.6±0.5 j
2.0±0.7 gk
2.6±0.8 l

DSC (%)
82±4 ac
90±3d
79±6 e
73±10 fh

Recall (%)
77±9 m
90±7
82±14
61±14

Precision (%)
88±6 n
91±6
80±13
93±6

ΔV (cm3)
-4.6±7.2
-0.1±2.0
0.1±3.3
-4.5±3.7

1.8±0.9

88±3 a

-

-

-

1.5±0.8 b
2.0±0.6
3.8±0.9 g
3.9±1.8
3.4±2.0 i
2.4±1.3 j
2.9±1.3 k
4.3±2.0 l

88±5 c
91±4 d
84±9 e
88±6 f
93±3
80±5
86±8 h
-

-

-

-

-

89±6 m
-

78±12 n
-

-

75

S
L

S
R

S

P

I

A

R

I

L
I

W.G. M.G Apex Base
MAD
1.7

1.3

1.3

2.1

85

92

85

80

84

97

83

73

87

88

86

87

-1.3

1.4

-0.2

-2.5

(mm)
DSC

Posterior view

Right view

Anterior view

(%)
Recall

A
R

(%)

L

Precision

P

(%)
ΔV
(cm3)

Apex

Mid-gland

S
L

Base

S
R

P

S
A

I

R

I

L
I

W.G. M.G Apex Base
MAD
1.8

1.2

1.8

2.4

82

92

80

75

79

96

98

61

86

88

68

99

-2.4

0.9

2.4

-5.6

(mm)
DSC

Posterior view

Right view

Anterior view

(%)
Recall

A
R

(%)

L

Precision

P

(%)
ΔV
(cm3)

Apex

Mid-gland

S
L

Base

S
R

P

I

S
A

R

I

L

W.G. M.G Apex Base

I

MAD
2.2

1.7

2.3

2.4

85

91

83

82

84

89

97

71

86

93

73

97

-0.9

-0.5

3.2

-3.6

(mm)
DSC
(%)
Recall

Posterior view

Right view

Anterior view

A
R

(%)
Precision

L

(%)

P

ΔV
(cm3)

Apex

Mid-gland

Base

Figure 2.5: Qualitative and quantitative results for three sample prostates. In the left
column, the semi-transparent surfaces show the manual segmentation as reference, and
the solid surfaces show the algorithm results. On the 2D cross sections, the manual
segmentation is shown with a solid line, and the algorithm’s segmentation is shown with
a dashed line. The most inferior and the most superior slices that contain both reference
and algorithm contours were, respectively, shown as the apex and base. In the right
column, the tables show the measured error metrics for that corresponding cases in whole
gland (W.G.), as well as apex, mid-gland (M.G.), and apex.
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For our multiple-operator evaluation of the semi-automated segmentation, Figure
2.6 shows the results for each of the 9 operators in comparison with STAPLE. The
average interaction time across 9 operators and 10 images was measured as 28±14 sec.
To determine whether there are significant differences between the means of the error
metrics for each operator we conducted one-way ANOVA followed by Bonferroni’s
pairwise tests with the null hypothesis that the means of the metrics for all the 9 operators
were the same. We showed the post ANOVA test results in Figure 2.6 for each region of
interest, where ANOVA detected significant inter-operator differences in terms of any of
the metrics (α=0.05). Table 2.3 also shows the average results across all 9 operators and
10 images and compares it to the results based on one operator on 42 images reported in
Table 2.2. For each metric, we applied a t-test with the null hypothesis that the means of
the metric resulting from the 9 operators’ segmentations of 10 images are the same as the
mean of the metric for one operator’s segmentation of 42 images (i.e. comparing the top
row of Table 2.3 to the bottom row, for each metric and within each anatomic region) .
Table 2.3: The average results across the nine operators and 10 images compared to the
single operator results across 42 images: mean±standard deviation of MAD, DSC, recall,
precision, and ΔV. Corresponding letters indicate statistically significant differences
between two modes (p < 0.05).
Methods

N

One operator
(Table 2.2)

42

Nine operators

10

Region of interest
Whole gland
Mid-gland
Apex
Base
Whole gland
Mid-gland
Apex
Base

MAD (mm)
2.0±0.5
1.6±0.5
2.0±0.7
2.6±0.8 a
2.2±0.7
1.7±0.7
2.0±1.0
2.9±0.8 a

DSC (%)
82±4 b
90±3
79±6
73±10 c
77±8 b
89±4
78±12
65±12 c

Recall (%)
77±9 d
90±7
82±14
61±14 e
72±12 d
88±8
84±15
54±17 e

Precision (%)
88±6
91±6
80±13
93±6
86±10
91±7
78±17
92±11

|ΔV| (cm3)
-4.6±7.2
-0.1±2.0
0.1±3.3
-4.5±3.7
-4.0±5.5
-0.1±1.7
0.6±3.3
-4.5±3.4

For each image, the apex and base slices were manually selected by each of the 9
operators. We calculated the resulting standard deviation of the slice positions for each
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image and obtained their average across all 10 images. The mean standard deviation of
the operators' selected apex and base slices were 1.8 slices (4 mm) for the apex and 1.3
slices (2.9 mm) for the base. The range of the maximum inter-operator difference at the
apex was 3 to 9 slices (6.6 mm to 19.8 mm) with a mean of 5.7 slices (12.5 mm), and this
range for base was 2 to 10 slices (4.4 mm to 22 mm) with a mean of 3.8 slices (8.4 mm).
The mean standard deviation of the APSA angle with respect to anteroposterior axis of
the MRI coordinate system was 3.2 degrees. The differences between operators ranged
from 4.0 to 17.8 degrees with a mean of 9.8 degrees.
For the center points, the measured distances ranged from 0 mm to 3.9 mm with
an average of 1.1 mm at the apex, 0.2 mm to 4.3 mm with an average of 1.3 mm at the
mid-gland, and 0.1 mm to 4.9 mm with an average of 1.7 mm at the base. The RMS of
the point distances were 1.3 mm, 1.5 mm, and 2.0 mm at the apex, mid-gland and base,
respectively. The actual range of distances by which the center points were perturbed
were [-5 mm, +5mm], [-7 mm, +7 mm], and [-8 mm, +8 mm] for the apex, midgland, and
base, respectively.
Table 2.4 shows the of manual and semi-automatic segmentations performed by
the same three operators on 10 images.
Table 2.4: Consistency of the manual and the semi-automatic segmentations: average of
means (average of standard deviations) of MAD, DSC, recall, precision, and ΔV across 3
manual and 3 semi-automatic segmentations of the prostate by 3 expert operators.
N
Manual
segmentation

10

Semi-automatic
segmentation

10

Region of interest
Whole gland
Mid-gland
Apex
Base
Whole gland
Mid-gland
Apex
Base

MAD (mm)
1.3 (1.6)
0.8 (0.9)
1.4 (1.8)
1.6 (1.9)

DSC (%)
90 (11)
95 (5)
86 (15)
86 (14)

Recall (%)
88 (19)
93 (10)
85 (24)
86 (22)

Precision (%)
94 (6)
97 (2)
93 (8)
91 (11)

ΔV (cm3)
3.9 (10.1)
0.8 (2.1)
1.4 (3.3)
1.6 (4.8)

1.9 (0.3)
1.5 (0.3)
1.8 (0.4)
2.7 (0.5)

80 (4)
90 (2)
82 (4)
68 (7)

75 (7)
90 (3)
87 (8)
57 (12)

88 (3)
91 (2)
80 (8)
93 (6)

-3.2 (2.9)
0.2 (0.7)
0.8 (1.2)
-4.2 (2.5)
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Figure 2.6: Inter-observer variability. Mean±standard deviation (a) MAD, (b) DSC, (c)
recall, (d) precision, and (e) V for each of the 9 operators for whole gland (W.G.), apex,
mid-gland (M.G.), and base (P < 0.05). The last two columns in each section show the
average variations of the metric using perturbed prostate center point, and anteroposterior
symmetry axes, respectively.

79

2.4.3 Sensitivity to initialization: Semi-automatic segmentation
The key result of this experiment was that the sensitivity of the algorithm
accuracy to center point and anteroposterior symmetry axis selection was substantially
lower than the measured error metric values. The means and standard deviations of the
variation of metrics with regards to center point and anteroposterior symmetry axes
variations are shown in Figure 2.6 for the whole gland as well as apex, mid-gland, and
base regions.
2.4.3.1 Sensitivity to centre point selection
For the whole gland, the mean and the range of variation ([minimum, maximum])
for MAD, DSC, recall, precision and ΔV, respectively, were 0.1 mm ([-1.3 mm, 2.0
mm]), -1% ([-24%, 11%]), -1% ([-33%, 16%]), -1% ([-19%, 16%]), and -0.2 cm3 ([-18.4
cm3, 15.4 cm3]). The mean and standard deviation of the differences between results
based on randomly generated center points and reference center points across 42 patients
and 1000 repetitions are shown in Table 2.5.
2.4.3.2 Sensitivity to anteroposterior symmetry axes selection
For the whole gland, the mean and the range of variation ([minimum, maximum])
for MAD, DSC, recall, precision and ΔV, respectively, were 0.0 mm ([-0.7 mm, 0.9
mm]), 0% ([-8%, 5%]), 0% ([-15%, 8%]), 0% ([-11%, 8%]), and -0.2 cm3 ([-9.2 cm3, 4.5
cm3]). Table 2.5 shows the mean and one standard deviation of the differences between
results based on randomly generated angles and the reference measurements across 42
patients and 1000 repetitions.
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Table 2.5: Sensitivity of the semi-automatic algorithm to initialization (center points and
anteroposterior symmetry axes): mean±standard deviation of MAD, DSC, recall,
precision, and ΔV offsets from reference measurements across 1000 repetitions × 42
patients.

Sensitivity to
center point
selection
Sensitivity to
anteroposterior
symmetry axes
selection

N

# of Iterations

42

1000

42

1000

Region of interest
Whole gland
Mid-gland
Apex
Base
Whole gland
Mid-gland
Apex
Base

MAD (mm)
0.11±0.30
0.14±0.44
0.09±0.39
0.09±0.41

DSC (%)
-1.0±2.6
-1.1±3.0
-0.9±3.2
-1.2±4.4

Recall (%)
-1.3±3.8
-1.4±4.5
-1.0±3.4
-1.3±6.0

Precision (%)
-0.7±2.6
-0.6±3.0
-0.7±4.7
-0.8±3.4

ΔV (cm3)
-0.2±2.0
-0.1±1.0
0.0±0.8
-0.1±1.1

0.02±0.15
0.03±0.19
0.00±0.23
0.04±0.22

-0.3±1.2
-0.2±1.2
-0.1±1.9
-0.4±2.4

-0.4±2.0
-0.4±2.3
-0.2±2.3
-0.5±3.6

-0.1±1.7
0.0±2.0
0.1±3.0
0.0±1.9

-0.2±1.1
0.0±0.6
-0.1±0.6
-0.1±0.6

2.4.4 Source of variability: Semi-automatic segmentation
The key result of this experiment was that the operator has less impact on the
algorithm accuracy, as compared to the reference and trainer. For all of the null
hypotheses tested by ANOVA, rejection was reported at the p < 0.05 level. For the midgland, there was a significant effect of the trainer on all the metrics and reference had a
significant impact on three of the metrics (ΔV, recall, and precision). There was no
significant impact of the operator on the metrics. For the apex, the reference had a
significant impact on 4 of the metrics (DSC, ΔV, recall, and precision) and the trainer and
operator had no significant impact on the metrics. For the base, the reference had a
significant impact on all of the metrics, the operator had significant impact on four
metrics (DSC, ΔV, recall and precision) and the trainer had significant impact on two
metrics (recall and precision) and a marginally significant (p < 0.1) impact on DSC.

2.5 Discussion
In the presented semi-automatic segmentation algorithm, we first trained our
algorithm to capture the inter-patient local appearance of the prostate border as well as
the prostate shape characteristics on different axial cross-sections. Then for an unseen
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MR image, the prostate border was locally defined based on the learned appearance
characteristics of the prostate border at the corresponding location. The defined border
was regularized on each 2D axial slice using the corresponding 2D shape model obtained
from training. Finally, a 3D shape regularization was applied to the result. In the
statistical modeling method referred to as an active appearance model [21], the global
appearance of the image is used in combination with the shape model of the prostate to
segment the prostate. Therefore, an inter-patient internal appearance variation of the
prostate gland that could be caused e.g. by differently-located prostate tumours or benign
prostatic hyperplasia nodules challenges the segmentation. Furthermore, using the
combination of the shape and appearance modeling challenges the simultanous shape
modeling when there is a local appearance difference between the test image and the
appearance model. We addressed this issue by separating the shape model from the
appearance based segmentation.

2.5.1 Inter-operator variability: manual segmentation
We observed substantial inter-operator variability in manual segmentation of the
prostate on T2W ER MRI (Table 2.1), with differences between operators ranging
between 0.7 mm and 3.5 mm in terms of MAD, and between 65% and 96% in terms of
DSC, depending on the observer pair and the anatomic location. There was more interoperator consistency in delineation of the mid-gland, with greater discordance at the apex
and base. These results suggest that measured errors for prostate segmentation algorithms
on T2W ER MRI may vary substantially as a function of the manual segmentation used
as the reference. Therefore, it is challenging to define a “gold standard” for this task.
Consequently, segmentation results reported for an algorithm using a single-operator
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reference may change substantially if a different operator were to delineate a set of
reference segmentations on the same data set. This inter-observer variability also renders
comparison of algorithm performance challenging when different data sets and reference
segmentations are used in different published results. One approach to mitigate this effect
is to evaluate algorithm performance against multiple expert reference segmentations,
and assess the algorithm’s segmentation error in the context of inter-operator variability
in manual segmentation on the same data set.

2.5.2 Accuracy and inter-operator variability: Semi-automatic segmentation
For comparison with previous work, we conducted a single-operator, singlereference experiment measuring the accuracy of our presented semi-automatic
segmentation algorithm. Some statistically significant differences were found with
respect to other published methods (Table 2.2) but were within the observed ranges of
human expert variability in manual delineation on our data set (Table 2.1). Concordant
with previously published results, our data show that segmentation of the apex and
(especially) the base is considerably more challenging than the segmentation of the midgland, with errors contributed not only by the unusual shape and appearance of these
structures in some patients (e.g. the shape of the base on the manual segmentation shown
in the right-hand panel of Figure 2.4), but also by the substantial variability we measured
in experts’ selections of the apex-most and base-most slices. Our results in Table 2.2
compare favorably with many of the segmentation error metric values reported from the
PROMISE12 challenge [16]; however, the different nature of the data sets in terms of ER
coil usage challenges the interpretation of this comparison. For the prostate as a whole,
our algorithm and the top performing algorithms in PROMISE12 appear to be
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asymptotically approaching human performance as reflected by inter-observer variability
in manual contouring. These observations suggest that further improvement of algorithms
for computer-assisted segmentation of the mid-gland are unlikely to provide measurable
impact, and that efforts toward improved accuracy and consistency in prostate apex and
base segmentation are a higher priority. Informal observations of our results suggest
negligible impact of magnetic field strength on segmentation error; however, this would
be an interesting area of future research on a larger data set of 1.5 Tesla and 3.0 Tesla
images.
We observed maximum inter-operator differences in apex-most and base-most
slice selection of 12.5 mm at the apex and 8.4 mm at the base on average; these represent
aggregates of the largest distances one might observe between these observers’ apex and
base-most slices, respectively. On the other hand, when the mean surface-to-surface
distances (i.e. the MAD values) were calculated for the same nine observers using the
semi-automatic algorithm (Table 2.3) and for a subset of three of the observers doing
manual contouring (Table 2.1), smaller values (~2–4 mm) were observed. Although the
mean surface-to-surface distances would be expected to be smaller than the measured
maxima (as observed), the magnitudes of the observed differences in our data suggest
that the bulk of the surfaces at the apex and base are in better spatial agreement than are
the extrema of the prostate, which cover a relatively smaller surface area and thus have
less influence on the calculated MAD metric values. Thus, there appear to be spatial
differences in terms of where most of the inter-observer variability lies; there is greater
variability in localizing the superior-most end of the apex and inferior-most end of the
base, compared to the variability in contouring the apex and base as a whole.
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Although our use of signed prostate volume differences as well as recall and
precision rates as complementary evaluation metrics is unusual with respect to previously
published work in this area, these metrics can be helpful in distinguishing different types
of segmentation errors in a way that could facilitate the understanding the clinical
applicability of the algorithm and facilitate adoption. For instance, in the lower-most
segmentation shown in Figure 2.5, the algorithm over-contours the apex and undercontours the base overall. These two errors are quite different in terms of potential
clinical impact; for example, in a radiation oncology context, under-contouring could
result in untreated cancer whereas over-contouring could result in radiation damage to
surrounding healthy tissue. The table adjacent to this example in Figure 2.5 indicates that
the MAD and DSC metrics, frequently reported in previous literature, are nearly identical
for the apex and base. However, for the apex, recall is substantially larger than precision,
and vice-versa for the base, capturing the nature of this segmentation error. The ΔV
metric also directly captures this error in a complementary fashion.
Our nine-operator experiment resulted in small degradations of accuracy (Table
2.3), although the results were still within the range of expert variability in manual
segmentation (Table 2.1). Our three-operator experiment directly comparing
segmentation error and variability for manual and semi-automated segmentation of the
same 10 images compared to the same STAPLE reference standard indicated an increase
in error with a concomitant decrease in variability when the semi-automated tool was
used. This suggests the presence of a tradeoff between segmentation accuracy and
variability that is related to the use of automation; computer-assisted delineation may
increase the consistency of segmentations at the expense of some accuracy. This lost
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accuracy could in principle be recovered through minor segmentation editing, but this
remains to be tested. The observed reduction in segmentation variability also suggests
that the semi-automatic segmentation tool could be valuable in the hands of the novice
radiologist or radiation oncologist, providing useful guidance in the form of a
segmentation that is consistent with a training set constructed based on segmentations
provided by experienced experts.

2.5.3 Sensitivity to initialization: Semi-automatic segmentation
Our data indicate that variability in the semi-automatic segmentation results
arising from varying the inputs to the algorithm (Table 2.5) is substantially smaller than
the segmentation accuracy and variability observed for both manual and semi-automatic
segmentation. This suggests that the algorithm is robust to the placement of center points
and orientation of the gland by the user, and helps to explain the accuracies we obtained
despite minimal user interaction; users do not need to exercise a high degree of timeconsuming accuracy and precision in interacting with this tool. Moreover, since the
prostate APSA is very close to the image AP axis, it might be possible to replace it with
the image AP axis and minimize the user interaction without loss of accuracy.

2.5.4 Source of variability: Semi-automatic segmentation
Our ANOVA test results indicated that in all regions of the prostate, the reference
segmentation used for evaluation had the most significant impact on segmentation error.
This reinforces our earlier observation (Section 2.5.1) that measurements of a
segmentation algorithm’s performance based on single reference segmentation could vary
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substantially according to the particular expert reference segmentation used for
evaluation.
With the exception of the base region, our test did not detect a significant impact
of the operator on any of the error metrics. This suggests that the use of the proposed
semi-automated segmentation tool could result in improved inter-operator consistency of
mid-gland and apex delineations, but that further work would be useful to improve the
consistency of delineation of the challenging area of base, where the prostate meets the
bladder neck.
The significant impact of the trainer on all the metrics (within the mid-gland), in
conjunction with the above observation regarding the impact of the operator, suggests
that in this region the semi-automatic segmentation algorithm might provide outputs that
mimic the trainer more than the operator. Hence, this tool could be useful in the hands of
an expert trainer and a relatively more novice operator. Further work involving a larger
sample size will be required to elucidate the impact of the trainer on the apex and base
regions.

2.5.5 Limitations
The results of this work must be considered in the context of its strengths and
limitations. To the best of our knowledge, this work represents the first use of the
complementary MAD, DSC, recall, precision and ΔV error metrics in the evaluation of a
prostate segmentation algorithm for T2W ER MRI, using multiple operators and multiple
reference standard segmentations. However, our study was limited in several ways. First,
our sample size (42 images for the single-operator experiment and 10 images for the
multiple-operator experiment) is small and therefore the results of this study should be
87

considered to be hypothesis-generating, and our conclusions should be interpreted
accordingly. Second, the only MR appearance information used by our segmentation
algorithm to delineate the border is MR image intensity; no derived quantities such as
image texture measures were utilized. Although using such features may add complexity
and computation time to the method, such an approach could yield improved results,
especially in the context of high variability of shape of the base and apex where our shape
regularization step is less applicable. Third, we did not provide the operators with the
opportunity to edit the semi-automatic segmentations to their satisfaction; an interesting
avenue of further work would be to measure the time required for the user to obtain a
satisfactory segmentation using the output of the semi-automatic tool as a starting point.
Finally, since all of the images in our data set are from patients with confirmed PCa, the
appearance of the prostate could have been locally modified in the presence of lesions
near the capsule, increasing the challenge of accurate prostate segmentation using a local
model of appearance; thus, our patient selection may have pessimistically affected our
reported semi-automatic segmentation results.

2.5.6 Conclusions
We presented a comprehensive evaluation of a 3D segmentation algorithm for
prostate T2W ER MRI, comprising boundary-, region-, and volume-based metrics
computed separately for the whole gland, mid-gland, apex and base. We tested the
algorithm using multiple reference segmentations and multiple operators, and observed
reduced inter-operator variability via the use of this semi-automated tool. Minimal
operator interaction of less than 30 sec, on average, was required. Based on our results,
further work in this area should be focused on improving segmentation accuracy and
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variability at the prostatic base and apex, including reducing inter-observer variability in
selecting the apex-most and base-most slices of the prostate. Due to high inter-operator
variability in the manual prostate segmentation, particularly at the apex and base, it
appears to be challenging to interpret reported improvements in segmentation algorithm
accuracy based on a single-operator manual reference standard. We anticipate that our
comprehensive approach to segmentation evaluation will facilitate the assessment and
adoption of our algorithm by clinical end users, who can interpret the segmentation
metrics as appropriate to their clinical use cases of interest.
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Chapter 3.
Accuracy and acceptability of an automated method for
prostate segmentation in magnetic resonance imaging †

3.1 Introduction
Prostate cancer (PCa) is the most commonly diagnosed cancer in men in North
America, excluding skin carcinoma. More than 30,000 deaths from PCa are predicted in
the United States and Canada for 2015 [1, 2]. Magnetic resonance (MR) imaging (MRI),
due to its promising potential in diagnosis and staging of PCa [3, 4], is one of the imaging
modalities utilized in multiple emerging diagnosis and therapeutic procedures.
Contouring of the prostate on MRI could assist with PCa diagnosis and therapy planning.
More specifically, T2-weighted (T2w) MRI is superior to other MRI sequences for
anatomic depiction of the prostate gland and the surrounding tissues [5]. The use of an
endorectal (ER) receive coil helps MRI acquisition performance in terms of image quality
and spatial resolution [6]. However, it deforms and displaces the prostate gland [7],
produces some ER coil-based imaging artifacts [8], and detects more edges and details
that challenge the adaptation of computer-assisted prostate contouring algorithms
designed for non-ER MRI to this context.

† A version of this chapter has been submited: M. Shahedi, D. W. Cool, C. Romagnoli, G. S. Bauman,
M. Bastian-Jordan, A. Fenster, and A. D. Ward, " Accuracy and acceptability validation of an automated
method for prostate segmentation in magnetic resonance imaging," Medical Physics.
92

Manual segmentation of prostate MRI is a laborious and time-consuming task that
is subject to inter-observer variability [9]. This motivates the need for fast and
reproducible segmentation algorithms for T2w ER prostate MRI. There have been several
algorithms published in the literature for segmentation of the prostate on T2w ER MRI.
Martin et al. [10] presented a semi-automatic algorithm for segmentation of the prostate
on MRI based on registration of an atlas to the test image. They evaluated their method
on 17 MR images using manual segmentations performed by a single operator as the
reference standard. To measure the accuracy of their method, they used a surface-based
metric for different regions of interest (ROIs) including the whole prostate gland, base,
midgland and apex regions. They also used region based metrics, but for the whole gland
only. They reported higher atlas registration error, yielding to higher segmentation error,
for their methods on small prostates (less than 25 cm3) compared to the atlas registration
error on the larger prostates. Vikal et al. [11] developed a two-dimensional (2D) slice-byslice segmentation algorithm based on shape modeling for three-dimensional (3D)
segmentation of the prostate on T2w MRI. Their semi-automatic method was initialized
by user selection of prostate centre point on one of the central slices of the prostate. In
their method, segmentation starts from the selected central slice. The segmentation on
each 2D slice is used as an initialization for segmenting its adjacent slice. They evaluated
their method on three images using the mean absolute distance (MAD) and Dice
similarity coefficient [12] (DSC), compared to a single reference standard developed by
consensus of two expert observers. Toth and Madabhushi [13] developed a semiautomatic segmentation algorithm based on a landmark-free active appearance model and
level set shape representation method. To evaluate their method they applied the
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algorithm to 108 T2w ER MRI and compared the results to manual segmentations
performed by one observer using the MAD for the whole gland only and the DSC for
whole-gland, apex, midgland and base. Although results were reported for a second
observer on a subset of 17 images, inter-observer variability of their method was not
reported. Liao et al. [14] presented a coarse-to-fine hierarchical automatic segmentation
algorithm for prostate segmentation on T2w MRI. They used the MAD, DSC and
Hausdorff distance error metrics for evaluation of their method on the whole gland using
a manual reference segmentation performed by one observer on 66 T2w MR images.
Cheng et al. [15] developed an automatic approach consisting of two main steps: first, a
coarse segmentation based on an adaptive appearance model and then a segmentation
refinement using a support vector machine. They used region-based metrics computed
only within the whole gland to evaluate their method, using manual reference
segmentations verified by one radiologist. In 2012, 11 teams were involved in a challenge
for prostate MRI segmentation, called PROMISE12, held as part of the Medical Image
Computing and Computer Assisted Intervention (MICCAI) conference. The challenge
tested the performance of the segmentation algorithm presented by each team in two
steps; online and live challenges. The image data set used by the challenge contained
both ER and non-ER MR images and the results were evaluated against one set of manual
segmentations provided by one expert and reviewed and edited, if necessary, by another
expert using surface-, region- and volume-based metrics for the whole gland, apex and
base regions [16].
In most previously published work, the segmentation result has been evaluated by
comparison against a single manual reference segmentation. However, there is high inter-
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observer variability in contouring the prostate in MRI [9] and changing the manual
reference segmentation used for segmentation evaluation likely has a substantial impact
on the reported segmentation performance. Therefore, it is necessary to consider this
variation when validating segmentation algorithms. Furthermore, in most published
studies, the algorithm results have been evaluated using only one or two error metrics.
Since each metric is sensitive to certain types of errors (e.g. the MAD is sensitive to
large, spatially localized errors, whereas the DSC is sensitive to smaller, global errors),
there is not a single globally-accepted metric for comprehensive evaluation of
segmentation algorithms. Thus, using a set of metrics that are sensitive to different types
of error such as surface disagreement, regional misalignment, and volume differences,
yields a more comprehensive algorithm evaluation. Moreover, the accuracy and
repeatability of the prostate segmentation varies for different parts of the gland in manual
[9] and computer-based [10, 11, 13, 17] segmentations. Some groups reported
segmentation error only for the whole prostate gland without reporting the error for the
gland subregions such as the apex, mid-gland and base. Segmentation error metrics
computed for the whole gland are challenging to interpret, since large errors in the apex
and base regions can be offset by smaller errors in the mid-gland. When the
segmentations are used to guide radiation or ablative interventions, this is especially
important since the apex and base are near to sensitive structures such as the bladder,
urethra, and penile bulb.
We previously described a semi-automatic segmentation approach for ER prostate
MRI based on local appearance and shape characteristics and evaluated its performance
in comparison with manual segmentation in terms of accuracy and inter-operator
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variability [17]. We applied our evaluation using different types of error metrics (i.e.
surface-, region- and volume-based metrics) and assessed the performance of the
algorithm over the whole prostate gland as well as within the apex, midgland and base
subregions. Our semi-automatic segmentation method required that the user select four
initial points to run the contouring algorithm. Thus, the algorithm’s segmentation results
depended on the user’s judgment of the correct loci for these points. This included a
requirement that the user indicate the apex-most and base-most slices of the prostate,
which is a challenging task with substantial inter-observer variability.
Although many segmentation algorithms have been proposed, an operatorindependent algorithm that has been comprehensively validated using multiple
complementary error metrics against a multi-observer reference standard remains elusive.
In this chapter, we build on our previous semi-automated segmentation algorithm to
develop a fully automated approach that has no dependence on user input. We compare
the fully automatic segmentation performance to the semi-automatic and manual
approaches. We address the following four research questions in this chapter. (1) What is
the accuracy of the automated segmentation algorithm when compared to a singleobserver manual reference standard? (2) What is the difference in the time required to
use our automated segmentation algorithm and our semi-automated segmentation
algorithm? (3) What is the difference in accuracy between our automated segmentation
algorithm and our semi-automated segmentation algorithm? (4) Is the measured
misalignment between the computer-assisted segmentations and manual segmentations
within the range of inter-expert variability in manual segmentation?
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3.2 Materials and Methods
3.2.1 Materials
The data set contained 42 axial T2w fast spin echo ER MR images acquired from
patients with biopsy-confirmed PCa. 23 of the images were acquired with TR = 4000–
13000 ms, TE 156–164 ms, NEX = 2, and for the other 19 images TR = 3500–7320 ms,
TE = 102–116 ms, NEX = 1–2. Nine and 33 images were obtained with 1.5 and 3.0 Tesla
field strengths, respectively. The voxel sizes varied from 0.27 × 0.27 × 2.2 mm to 0.44 ×
0.44 × 6 mm, covering the range typically seen in clinical prostate MRI. Four different
MRI scanners were used for image acquisition: MAGNETOM Avanto, MAGNETOM
Verio (Siemens Medical Solutions, Malvern, PA), Discovery MR 750 and Signa Excite
(General Electric Healthcare, Waukesha, WI). The study was approved by the research
ethics board of our institution, and written informed consent was obtained from all
patients prior to enrolment. All 42 MR images were initially segmented manually by one
observer (either a radiologist or a graduate student under advisement of a radiologist)
followed by review and adjustment of the contours by an expert senior radiology resident
with experience reading >100 prostate MRI scans. Two additional manual segmentations
were performed on a subset of 10 images performed by two expert observers (one
radiologist and one radiation oncologist). To select this subset of 10 images, we
qualitatively assigned easy-, moderate- and difficult-to-segment labels to a set of images
acquired at our institution and randomly select 10 images from all the three categories.
The prostate volumes in the data set calculated based on the available manual
segmentations ranged from 15 to 89 cm3 with mean ± standard deviation of 35 ± 14 cm3.
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3.2.2 Automated segmentation
Our automatic segmentation approach consists of two main parts: training and
segmentation, described in sections 3.2.2.1 and 3.2.2.2, respectively. In this chapter, we
focus on automation of the manual steps of our previously-published semi-automated
method. Thus, we describe elements common to our automatic and semi-automatic
approaches at a high level; full details on these elements are available in [17].
3.2.2.1 Training
We use the approach to training described in reference [17] reporting on our semiautomated segmentation method. The training method is described at a high-level here.
During training, the algorithm learns the local appearance of the prostate border by
extracting 36 locally defined circular mean intensity image patches, and generates a 2D
statistical shape model for the prostate on each axial cross-section of the prostate. To
extract the mean intensity image patches, we first spatially normalized all the prostates in
the training set to define a spatial correspondence between axial slices of all the training
images. For each slice in a set of corresponding axial slices, a set of 36 anatomically
corresponding points was defined on the prostate border and for each point, a circular
patch centered at that point was selected. By computing the average of the intensities of
the corresponding pixels across all the patches obtained from the corresponding points, a
set of 36 mean intensity patches were generated, each corresponding to one anatomical
point on the prostate border. The 36 defined border points were also used for building a
statistical point distribution model (PDM) of prostate shape on each selected axial crosssection.
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3.2.2.2 Segmentation
To segment the prostate in a new MR image, the algorithm first coarsely localizes
the region containing the prostate by automatically positioning a template shaped
similarly to a prototypical prostate on the mid-sagittal plane (blue polygon in Figure 3.1).
The algorithm then searches within a region defined according to this template to define
the 3D prostate boundary. This high-level process resolves to a four-step procedure: (1)
anterior rectal wall boundary determination, (2) inferior bladder boundary determination,
(3) coarse prostate localization by template fitting, and (4) 3D prostate boundary
localization. Each of these four steps is described in detail below.
The first step was to fit a line to the anterior rectal wall boundary on the midsagittal slice of the MRI. Candidate points lying on the anterior rectal wall boundary were
selected by finding loci of minimum first derivative along line intensity profiles oriented
parallel to the axial planes and running from anterior to posterior on the mid-sagittal
plane. This approach was chosen due to the observation that the intensity generally
transitions sharply from bright to dark at the rectal wall boundary. To reduce the search
space, we restricted our search to a domain covering 50% of the width of the mid-sagittal
plane in the anteroposterior direction, offset 20% from the posterior-most extent of the
mid-sagittal plane. Within this domain, 10 equally-spaced lines (every second line)
nearest to the mid-axial plane were searched. For robustness to outlier candidate points,
we computed a least-trimmed squares fit [18] line to the candidate points, with the
optimizer tuned to treat 40% of the candidate points as outliers. We took the resulting
best-fit line to represent the anterior rectal boundary (posterior-most yellow dashed line
in Figure 3.1).
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The second step was to fit a curve to the inferior bladder boundary on the midsagittal slice of the MRI. Candidate points lying on the inferior bladder boundary were
selected by finding loci of minimum first derivative along line intensity profiles oriented
parallel to the anterior rectal boundary determined in the previous step and running from
superior to inferior on the mid-sagittal plane. This approach was chosen due to the
observation that the intensity generally transitions sharply from bright to dark at the
inferior bladder boundary. To reduce the search space we restricted our search to line
segments lying within the superior half of the image, starting 5 mm anterior to the rectal
wall with 2 mm spacing between them. We eliminated implausible candidate points in
two stages. In the first stage, points forming a locally concave shape near the posterior
side, inconsistent with anatomy of the inferior aspect of the bladder, were eliminated. In
the second stage, we computed a least-trimmed squares fit [18] polynomial curve
(second-order curve in the case of a point configuration yielding a convex shape; firstorder curve otherwise) to the remaining candidate points, with the optimizer tuned to
treat 20% of the candidate points as outliers. We took the resulting curve to represent the
inferior bladder boundary (superior-most yellow dashed curve in Figure 3.1).
The third step was to fit the prostate template (described by the dimensions shown
in Figure 3.1) to the image using the anatomic boundaries found in the first and second
steps. This was done by defining the dimensions of the template to match the
anteroposterior (AP) and inferior-superior (IS) dimensions of the prostate on the test
image; this information is readily available in every clinical case from the prostate
ultrasound examination conducted prior to MRI. The template was then positioned
parallel to and 3 mm anterior to the rectal wall line (along a line perpendicular to the
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rectal wall line), inferior to the bladder boundary curve with a single point of contact
between the bladder boundary and the template (Figure 3.1).
The fourth and final step was to define the 3D surface of the prostate detected and
localized by the template. After fitting the template to the image, we extract a set of three
points (three blue crosses in Figure 3.1) from the template: the prostate centre points on
(1) the apex-most slice, (2) the base-most slice, and (3) the midgland slice equidistant to
the apex- and base-most slices. We then interpolate these three centre points using
piecewise cubic interpolation to estimate the centre points for all of the axial slices
between the apex and base. We then use the approach to prostate boundary localization
described in reference [17] reporting on our semi-automated segmentation method. The
approach is described at a high level here. For each slice, we oriented a set of 36 equally
spaced rays emanating from the centre point, one corresponding to each of the learned
mean intensity patches. For each ray we translated the corresponding mean intensity
patch to find the point whose circular image patch has the highest normalized crosscorrelation with the corresponding mean intensity path. Shape regularization was
performed within each slice using the corresponding PDM, followed by 3D shape
regularization. Full details are available in [17].
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Figure 3.1: Automatic coarse localization of the prostate. The dashed line shows the
estimated tangent line to the rectal wall. The dashed curve shows the estimated bladder
border. The solid line polygon is the template used to select the centre points for apex,
midgland and base. The prostate border based on manual segmentation has been overlaid
in dotted line as a reference. AP and IS are ,respectively, anterioposterior and inferiorsuperior dimensions of the prostate measured during routine clinical ultrasound imaging.
The three indicated points on the template define the three estimated centre points for the
prostate.

3.2.3 Validation
To evaluate the accuracy of the segmentation algorithm, we used complementary
boundary-based, regional overlap-based, and volume-based metrics. This allows the user
of the method to understand its applicability to a specific intended workflow. For
instance, the use of this algorithm for planning whole-prostate radiation would increase
the importance of low error in a boundary-based metric, whereas the use of the algorithm
in a retrospective study correlating prostate size with clinical outcome would focus on
accuracy of a volume-based metric. We used the MAD as the boundary-based error
metric; the DSC, recall rate and precision rate as regional overlap-based error metrics;
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and the volume difference (ΔV) metric to evaluate the automatic segmentation against
manual segmentation. We measured the metrics in 3D for the whole prostate gland and
also for the inferior-most third of the gland (corresponding to the apex region), the
middle third of the gland (corresponding to the midgland region) and the superior-most
third of the gland (corresponding to the base region).
MAD measures the misalignment of two surfaces in 3D in terms of absolute
Euclidean distance. To calculate the MAD in a unilateral fashion, the surface of each
shape is defined as a set of points, with one of the two shapes designated as the reference.
The MAD is the average of the absolute Euclidean distances between each point on the
non-reference set to the closest point on the reference set. Specifically,
𝑀𝐴𝐷(𝑋, 𝑌) =

1
∑ min 𝐷(𝑝, 𝑞) ,
𝑞∈𝑌
𝑁

(3.1)

𝑝∈𝑋

where X and Y are the point sets (Y is the reference set), N is the number of points in X, p
is a point in X, q is a point in Y, and D(p,q) is the Euclidean distance between p and q.
The MAD is an oriented metric and is therefore not invariant to the choice of
reference shape. This can be addressed by calculating the bilateral MAD, which is the
average of the two unilateral MAD values calculated taking each shape as the
reference.To calculate the DSC [12], recall rate and precision rate [17], we measured the
volume overlap between the two 3D shapes. Figure 3.2 and equations (3.2), (3.3) and
(3.4) define DSC, recall and precision, respectively.
𝐷𝑆𝐶(𝑋, 𝑌) =

2(𝑋 ∩ 𝑌)
2𝑇𝑃
=
𝑋+𝑌
𝐹𝑃 + 2𝑇𝑃 + 𝐹𝑁

𝑅𝑒𝑐𝑎𝑙𝑙(𝑋, 𝑌) =

𝑇𝑃
𝑇𝑃 + 𝐹𝑁
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(3.2)
(3.3)

𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛(𝑋, 𝑌) =

𝑇𝑃
𝑇𝑃 + 𝐹𝑃

(3.4)

We subtract the volume of the reference shape from the volume of the test shape
to calculate the signed volume difference (ΔV) metric
∆𝑉(𝑋, 𝑌) = 𝑉𝑎𝑙𝑔𝑜𝑟𝑖𝑡ℎ𝑚 − 𝑉𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 ,

(3.5)

where Valgorithm and Vreference are the prostate volumes given by the segmentation algorithm
and manual reference segmentation, respectively. Negative and positive values of ΔV
indicate under-segmentation and over-segmentation, respectively.

Y

X
FP

(reference)

FN
(TP)

Figure 3.2: Elements used to calculated the DSC, recall, and precision validation metrics.
X and Y are the two shapes, with Y taken as the reference shape. FP: false positive, TP:
true positive, FN: false negative.

3.3 Experiments
For all of the experiments in this chapter, all algorithm parameters were tuned
identically to those used in reference [17] to allow for direct comparison of the results.

3.3.1 Comparison of automatic and semi-automatic segmentation: accuracy
and time
We ran the automatic segmentation algorithm on our data set of 42 3D images and
compared the results to a single manual reference segmentation using leave-one-patient104

out cross validation. We compared each segmentation result against the reference using
our five error metrics on the four ROIs; the whole gland, apex, midgland and base
regions. We applied one-tailed heteroscedastic t-tests [19] to compare the performance of
the automatic segmentation to the semi-automatic segmentation. We measured the
average execution time for the automatic segmentation approach across the 42 images
and compared it to the average of semi-automatic execution time across the same data set
and identical running conditions, using a one-tailed t-test.

3.3.2 Comparison of automatic and semi-automatic segmentation versus
inter-operator variability in manual segmentation
We ran the automatic algorithm on the subset of 10 images for which we had
three manual reference segmentations. For comparison, we also applied our semiautomatic algorithm [17] to the same data set using nine different operators (four
radiation oncologists, one radiologist, one senior radiology resident, one imaging
scientist, and two graduate students, all with clinical and/or research experience with
prostate imaging). We used the remaining 32 images for training both algorithms. We
compared each segmentation result against the manual reference segmentations using our
five error metrics on the four ROIs; the whole gland, apex, midgland and base regions.
For the automatic segmentation method, we calculated the mean and standard
deviation of each metric for each ROI across all 10 images and three references, defined
as
𝑀

𝑎
̅ 𝑀𝑒𝑡𝑟𝑖𝑐
ℳ
=

𝐾

1
∑ ∑ 𝑀𝑒𝑡𝑟𝑖𝑐(𝐿𝑎𝑖 , 𝐿𝑘𝑖 ) and
𝑀×𝐾
𝑖=1 𝑗=1
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(3.6)

𝑀

𝑎
𝜎𝑀𝑒𝑡𝑟𝑖𝑐
=√

(3.7)

𝐾

1
̅ 1𝑎 ]2 ,
∑ ∑[𝑀𝑒𝑡𝑟𝑖𝑐(𝐿𝑎𝑖 , 𝐿𝑘𝑖 ) − ℳ
(𝑀 × 𝐾 − 1)
𝑖=1 𝑗=1

𝑎
̅ 𝑀𝑒𝑡𝑟𝑖𝑐
where 𝑀𝑒𝑡𝑟𝑖𝑐 is a function computing any one of the five metrics (e.g. MAD); ℳ

is the mean value of the metric for automatic segmentation across all the images and all
𝑎
the references; 𝜎ℳ1
is the standard deviation of the metric; M=10 and K=3 are the

number of images and references, respectively; 𝐿𝑘𝑖 is the manual segmentation by the kth
operator on the ith image; and 𝐿𝑎𝑖 is the automatic segmentation on the ith image. For the
semi-automatic segmentation, we calculated the mean and standard deviation of each
metric for each ROI across all 10 images, three references and nine operators, defined as
𝑀

𝑠
̅ 𝑀𝑒𝑡𝑟𝑖𝑐
ℳ

𝑁

𝐾

1
𝑠𝑗
=
∑ ∑ ∑ 𝑀𝑒𝑡𝑟𝑖𝑐(𝐿𝑖 , 𝐿𝑘𝑖 ) and
𝑀×𝑁×𝐾

(3.8)

𝑖=1 𝑗=1 𝑘=1

𝑀

𝑠
𝜎𝑀𝑒𝑡𝑟𝑖𝑐

𝑁

𝐾

(3.9)

2
1
𝑠𝑗
̅ 1𝑠 ] ,
=√
∑ ∑ ∑[𝑀𝑒𝑡𝑟𝑖𝑐(𝐿𝑖 , 𝐿𝑘𝑖 ) − ℳ
(𝑀 × 𝑁 × 𝐾 − 1)
𝑖=1 𝑗=1 𝑘=1

𝑠
̅ 𝑀𝑒𝑡𝑟𝑖𝑐
where ℳ
is the mean value of the metric across all the semi-automatic labels, all
𝑠
the images and all the references; 𝜎ℳ1
is the standard deviation of the metric; N=9 is the
𝑠𝑗

number of operators; and 𝐿𝑖 is the semi-automatic segmentation by the jth operator on the
ith image.
We used Simultaneous Truth and Performance Level Estimation (STAPLE) [20]
to generate one reference segmentation from each triplet of manual segmentations
𝑎
𝑠
̅ 𝑀𝑒𝑡𝑟𝑖𝑐
̅ 𝑀𝑒𝑡𝑟𝑖𝑐
performed on each image. We then computed ℳ
and ℳ
using the STAPLE

reference exactly as in Equations (3.6)–(3.9), with 𝐾 = 1 (reflecting the use of a single
STAPLE reference rather than 3 manual references).
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We compared the semi-automatic and automatic approaches separately for both
explained scenarios (three manual references and single STAPLE reference) using onetailed heteroscedastic t-tests. We defined the range of mean values of each metric
𝐿
𝐻
(𝐵𝑀𝑒𝑡𝑟𝑖𝑐
𝑡𝑜 𝐵𝑀𝑒𝑡𝑟𝑖𝑐
) when we compared three manual segmentations pairwise reported in

[17] as follows:
𝑚,𝑛
𝐿
̅ 𝑀𝑒𝑡𝑟𝑖𝑐
𝐵𝑀𝑒𝑡𝑟𝑖𝑐
= min ℳ
and

(3.10)

𝑚,𝑛
𝐻
̅ 𝑀𝑒𝑡𝑟𝑖𝑐
𝐵𝑀𝑒𝑡𝑟𝑖𝑐
= max ℳ
,

(3.11)

𝑚,𝑛

𝑚,𝑛

Where
𝑀

𝑚,𝑛
̅ 𝑀𝑒𝑡𝑟𝑖𝑐
ℳ

1
𝑛
= ∑ 𝑀𝑒𝑡𝑟𝑖𝑐(𝐿𝑚
𝑖 , 𝐿𝑖 ) and
𝑀

(3.12)

𝑖=1

𝑛
th
𝐿𝑚
𝑖 and 𝐿𝑖 are the manual segmentations for i image by observers m and n, respectively.

Wecompared the mean metric values for semi-automatic and automatic segmentation
𝑎
𝑠
̅ 𝑀𝑒𝑡𝑟𝑖𝑐
̅ 𝑀𝑒𝑡𝑟𝑖𝑐
(ℳ
and ℳ
) to this range. If the average of a metric at one ROI is within this

manual segmentation variability range or even the observed average error is below the
range, we took it into account as an improvement in accuracy and variability of the
algorithms compared to manual segmentation.

3.4 Results
3.4.1 Comparison of automatic and semi-automatic segmentation: accuracy
and time
The results in this section address research questions (1), (2), and (3) as described
in the introduction. Table 3.1 shows our automatic segmentation accuracy on 42 T2w MR
images against one manual reference segmentation. The results of the t-tests (with
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α=0.05) showed that using the automatic algorithm significantly increased the error in
terms of MAD and DSC in all the ROIs. Recall rates significantly decreased for the
whole gland, apex and midgland and significantly increased for the base when we used
the automatic segmentation algorithm. The precision rate also showed more error within
the whole gland, midgland and base. No significant changes were detected within the
apex in terms of the precision rate. We did not detect a significant increase in error for the
whole gland and midgland in terms of ΔV. The absolute value of ΔV was significantly
increased within the apex and significantly decreased within the base.
The mean ± standard deviation execution time using an unoptimized MATLAB
platform on a single CPU core for coarse prostate localization was 3.2 ± 2.1 sec. and for
3D segmentation was 54 ± 13 sec.
Table 3.1: Accuracy of automatic segmentation: mean ± standard deviation of MAD,
DSC, recall, precision, and ΔV. § and * show statistically significant accuracy gain and
loss, respectively, when compared to the results of semi-automatic segmentation in [17]
(p < 0.05).
Region of
Interest

MAD
(mm)

Whole Gland
Apex
Midgland
Base

3.2 ± 1.2*
2.8 ± 1.3*
2.8 ± 1.1*
3.8 ± 1.7*

DSC
(%)
71 ±
66 ±
82 ±
64 ±

11*
15*
9*
15*

Recall
(%)
69 ±
62 ±
82 ±
71 ±

15*
23*
15*
21§

Precision
(%)
76 ±
81 ±
84 ±
69 ±

12*
17
10*
22*

ΔV
(cm3)
-3.6 ± 10.4
-3.3 ± 5.1*
-0.5 ± 3.6
0.2 ± 7.5§

3.4.2 Comparison of automatic and semi-automatic segmentation versus
inter-operator variability in manual segmentation
The results in this section address research question (4) as described in the
introduction. In this experiment, the key result was that the accuracy of semi-automatic
and automatic segmentation algorithms approaches the observed inter-operator variability
range in manual segmentation. Figure 3.3 shows the mean ± standard deviation of the
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five metric values for each ROI for semi-automatic and automatic segmentation
algorithms, compared with the range of the mean of each metric within each ROI in pairwise comparison of the three manual reference segmentations. Figure 3.4 shows the mean
± standard deviation values for the five metrics for each region of interest for semiautomatic and automatic segmentation algorithms in comparison with STAPLE reference
segmentations. We overlaid the results of each metric lower and upper bounds at each
ROI in comparison of the three manual reference segmentations against STAPLE
reference using dashed lines. Note that in both Figure 3.3 and Figure 3.4 if the metric
value for each algorithm located within the range or at the lower error side it means that
the algorithm accuracy reached the observed inter-expert observer variation in manual
segmentation, and if the metric value located beyond the higher error bound that means
there could be still room for improvement of the algorithm accuracy. As these figures
show depends on the metric and ROI each of the algorithms might have outperformed the
other. In terms of some of the metrics at some of the ROIs no statistically significant
difference were detected between semi-automatic and automatic algorithms.

109

7

120

S. v M.
A. v M.

6

S. v M.
A. v M.

100

5

DSC (%)

MAD (mm)

80
4

60

3
40
2

20

1

0

W.G.

Apex

M.G.

0

Base

(b)

80

80
Precision (%)

Recall (%)

100

60

40

20

20

M.G.

S. v M.
A. v M.

60

40

Apex

Base

120

100

0

Base

W.G.

Apex

M.G.

ROI

ROI

(c)

(d)

20

20

M.G.
ROI

S. v M.
A. v M.

W.G.

Apex

(a)
120

0

W.G.

ROI

S. v M.
A. v M.

15

Base

Semiautomatic
vs. manual
S.
v M.
Automatic
A.
v M. vs. manual

10

5

3

Volume Difference (cm)

15

10

0

•5
-5

•10
-10

3

Volume Difference (cm)

•15
-15

-20
•20

5

-25
•25

W.G.

Apex

M.G.

Base

ROI

(e)

0

Figure 3.3: Accuracy of the computer-based segmentations vs. inter-operator variability
of manual segmentation. The average accuracy of one set of 10 automatic and nine sets of
10 semi-automatic segmentations in comparison with three manual reference
segmentations in terms of (a) MAD, (b) DSC, (c) recall, (d) precision and (e) ΔV. The
dashed line segments show the observed range of each metric at each ROI in pair-wise
comparison between three manual segmentations. For ΔV, the ranges are based on the
absolute value of ΔV due to lack of reference in comparison of two manual
segmentations. The significant differences detected between semi-automatic and
automatic segmentation at different ROIs have been indicated on the graphs (p-value <
0.05).
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Figure 3.4: Accuracy of the computer-based segmentations vs. inter-operator variability
of manual segmentation. The average accuracy of one set of 10 automatic and nine sets of
10 semi-automatic segmentations in comparison with STAPLE reference segmentation in
terms of (a) MAD, (b) DSC, (c) recall, (d) precision and (e) ΔV. The dashed line
segments show the observed range of each metric at each ROI in comparison between
three manual segmentations and STAPLE reference. The significant differences detected
between semi-automatic and automatic segmentation at different ROIs have been
indicated on the graphs (p-value < 0.05).
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3.5 Discussion
In this work, we measured the segmentation accuracy gained or lost when using a
fully-automatic version of a previously-published semi-automatic segmentation
algorithm. Such comparisons are routinely performed in the literature, often using a small
number of validation metrics and a single-observer reference standard. In this work, we
extended our analysis beyond this traditional approach to include a comparison of the
algorithm performance differences to inter-observer variability in segmentation error
metrics resulting from different expert manual segmentations. Measuring performance
differences between algorithms – those presented in this chapter or in other literature – in
the context of expert manual segmentation variability is important to understanding the
practical importance of algorithm performance differences.

3.5.1 Comparison of automatic and semi-automatic segmentation: accuracy
and time
For comparison to our previous results and other published work, we conducted
an experiment using a single manual reference segmentation to measure the accuracy of
our automatic algorithm. In terms of most of the metrics, there was a statistically
significant difference between automatic and semi-automatic segmentation errors. On
average, by switching from semi-automatic segmentation to automatic segmentation,
MAD increases by 1.2 mm, DSC decreases by 11%, recall decreases by 8%, precision
decreases by 12%, and the error in prostate volume decreases by 1 cm3 for the whole
gland. According to the results based on our multi-reference and/or multi-operator
experiments (Figure 3.3), the absolute value of the average ΔV based on automatic
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segmentation on whole gland significantly decreased from approximately 7 cm3 to less
than 1 cm3. This illustrates the complementary nature of the validation metrics and the
varying utility of different segmentations for different purposes. Whereas the automatic
segmentations may be less preferable to the semi-automatic segmentations for therapy
planning, the automatic segmentations may be preferable for correlative studies involving
prostate volume and clinical outcomes.
The nature of the data set used in PROMISE12 challenge is different from our
data set in terms of the consistent use of the an ER coil for MRI acquisition; our data set
contained only images acquired using the ER coil, whereas the PROMISE12 data set
contained a some with and some without the ER coil. However if we compare our results
in Table 3.1 to the published results in [16] where applicable, our results are within the
range of the metric values reported for the PROMISE12 challenge.
In the semi-automatic approach, the operator provided coarse prostate
localization, whereas in the automatic approach, this was done entirely by the algorithm.
To compare the time required for this step in both contexts, the mean measured operator
interaction time for semi-automatic segmentation was approximately 30 seconds [17],
whereas the mean measured time required for automatic coarse prostate localization was
measured in this study to be approximately 3 seconds using unoptimized MATLAB code
on a single CPU core.
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3.5.2 Comparison of automatic and semi-automatic segmentation versus
inter-operator variability in manual segmentation
The measured accuracy differences between the automatic and semi-automatic
approaches are nearly always smaller than the measured differences between manual
observer contours (differences between gray and black bars versus differences between
dashed lines on Figure 3.3), and also smaller than the measured differences between
manual observer contours and a STAPLE consensus contour (Figure 3.4). This suggests
that the performance differences measured between these two algorithms may be less
than the differences we would expect when comparing different observers’ manual
contours.
We observe that the top of the dark gray bar corresponding to the MAD metric in
Figure 3.3 for the whole gland lies within the range of variability between expert
observers’ manual contours. This indicates that on average, the semi-automatic
segmentation algorithm’s whole-gland segmentation accuracy, as measured by MAD, is
within the range of human expert variability in manual contouring. This means that
further investment of engineering efforts to improve this metric for this algorithm may
not be beneficial to the ultimate clinical workflow, since the algorithm’s error is already
smaller than the difference that might be observed between expert observers’ manual
contours. The fact that the top of the light gray bar in the same part of the figure lies
higher than the range given by the dashed lines indicates that this is not the case for the
fully automatic algorithm; further accuracy improvement in terms of MAD on the whole
gland may be warranted, with the caveat that such improvement must be measured using
a multi-observer reference standard. Inter-observer variability in manual segmentation
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would likely mask small improvements in the MAD; this is evidenced by the size of the
gap between the dashed lines (1.8 mm), compared to the 0.6 mm improvement in the
MAD that would be necessary to yield equal performance to the semi-automatic
algorithm. We observe in Figure 3.3 that for the MAD, DSC, precision, and ΔV metrics,
algorithm performance is near or within the range of human expert variability; this is the
case more often for the semi-automatic algorithm. The performance of the algorithms in
terms of the recall metric suggest that overall, both algorithms tend to undersegment the
prostate to an extent where there is practically important room for improvement. This is
especially true for the base region of the prostate. Interestingly, in terms of the recall
metric, the automatic algorithm had statistically significantly better performance than the
semi-automatic algorithm for every anatomic region except for the apex, with
substantially better performance in the base region. This is concordant with our
observations [17] of large inter-observer variability in determining the slice location of
the base during initialization of the semi-automated algorithm; determining where the
prostate base ends and the bladder neck begins is a challenging task even for expert
physicians. The observations made in Figure 3.4, where the range of observer variability
relative to a STAPLE reference are shown, are generally concordant with observations
made on Figure 3.3.
Taken as a whole, these observations highlight the value of measuring interobserver variability in manual segmentation, using complementary segmentation error
metrics, and measuring segmentation error in different anatomic regions known to pose
varying levels of challenge to expert operators and automated algorithms. Analysis of
these quantities as performed above allows us to determine the best ways to focus further
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engineering efforts to improve automated segmentation algorithms. A clinical end user
can identify the segmentation error metrics of greatest relevance to the user’s intended
application of the algorithm and use the plots in Figure 3.3 to determine whether a
particular algorithm’s accuracy in terms of those metrics is within the range of human
expert variability in manual segmentation. If so, the algorithm is ready to be moved
forward for full retrospective validation and then prospective testing within the intended
clinical workflow. If the analysis shows there is room for improvement to bring the
algorithm within the range of human performance for one or more anatomic regions,
further engineering efforts can be specifically focused accordingly. We anticipate that
this form of segmentation performance analysis will enrich future studies of automated
segmentation algorithms intended for use on the prostate and other anatomic structures,
enabling a means for determining the point at which an algorithm is ready to move
forward from bench testing toward clinical translation.

3.5.3 Limitations
The results of our work should be considered in the context of its strengths and
limitations. First, although the automatic segmentation algorithm does not require any
user interaction with the images, it does depend on the IS and AP dimensions of the
prostate as determined on the routine clinical ultrasound imaging that is performed as part
of guided biopsy before any MRI study would be conducted. In this study, the IS and AP
dimensions taken from manual MRI prostate segmentation were used as surrogates for
the measurements that would be taken during clinical ultrasound, and the performance
sensitivity of the automatic segmentation method to these measurements was not
determined. Second, our 3D segmentation algorithm requires the AP symmetry axis of
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the prostate for orientation information. Since during MRI acquisition the scanner
operator aligns the midsagittal plane of the scan to the midsagittal plane of the prostate
using localizer scans, we assumed that the AP symmetry axis of the prostate gland is
oriented parallel to AP axis of the image and assumed that all three prostate centre points
(at the apex, mid-gland and base) are located on the mid-sagittal plane of the image.
These assumptions are supported by our observations that segmentation algorithm is
robust to perturbations of the AP symmetry axis and centre point selection [17] but
nevertheless we felt it important to acknowledge these assumptions. Third, the small size
of our data set (42 single-reference images and 10 multi-reference images) limits the
strength of the conclusions of our work. Finally, we used MR image intensity as the only
image feature for prostate border detection and we did not use other image-derived
features such as image texture. Using other features might add complexity to the method
and may make the algorithm slower, however it could improve the accuracy of the
segmentation. Moreover, to have a more reliable assessment on the segmentation
algorithm, we still need to study the effects of post-segmentation manual editing on
prostate segmentation time, accuracy and reproducibility; this is the subject of our
ongoing work.

3.5.4 Conclusions
In this work, we described an automatic 3D prostate segmentation method
intended for use on T2w prostate MRI acquired using an endorectal receive coil. We
compared it to a semi-automated algorithm using complementary error metrics separately
in the apex, mid-gland, and base. We evaluated the algorithms’ accuracies in the context
of expert variability in manual segmentation. We addressed four key research questions
117

described in the introduction section of this chapter, the answers to which are enumerated
accordingly here. (1) When compared to a single-observer reference standard, the
automatic algorithm has an average MAD of 2.8 mm, DSC of 82%, recall of 82%,
precision of 84%, and volume difference of 0.5 cm3 in the mid-gland. Concordant with
results from other published algorithms, accuracy was highest in the mid-gland and lower
in the apex and base regions of the prostate. (2) The use of the automated algorithm
eliminated the need for 30 seconds of user interaction to perform coarse localization of
each prostate, replacing this step with a fully automatic approach requiring no user
interaction and needing 3 seconds of computation time. (3) The automatic algorithm’s
accuracy did not differ from the semi-automatic algorithm’s accuracy by more than 1 mm
in terms of MAD; 5% in terms of DSC, precision, and recall; and 8 cm3 in terms of
volume. The differences between the automatic and semi-automatic segmentation error
metrics were consistently smaller than the differences observed between manual contours
performed by experts. (4) The segmentation error metric values were near to or within the
range of expert manual segmentation variability for all but the recall metric, especially in
the prostatic base. This suggests that for our algorithms, engineering efforts should be
focused on further improvement of the segmentation of the base, which is challenging
even for human experts. The analysis approach taken in this chapter provides a means for
determining the readiness of a segmentation algorithm for translation toward clinical trial
for a specific purpose, and for focusing further engineering efforts on the most practically
relevant performance issues, supporting eventual achievement of clinical translation.
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Chapter 4.
Impact of physician editing on repeatability and time
for manual and computer-assisted prostate
segmentation on magnetic resonance imaging †

4.1 Introduction
In 2014, prostate cancer (PCa) was one of the most commonly diagnosed types of
cancer and the second leading cause of death from cancer among men in North America
[1, 2]. Due to its high soft tissue contrast, magnetic resonance (MR) imaging (MRI) has
demonstrated potential for detection, localization and staging of PCa [3-6] and therefore
in several centers MRI is being used for PCa diagnosis, treatment planning and therapy
guidance [3, 6-8]. Using an endorectal receiver (ER) coil during MRI acquisition yields
images with higher resolution and improved signal-to-noise ratio, with reported positive
impact on PCa diagnosis [7, 9, 10].
Delineation of the prostate capsule on MRI is required for several clinical
procedures in which MR images are employed. T2-weighted (T2w) prostate MRI plays
an important role in anatomy description [11, 12], PCa detection and localization [13],
and therefore, prostate contouring is usually performed on T2w MRI. However, three-

† A version of this chapter is in preparation for submission: M. Shahedi, D. W. Cool, C. Romagnoli,
G. S. Bauman, M. Bastian-Jordan, G. Rodrigues, B. Ahmad, M. Lock, A. Fenster, and A. D. Ward, "
Impact of physician editing on repeatability and time for manual and computer-assisted prostate
segmentation on magnetic resonance imaging," (in preparation).
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dimensional (3D) manual prostate contour delineation is laborious and time-consuming,
and subject to substantial inter-operator variability [14].
Several algorithms have been presented in the literature for 3D segmentation of
the prostate on T2w MRI, as described in a recent survey [15]. However, a minority of
these methods have been validated for use on T2w MRI acquired using an ER coil
(henceforth referred to as ER MRI). Although ER MRI can improve PCa detection, its
improved contrast results in the presence of additional high-frequency details in the
images. This makes automatic segmentation more challenging, especially for algorithms
designed for use on non-ER MRI where the intraprostatic signal is more homogeneous.
Furthermore, the ER coil deforms and displaces the prostate gland and produces MRI
artifacts [16] that further challenge automatic segmentation. We have previously reported
on semi-automatic [17] and automatic (Chapter 3) segmentation algorithms developed in
our laboratory. Full details are available in the original publications; we describe details
relevant to this study here. These methods are based on prostate shape and appearance
models learned from a training set. Segmentation is performed in two steps: coarse
localization of the prostate, followed by 3D segmentation boundary detection and
refinement. In the semi-automated approach, coarse localization is performed by the
operator with four mouse clicks requiring approximately 30 seconds of user interaction
time. In the automated approach, coarse localization is performed automatically within 3
seconds of computation time, with no requirement for user interaction.
A range of segmentation accuracy values has been reported in the literature for
automated and semi-automated algorithms (Table 4.1). Typically, reported error metrics
include the mean absolute distance (MAD) between the boundaries of the automatic and
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manual segmentations, and/or the Dice similarity coefficient (DSC). Reported MAD
values range from 1.5–3.4 mm [17-20], and reported DSC values range from 82%–91%
[17-21]. Reasons for the range of different error values reported include algorithm design,
the use of single-operator manual reference segmentations for validation in most studies,
and the use of different imaging data sets. These differences notwithstanding, the errors
yielded by state-of-the-art segmentation methods are asymptotically approaching the
differences observed between human expert operators [14]. It is thus timely to shift the
focus of research in this area to studies aimed at enabling clinical translation of these
techniques so that they can be of benefit to those suffering from cancer.
For reasons of diagnostic accuracy and patient safety, the integration of any
computer-assisted segmentation algorithm, fully automatic or otherwise, into clinical use
will require that an expert reviews and edits each segmentation as necessary before
proceeding. This will always be necessary since regardless of the reported accuracy of a
given segmentation algorithm, unusual cases will occur in the clinic that result in poorquality computer-assisted segmentations, with potentially disastrous consequences to the
patient if such segmentations were used to guide treatment. Therefore, the clinical utility
of a method will depend not only on its accuracy metric values, such as the MAD and
DSC, determined on a testing data set, but also on the amount of editing deemed
necessary by expert physicians in order to render the segmentation suitable for clinical
use. This editing can be measured spatially using standard metrics such as MAD and
DSC, to compare the segmentation as output by the algorithm to the segmentation after
editing, and these metrics can be computed on anatomically distinct regions to learn
about the portions of the prostate requiring the most editing. Potentially of even greater
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importance, the amount of required editing time can be measured. For a segmentation
algorithm to have clinical utility, it must allow the expert physician to obtain a
segmentation deemed clinically acceptable by him/her in less time than would be
required to perform a manual segmentation. This statement holds true regardless of the
reported segmentation accuracy metrics (e.g. MAD, DSC) for an algorithm in the
literature. To the best of our knowledge, questions of editing magnitude and time have
not been extensively studied for ER MRI prostate segmentation algorithms reported in
the literature.
In this chapter, we conducted a user study to answer four research questions. (1)
How much spatial segmentation editing do expert operators perform to obtain clinically
useful segmentations? (2) What is the inter-operator variability in segmentation? (3)
How much segmentation editing time do expert operators require to obtain clinically
useful segmentations? (4) Can the necessary time requirement for segmentation editing
be predicted from spatial segmentation error metrics? Questions (1), (2), and (3) were
answered and compared under three conditions, where the segmentations provided to the
operators for editing came from (a) our automatic segmentation algorithm, (b) our semiautomatic segmentation algorithm, and (c) manual segmentation performed by another
expert operator. As the scope of question (4) is limited to evaluation of computer-assisted
segmentation algorithms, it was answered under conditions (a) and (b) only.
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Table 4.1: Reported segmentation errors for prostate segmentation algorithms intended
for use on T2w ER MRI.
Algorithm

Technique

Data set size

Accuracy

Our semiautomatic
algorithm [17]
(described in
Chapter 2)

Local appearance and
shape model (semiautomatic)

42
(test and
training)

Whole gland:
MAD: 2.0 ± 0.5 mm
DSC: 82% ± 4%
Recall: 77% ± 9%
Precision: 88% ± 6%
ΔV: -4.6 ± 7.2 cm3

Our automatic
algorithm
(described in
Chapter 3)

Local appearance and
shape model (automatic)

42
(test and
training)

Cheng et al. [21]

Atlas-based (automatic)

100
(training) and
40 (test)

Liao et al. [18]

Multi-atlas-based
(automatic)

66 (test)
9 (atlas)

Toth and
Madabhushi [19]

Active appearance model
(semi-automatic)

108

Vikal et al. [22]

Shape model (semiautomatic)

3

Whole gland:
MAD: 3.2 ± 1.2 mm
DSC: 71% ± 11%
Recall: 69% ± 15%
Precision: 76% ± 12%
ΔV: -3.6 ± 10.4 cm3
Whole gland:
TP: 91.2%
DSC: 87.6%
ΔV: 8.4%
Whole gland:
MAD: 1.8 ± 0.9 mm
DSC: 88% ± 3%
Whole gland:
MAD: 1.5 ± 0.8 mm
DSC: 88% ± 5%
Has not reported for whole gland

Whole gland:
Atlas-based (semi1 (reference)
MAD: 3.4 ± 2.0 mm
Martin et al. [20]
automatic)
17 (test)
Recall: 89% ± 6%
Precision: 78% ± 12%
MAD: mean absolute distance, DSC: Dice similarity coefficient, ΔV: Volume difference, TP: true positive

Segmentation time
Operator interaction:
28 ± 14 sec. (across
10 images and 9
operators)
Execution: 85 ± 20
sec. (across 42
images, one
operator)
Execution: 54 ± 13
sec. (across 42
images)

NA

Execution: 2.9 min.

Execution: 150 sec.
Execution: 23 sec.

NA

4.2 Materials and Methods
4.2.1 Materials
Our sample consisted of 10 axial T2w fast spin echo ER MRI acquired at 3.0
Tesla field strength, all from patients with biopsy-confirmed PCa. Images were acquired
with TR = 4000–13000 ms, TE 156–164 ms, NEX = 2. The voxel sizes were 0.27 × 0.27
× 2.2 mm as is typically seen in clinical prostate MRI. The images were acquired using a
Discovery MR750 (General Electric Healthcare, Waukesha, WI). The study was
approved by the research ethics board of our institution, and written informed consent
was obtained from all patients prior to enrolment. All 10 MR images were segmented
manually by three operators: one radiologist, one radiation oncologist and an expert
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radiology resident with >3 years’ experience reading >100 prostate MRI studies in
tandem with a board-certified radiologist as part of a trial conducted at our centre. Editing
was conducted by four radiation oncologists with genitourinary specialization and the
same expert radiology resident. The ITK-SNAP software tool [23] was used for manual
segmentation.
T2w MRI
(n = 5)

T2w MRI
(n = 10)

T2w MRI
(n = 5)

Condition (a):
Auto seg
(operator N/A)

Condition (b):
Semiauto seg
(operator i)

Condition (c):
Manual seg
(operator j ≠ i)

Editing
(operator i)

Editing
(operator i)

Editing
(operator i)

Editing metrics
(auto seg)

Editing metrics
(semiauto seg)

Editing metrics
(manual seg)

Comparison of spatial and temporal metrics

Figure 4.1: Study design showing the workflow for a particular operator #i. The operator
edited three sets of segmentations: five automatic segmentations, five semi-automatic
segmentations performed by the operator, and five semi-automatic segmentations
performed by a different operator #j. Spatial and temporal segmentation metrics were
collected to measure the editing task and compared across the three conditions.

4.2.2 Study design
Our study design is shown in Figure 4.1. Each operator #i edited a total of 15
segmentations under three conditions: (a) five automatic segmentations, (b) five semiautomatic segmentations performed based on the operator’s own inputs as the semiautomatic segmentation algorithm operator, and (c) five manual segmentations performed
by a different expert operator #j. Operator #j was the same individual throughout the
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entire experiment; operator #j only provided manual reference segmentations and did not
take part in this editing study in any other way. Editing was performed in slice-by slice
mode using the ITK-SNAP interface on axially-oriented slices. Changes were applied
only on the axial slices but sagittal and coronal views were also provided to the operator
during editing, so the operator could check for spatial coherence of the segmentations in
these views. The operators used the adjustable-size paint brush tool in ITK-SNAP to
add/remove area to/from the segmentation labels. They were able to adjust window and
level and zoom in and out during editing. Spatial and temporal metrics were collected for
each of the three conditions to compare the editing that was performed within each
operator and between operators. To enable direct comparison of the editing of the
automatic and semi-automatic segmentations, we used the same subset of 5 MRI scans
for each operator for these two conditions. To mitigate possible effects of the order of
MRI scan presentation on the experiment, the 15 segmentations were presented in a
different randomized order for each operator, with a constraint that between any two
presentations of the same MRI scan to the operator (i.e. once for automatic segmentation,
and again with the same scan for semi-automatic segmentation), there were at least six
MRI scans from other patients presented.

4.2.3 Spatial editing magnitude and inter-operator variability
We compared the pre-editing segmentations to the post-editing segmentations in
each of the three conditions shown in Figure 4.1, answering research question (1). We
used five different metrics, including MAD, DSC, recall, precision and volume difference
(ΔV), to perform comparisons in terms of surface disagreement, regional misalignment
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and volume difference. Where applicable, the post-editing segmentation was defined as
the reference segmentation. These metrics are defined in detail below.
4.2.3.1 Mean absolute distance
The MAD metric measures the disagreement between two 3D surfaces as the
average of a set of Euclidean distances between corresponding surface points of two
shapes. For each point on one surface, the closest point on the other surface is defined as
the corresponding point. Equation (4.1) shows the MAD of X and Y as two surface point
sets, where D(p,q) is the Euclidean distance between points p and q. A MAD of zero
indicates ideal agreement between two shapes.
𝑀𝐴𝐷(𝑋, 𝑌) =

1
∑ min 𝐷(𝑝, 𝑞)
𝑞∈𝑌
𝑁

(4.1)

𝑝∈𝑋

The MAD calculation needs to consider one of the shapes as the reference (e.g.
point set Y is the reference in equation (4.1). Therefore, when two segmentations are to be
compared and there is no reference segmentation, we use the bilateral MAD which is the
average of the two MAD values obtained using each segmentation as the reference.
4.2.3.2 Dice similarity coefficient
The DSC is a region-based metric that measures the proportion of the volume of
the overlap region between two shapes and the average of their volumes in 3D (equation
(4.2)). The DSC is a unitless metric and will be 100% in the case of ideal segmentation
and 0 when there is no overlap.
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4.2.3.3 Recall and precision rates
Recall (or sensitivity) and precision are also unitless error metrics that measure
the regional misalignment in terms of the overlap region with 100% and 0 as the ideal
and worst-case measurement values, respectively. To calculate recall and precision, we
need to consider one shape as the reference. Recall measures the proportion of the
reference that is within the segmentation (equation (4.3)) and precision measures the
proportion of the segmentation that is within the reference (equation (4.4)).
𝐷𝑆𝐶(𝑋, 𝑌) =

2(𝑋 ∩ 𝑌)
2𝑇𝑃
=
× 100 ,
𝑋+𝑌
𝐹𝑃 + 2𝑇𝑃 + 𝐹𝑁

𝑅𝑒𝑐𝑎𝑙𝑙(𝑋, 𝑌) =

𝑇𝑃
× 100 ,
𝑇𝑃 + 𝐹𝑁

𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛(𝑋, 𝑌) =

𝑇𝑃
× 100 ,
𝑇𝑃 + 𝐹𝑃

(4.2)
(4.3)

(4.4)

where TP is the true positive or correctly identified region, FP is the false positive or
incorrectly identified region, and FN is the false negative or incorrectly ignored region
(see Figure 3.2).
4.2.3.4 Volume difference
To calculate ΔV we subtract the reference shape volume from the segmentation
shape volume. Therefore ΔV is a signed error metric; i.e. negative values of ΔV show
that the segmentation is smaller than the reference and positive values of ΔV show that
the segmentation is larger than the reference.
To quantify inter-operator variability in segmentation and editing (answering
research question (2)), we calculated simultaneous truth and performance level
estimation (STAPLE) [24] consensus segmentations from the five operator segmentations
before and after editing under all three conditions, with two exceptions. In the case of the
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pre-editing automatic segmentations, no operators were involved, so no STAPLE
segmentation was calculated. In the case of the pre-editing manual segmentations, only
the segmentations of a single operator #j were edited in this study. To obtain a measure of
inter-operator variability in pre-editing manual segmentations, we computed a STAPLE
segmentation from manual segmentations performed by three of our operators on the
same five images that were used for manual segmentation editing in our study. There
were thus five sets, each containing five segmentations performed by different operators,
with accompanying STAPLE consensus segmentation: (1) pre-editing semi-automatic,
(2) post-editing semi-automatic, (3) post-editing automatic, (4) pre-editing manual, and
(5) post-editing manual. Within each of these five sets, our five segmentation error
metrics were computed to compare each operator’s segmentation to the corresponding
STAPLE segmentation, with the means of the metric values indicating the amount of
inter-operator variability. We used one-tailed pairwise heteroscedastic t-tests to test for
statistical significance of differences in these inter-operator variability measurements
between paired elements of the five sets. This allows us, for instance, to measure whether
there is a statistically significant reduction of inter-operator variability in edited semiautomatic segmentations, versus edited automatic segmentations.

4.2.4 Required editing time and correlation with spatial error metrics
For each label, we recorded the interaction time that was required to have a
clinically acceptable segmentation using manual, semi-automatic and automatic
segmentation methods, answering research question (3). We recorded the time from the
moment when the operator began reviewing and editing the segmentation until the
moment the operator verbally confirmed that the segmentation was ready to be used in
130

clinic. The editing time included browsing through the slices in the 3D volume,
reviewing the segmentation, adding to and removing from the segmentation, window and
level adjustment, editing tool selection and adjustment, and zooming in and out. For each
of the three conditions, we calculated the mean and standard deviation of the interaction
time across the five presented MRI scans separately for each operator, and also in
aggregate across all five operators. For the semi-automatic algorithm we measured the
interaction time required for algorithm operation and included this interaction time as part
of the time required for the condition involving semi-automatic segmentation.
We measured the degree to which measured spatial error metric values can be
used as surrogates for the amount of editing time needed to achieve a segmentation that is
satisfactory to the operator, answering research question (4). To do this, we calculated all
five of our error metrics for the whole gland, apex, mid-gland, and base, comparing the
pre-editing segmentation to the post-editing segmentation for the automatic and semiautomatic segmentations (conditions 1 and 2 in Figure 4.1), using the post-editing
segmentation as the reference where applicable. We measured the monotonicity of the
relationship between each metric value and editing time using Spearman’s rank-order
correlation (ρ). We tested the statistical significance of the correlation coefficients using
the null hypothesis that there was no association between the error metric values and
editing time values. For all tests, the sample size was 50 (10 images each contoured by 5
operators).
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4.3 Results
4.3.1 Spatial editing magnitude and inter-operator variability
Figure 4.4 shows the spatial magnitude of editing required for automatic, semiautomatic, and manual segmentations for operators to achieve final edited segmentations
suitable for clinical use. As might be expected, the general trend is that the automatic
segmentations required the most editing, followed by the semi-automatic and manual
segmentations. However, this trend was not reflected in all of the error metrics. For
instance, looking at the DSC and recall metrics, we detected no significant difference in
the amount of editing applied to the automatic vs. semi-automatic segmentations.
Operator editing of manual segmentation consistently decreased segmentation volume
without substantially affecting precision. This suggests that the manual pre-editing
segmentations were deemed by the operators to be oversegmentations, and editing drew
the boundaries inward by an amount reflected by the MAD metric values in Figure 4.4
(MAD < 1 mm in general). Figure 4.3 shows the inter-operator variability in
segmentation before and after editing, reported using the mean of each segmentation
error metric across all operators for each image, with respect to a STAPLE reference
standard. This analysis revealed significant differences in inter-operator variability for
most of the conditions, for all metrics expect for the volume difference. Note the
substantial inter-operator variability in manual segmentation (reflected by large mean
metric values and large variability indicated by the whiskers) for many metrics, relative
to the inter-operator variability in semi-automatic and automatic segmentations, even
when manual editing is applied (e.g. compare the “manual-pre” measurements to the
other measurements for the MAD metric in Figure 4.3). Overall, post-editing variability
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is lower than pre-editing variability, with post-editing automatic and semi-automatic
segmentations having similar variability. The MAD, DSC, and precision metrics revealed
that editing reduced the amount of inter-operator variability for the semi-automatic
segmentation condition (compare SA (pre) to SA (post) in Figure 4.3 for these three
metrics). Interestingly, a similar pattern was observed for the manual segmentations. No
significant differences were found between pre-editing manual segmentations and
computer-assisted segmentations for any of the conditions or metrics. Post-editing
automatic segmentation consistently demonstrated lower variability than pre-editing
semi-automatic segmentation. No significant differences were found between postediting automatic segmentation and post-editing semi-automatic segmentation.
Table 4.2: User manual interaction time for ready to use prostate segmentation in T2w
MRI.
Segmentation labels

No. of images No. of Operators User interaction time

Manual

5

5

213 ± 90 sec (3:33 ± 1:30 min)

Semi-automatic

5

5

328 ± 126 sec (5:28 ± 2:06 min)

Semi-automatic (user interaction time included)

5

5

351 ± 128 sec (5:51 ± 2:08 min)

Automatic

5

5

393 ± 146 sec (6:33 ± 2:26 min)
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Figure 4.2: User manual interaction time on manual, semi-automatic (S.A.) and
0
automatic segmentations.The statistically significant
differences
indicated
Manual
S.A. with * on
S.A. the
(inc. initialization)
Edited labels
averages of the groups across all the five images (p < 0.05).

4.3.2 Required editing time and correlation with spatial error metrics
Table 4.2 shows the mean ± standard deviation of the recorded time required for
each of the three conditions. For the semi-automatic condition, the time required only for
editing, as well as the time required for editing plus the time required to interact with the
semi-automated algorithm, are reported separately. Figure 4.2 shows the breakdown of
these editing times for each image. Significant differences were found between editing
times for all conditions, except when comparing automatic segmentation to semiautomatic segmentation. To provide context for these editing times, according to the
literature, the time required for manual prostate delineation on MRI can range from
approximately 5 minutes [25] to approximately 20 minutes per patient [26], or about 1.6
minutes for each 2D slice [27]. Our experience is concordant with this reported time
range; timing of manual segmentation on the five images used in conditions (a) and (b)
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for one expert operator yielded a mean ± standard deviation segmentation time of 564 ±
162 sec (9:20 ± 2:42 min). Based on Table 4.2, we observe that operators spent
approximately 2–3 additional minutes editing computer-assisted segmentations,
compared to the amount of time spent editing manual segmentations performed by a
different expert operator.

4.3.3 Correlation of editing time with the metric values
Table 4.3 shows the correlations between editing time and spatial editing
magnitudes as measured using our segmentation error metrics. There were few significant
correlations and none had magnitude > 0.5. Significant correlations were predominantly
in the base of the gland. In the base, recall was positively correlated with editing time,
and precision and volume difference were negatively correlated with editing time. This
pattern was observed in the whole gland as well but only weakly in the mid-gland and not
in the apex.
Table 4.3: Correlation between editing time and spatial editing magnitude measured
using five metrics. Each value is the Spearman’s correlation coefficient between the
value of each error metric and editing time. The bold numbers indicate statistically
significant correlations (p < 0.05)
Anatomic region

MAD

DSC

Recall

Precision

ΔV

Whole gland

0.204

0.18

0.361

-0.341

0.417

Apex

0.206

-0.081

-0.194

-0.138

0.092

Mid-gland

0.263

-0.149

0.149

-0.282

0.312

Base

-0.14

0.367

0.428

-0.305

0.406
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Figure 4.3: Inter-operator variability. Each bar shows the average metric value for one
image across five operators. The 400
error bars indicate one standard deviation. The
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groups across all the five operators 200
and five images (p < 0.05). SA: semi-automatic.
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Figure 4.4: Editing magnitude, showing the differences between the segmentations preand post-editing for each of the three conditions.Each bar shows the average metric value
for one image across five operators. The error bars indicate one standard deviation. The
horizontal lines indicated statistically significant differences on the averages of the
groups across all the five operators and five images (p < 0.05).
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4.4 Discussion
4.4.1 Spatial editing magnitude and inter-operator variability
As shown in Figure 4.4, there was a nonzero difference between pre-editing and
post-editing expert manual segmentations for all metrics. The amount of editing
performed on the manual segmentations provides valuable perspective on the amount of
editing performed on the automatic and semi-automatic segmentations. One might expect
that improvements to computer-assisted segmentation algorithms would require amounts
of editing asymptotically approaching the amounts of editing that operators deem
necessary for expert manual segmentations provided by other experts (i.e. expert
operators would elect to edit outputs from even an ideal computer-assisted segmentation
algorithm). For studies of computer-assisted segmentation algorithms using singleoperator manual reference standard segmentations for validation, this observation is
especially important; this suggests that algorithms yielding segmentation error metric
values within the range observed in expert editing of manual expert segmentations could
be considered to have essentially the same performance. For instance, Figure 4.4 would
suggest that two algorithms reporting DSC values of 94% and 96% would be considered
to perform equally, as these values are well within the range of manual editing of manual
segmentations. This observation could have ramifications for the ranking schemes used
for segmentation grand challenges (such as PROMISE12 [28]), suggesting a practical
equivalence of some top-ranked algorithms and a potential means for deciding when topranked algorithms are ready to be moved to the next stage of translation to clinical use.
Although some metrics revealed a significant difference in the amount of editing required
for automatic vs semi-automatic segmentations, this significance (and the magnitude of
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the difference) varied across metrics. This observation emphasizes the need for multiple,
complementary spatial metrics to comprehensively assess the performance of a
segmentation algorithm.
Our analysis in Figure 4.3 indicates that in general, allowing operators to edit
provided segmentations reduces inter-operator variability in segmentation, compared to
the inter-operator variability resulting from manual segmentations performed from
scratch. The trend held even when comparing manual segmentations performed from
scratch to manual segmentations that have been edited to satisfaction by another operator.
This result underscores the value of providing operators with a starting segmentation for
editing as this could improve the reproducibility of prostate segmentation, which is
important for multi-operator clinical trials and consistency of patient care in clinical
practice. Whereas the lowest inter-operator variability resulted from giving operators a
starting segmentation performed manually by another expert, in clinical practice this is
clearly impractical. From this perspective, the automatic segmentation could be seen as a
practical alternative approach to obtain the starting segmentation. Although the difference
in inter-operator variability between post-editing manual segmentations and post-editing
automatic segmentations was statistically significant, inspection of Figure 4.3 reveals that
this difference is very small from a practical perspective. This leads to the hypothesis that
providing operators with an automatic segmentation with accuracy metric values similar
to ours (Table 4.1) as a starting point will yield superior inter-operator reproducibility
even after editing, compared to manual segmentations performed from scratch. This
hypothesis needs to be tested in a larger study covering a broader range of segmentation
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algorithms, a larger data set, and a larger pool of operators having different experience
levels.

4.4.2 Required editing time and correlation with spatial error metrics
Our results suggest that the use of automatic or semi-automatic segmentation
algorithms to provide a starting segmentation for editing should reduce the total amount
of time required to achieve a clinically acceptable segmentation, relative to typical
reported times required for manual segmentations performed from scratch. Our results
also suggest that the difference in total time required to use our automatic vs semiautomatic segmentation algorithms for this purpose is small, when the time required to
interact with the semi-automatic segmentation algorithm is taken into account. Thus, the
choice in this regard may come down to operator preference; the semi-automatic
segmentation algorithm allows the operator to specify the apex-to-base extent of the
prostate, reducing the need for editing involving adding or removing entire slices in these
regions. This comes at the cost of needing to wait for < 60 seconds for the segmentation
to be computed online, whereas the automatic segmentations can be computed offline
immediately after MRI scanning and thus would appear instantaneously to the operator at
time of editing. Our results also showed that operators spent more time editing the
computer-assisted segmentations, compared to the time spent editing manual
segmentations by another expert operator. We posit that this difference in editing time is
an important metric for determining the suitability of a computer-assisted segmentation
algorithm for translation to clinical use in scenarios where for safety or other reasons,
expert operator verification for necessary editing will be performed on every
segmentation. From this perspective, there is room for improvement in our semi140

automatic and automatic algorithms of approximately 2–3 minutes of editing time per
prostate in order to achieve concordance with the amount of editing performed on manual
segmentations.
Table 4.3 indicates a consistent negative correlation of the precision metric value
with editing time, with statistically significant correlations in all anatomic regions except
for the apex. This implies that the greater the false positive area in a computer-assisted
segmentation, the greater the time that will be required to edit the segmentation to a
clinically acceptable level. This is corroborated by the consistent positive correlation with
the volume difference metric (again, significant everywhere except the apex), implying
that the greater the amount of oversegmentation performed by computer-assisted
segmentation algorithm, the more editing time that will be required. Comparing the
correlation coefficients for precision and volume difference within the apex, mid-gland,
and base, the strongest correlations were found in the base region. This implies that the
above relationships are especially applicable for false positive regions and
oversegmentation of the base. However, based on these observations one could make
only a weak recommendation that the amount of necessary editing time could be
estimated based on the precision and volume difference spatial error metric values;
although the correlation coefficients are statistically significant in many cases, they do
not have high magnitude.
The lack of strong correlations in Table 4.3 implies weak relationships between
editing time and spatial editing magnitudes as measured by our segmentation error
metrics. The observations in the previous paragraph notwithstanding, this implies that in
general, one cannot use spatial metrics such as the MAD, DSC, precision, recall, and
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volume difference to estimate the amount of time that an operator will require to produce
a clinically acceptable segmentations using the output of a segmentation algorithm as a
starting point. This is an important observation since in most clinical workflows, time is a
scarce and valuable resource; if it takes (nearly as) long to edit a segmentation from an
algorithm as it does to perform a manual segmentation from scratch, the clinician may be
inclined toward the simpler approach of performing manual segmentation. We surmise
that this issue is a major contributor to the present state of affairs, where the academic
literature has produced many hundreds of computer-assisted segmentation algorithms and
yet very few of them have moved forward to clinical use. This leads to the conjecture that
the most important metrics to compute when evaluating the suitability of an algorithm for
clinical translation are operator variability, measured using spatial metrics such as MAD,
DSC, etc., and editing time, measured directly using a sample of multiple operators.
Viewed through this lens, the ideal segmentation algorithm would yield low operator
variability and low editing time. This suggests that a potential reevaluation of the use
spatial metrics for measuring segmentation accuracy may be in order, since in most
practical clinical workflows, the final segmentation as edited and approved by the
clinician will be used for its clinical purpose and could be considered 100% “accurate”
for practical purposes. This observation supports engineers and computer scientists
aiming for the concrete goal of producing a clinically useful segmentation in a minimum
amount of time, in lieu of setting our aims according to the nebulous notion of accuracy,
with all of its attendant issues (e.g. differing expert opinions on what constitutes a correct
segmentation, issues regarding whether “gold standard” expert segmentations truly
delineate the histologic boundary of the target of interest).
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Comparing our algorithms to a hypothetical segmentation algorithm that
demonstrated better performance based all five introduced error metrics in a multioperator and multi-reference study, and noting that no such algorithm has been reported
in the literature due to a lack of comprehensive validation:
(1) We expect that less editing of the segmentation results would be required, but
not less than the amount of editing applied by an expert on to a manual segmentation
provided by another expert.
(2) Since there was not a big difference in terms of editing time measured for
automatic and semi-automatic segmentation algorithms, and no strong correlation
between segmentation error metric values and the required editing time, we cannot
speculate as to whether this hypothetical algorithm would result in reduced editing time.
(4) We acknowledge that our observed lack of correlation between spatial error
metric values and editing time only applies to the range of spatial error metric values that
we observed for our algorithms. Such a correlation is possible for different error metric
value ranges; e.g. containing the better metric values given by this hypothetical
algorithm.

4.4.3 Limitations
This work must be considered in the context of its strengths and limitations. We
acknowledge that given our image sample size and number of operators participating in
the study, in some aspects, this is a descriptive, hypothesis-generating study that points
the way to potentially fruitful studies on larger sample sizes with sufficient statistical
power to draw firmer conclusions. We also acknowledge that although the editing
interface we used, involving a mouse-driven variable-sized paintbrush tool, is concordant
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it its mode of operation with the interfaces used in many clinical workflows, it does
constitute only a single mode of performing segmentation editing. Thus, our study
generates no knowledge about the impact of the choice of editing tool on editing times,
and this would be a subject of valuable further study. Finally, in this user study we tested
only two computer-assisted segmentation algorithms; a more comprehensive future study
involving a broader cross-section of current algorithms is warranted.

4.4.4 Conclusions
In this chapter, we conducted a user study measuring the amount of spatial editing
performed by expert users on segmentations generated manually, semi-automatically, and
automatically. We measured the inter-operator variability in segmentation before and
after editing, and measured the relationship between editing magnitude and time spent
editing. With reference to the enumerated research questions in the introduction section
of this chapter, we have reached four main conclusions, with the acknowledgment that
our sample size implies that these conclusions should be considered as hypotheses to test
in future, larger studies. (1) As would be expected, the operators performed the most
spatial segmentation editing on the automatic segmentations, followed by the semiautomatic segmentations, and the least amount of editing on the manual segmentations.
The measured editing magnitudes varied according to the error metric used, reinforcing
the value of using multiple, complementary error metrics in segmentation studies, rather
than focusing on one or two typically used metrics (e.g. the MAD and DSC). (2)
Providing operators with a starting segmentation for editing, either performed manually
by another operator or (semi-)automatically via an algorithm, yielded lower interoperator variability in the final segmentation, compared to inter-operator variability in
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manual segmentations performed from scratch (as is frequently performed in clinical
workflows currently). Inter-operator variability resulting from using our automatic
algorithm to generate starting segmentations was not substantially higher than that
resulting from using expert manual segmentations as starting segmentations, suggesting a
role for our automated segmentation algorithm in this context. (3) The use of our
automatic or semi-automatic segmentation algorithms to generate starting segmentations
for editing is expected to decrease the total required segmentation time, compared to the
time required to perform manual segmentations from scratch, and the choice of automatic
vs. semi-automatic segmentation for this purpose comes down to operator preference. (4)
The necessary time requirement for segmentation editing cannot be reliably predicted
from spatial segmentation error metrics in all anatomic regions of the prostate. Thus, for
the many clinical workflows where manual segmentation review and editing will be
performed for safety and other reasons, and minimization of editing time is a primary
goal, the fact that one algorithm outperforms another in terms of spatial metrics such as
the MAD and DSC does not imply that the algorithm is more suitable for clinical
translation. In such contexts, where the medical expert’s final edited segmentation is
taken as correct for practical purposes, the ideal segmentation algorithm supports the
expert’s obtaining of a clinically acceptable segmentation in a minimum amount of time
while minimizing inter-operator segmentation variability. This increases the volume of
patients that can be treated and simultaneously supports consistent quality of the
intervention patients receive.
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Chapter 5.
Conclusions and directions for future work
5.1 Conclusions
The work in this thesis has resulted in the following advances in technology and
knowledge, enumerated according to the objectives given in Section 1.9:
1. Chapter 2 described a novel system for semi-automatic prostate segmentation
on T2w ER MRI. An important aspect of this system is that the main computational step
of the segmentation is in computing loci of candidate boundary points, and our algorithm
is such that the estimation of each locus is completely independent of all other loci, with
regularization as a post-processing step. Therefore, the algorithm has high potential for
further speedup via a parallel computing implementation. The accuracy and interobserver variability of this system was measured using a set of complementary error
metrics on multiple anatomic regions of interest within the prostate. We used a validation
methodology in which three different types of error (surface disagreement, region
misalignment and volume difference) in segmentation results were quantified using five
error metrics. The error measurements were applied to the prostate gland as a whole, and
to the apex, midgland and base regions separately. The system improved the
reproducibility of the prostate segmentation, compared to manual segmentation,
supporting the central hypothesis of this thesis. The system was shown to require
minimal user interaction (30 seconds). Our results showed that the choice of manual
reference segmentation had the biggest impact on segmentation variability, reinforcing
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the need for multi-operator reference standard segmentations for algorithm validation.
This study also showed that not only is prostate apex and base challenging (both semiautomatically and manually), but in fact there is high inter-observer variability in even
defining the apex-most and base-most extents of the prostate. This sheds light on the
most critical areas of focus for future development of prostate segmentation algorithms
on MRI.
2. Chapter 3 described a novel system for automatic prostate segmentation on
T2w ER MRI, with accuracy and inter-observer variability measured as in Chapter 2.
This method takes advantage of the availability of prostate size measurements that are
obtained during clinical standard TRUS imaging prior to MRI to facilitation an automatic
coarse localisation of the prostate prior to segmentation refinement using the same
algorithm as presented in Chapter 2. This method replaced the 30 seconds of manual
operator interaction time required to use the semi-automatic method in Chapter 3 with 3
seconds of computation time, at the expense of a statistically significant but small
decrease in accuracy. The use of the automated algorithm substantially mitigated the
inter-observer variability observed in Chapter 2 of the segmentation of the base region of
the prostate by eliminating the need for an operator to decide on the apex-most and basemost extents of the gland, supporting the central hypothesis of this thesis. The automatic
algorithm provided improved accuracy, compared to the semi-automatic algorithm, in
measuring overall prostate volume.
3. Chapter 4 described an expert user study measuring the impact of using semiautomatic and automatic segmentations on physicians’ ability to obtain a clinically
acceptable segmentation via editing a provided starting segmentation, compared to
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achieving the same end via fully manual segmentation. Although the amount of editing
required was directly proportional to the amount of automation used to produce the
starting segmentation (i.e. via fully automated, vs semi-automated, vs manual
segmentation by another operator), the use of an automatically generated starter
segmentation yielded lower inter-operator segmentation variability in the final
segmentation, compared to from-scratch manual segmentation, supporting the central
hypothesis of this thesis. Using such a starter segmentation was also found to reduce the
total time required to achieve a clinically acceptable segmentation, also supporting the
central hypothesis of this thesis. Finally, we found that spatial error metrics such as the
MAD and DSC are not strongly correlated with the amount of editing time required to
render a segmentation clinically acceptable. This observation challenges the comparison
between two algorithms’ performance based on the values of the spatial metrics. Since
for clinical purposes, a segmentation judged by a physician to be clinically acceptable can
be taken to be accurate (because the physician will use this segmentation for the
intervention at hand), the practical purposes of computer-assisted segmentation are (1) to
assist the physician in obtaining a segmentation that is clinically acceptable to him/her in
less time than would be required for manual segmentation, and (2) to increase
consistency of patient care for procedures depending on prostate segmentation on MRI.
Thus, to evaluate an algorithm’s suitability for clinical translation, algorithm developers
need to directly measure the required editing time for multiple operators to achieve
clinically acceptable segmentations; spatial error metrics cannot be used as a surrogate
for editing time. Rather, the value of spatial error metrics is in measuring inter-operator
segmentation variability; decreasing this variability is a step toward increasing
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consistency of patient care and increasing consistency of execution of multi-operator and
multi-centre clinical trials involving prostate segmentation on MRI.

5.2 Applications and future directions
The segmentation techniques and evaluation methods developed in this thesis
support research applications in which prostate segmentation in T2w ER MRI is either
being studied or being employed, or clinical applications that require prostate
segmentation on T2w ER MRI. In the following section, several applications that could
potentially benefit the segmentation algorithm will be discussed. Some remaining gaps in
knowledge that could be covered as part of future work will also be discussed.

5.2.1 Applications in ongoing clinical research studies
In an ongoing clinical research studies in our group [1], for a mechanicallyassisted targeted prostate biopsy system, surface-based MRI-TRUS registration was
required. The TRUS images were segmented using a semi-automatic algorithm. For the
MR images, manual segmentation of the prostate was used. Our segmentation algorithms
could be used to facilitate the surface-based image registration and MRI-TRUS fusion, to
decrease processing time and mitigate inter-observer variabiility. The impact of MRI
segmentation error and variability on the MRI-TRUS registration error could be studied
before and after applying manual editing to the segmentation labels, with the ultimate
endpoint being the impact on positive yield at biopsy as measured in a prospective study.
In another clinical research study [2, 3], manual segmentation of the prostate on
T2w MRI has been employed in an MRI-compatible mechatronic system that was
developed for MRI-guided needle insertion to the prostate. In this system, a preoperative
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and an intraoperative ER prostate MR image are manually segmented and registered
together for mapping defined targets from the preoperative image to the intraoperative
image. Our segmentation algorithms could be applied to both pre- and intra-operative
images. Our automated algorithm could be particularly helpful to speeding up the
intraoperative MR image segmentation to reduce the total amount of in-bore procedure
time required.
There are also other research studies or clinical applications in which ER prostate
MRI segmentation is required [4, 5]. In these studies manual prostate segmentation on
pre-operative T2w MRI was used for surface-based image registration between preoperative MRI and either intra-operative MRI or pre-operative ultrasound to localize PCa
tumours in image-guided biopsy or focal therapy. Therefore, the impact of using our
algorithm could be investigated in terms of processing time and/or procedure accuracy
and reproducibility, compared to using manual segmentation.

5.2.2 Suggestions for future work
We have studied the accuracy and reproducibility of a segmentation algorithm as
well as the segmentation time that is required to have clinically acceptable contours. To
the best of our knowledge, the impact of segmentation error on the final results of a
clinical procedure has not been extensively studied; e.g. the impact of MRI segmentation
error on PCa targeting in an MRI-targeted TRUS-guided prostate biopsy, or on the results
of radiation therapy dosimetry. Hence, it is also important to study the impact of the
segmentation error and variability, before and after manual editing, on the performance of
some of the clinical applications in which ER prostate MRI segmentation is used.
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The presented segmentation approaches, although highly amenable to parallel
implementation, were implemented sequentially. Hence, an important future step for this
work would be implementation of the algorithm for parallel computing on a graphics
processing unit (GPU), and we would expect at least an order of magnitude lower
computation times from such an implementation. Using an unoptimized implementation
of the algorithm on a Matlab research platform and running on a single central processing
unit core, the segmentation takes less than 90 seconds, on average. We would expect a
GPU implementation to therefore run in well under 10 seconds.
Our observation of no meaningful correlation between the values of the five error
metrics used in this work and the required editing time to achieve a clinically acceptable
segmentation leads to the recommendation that editing time must be measured directly
for multiple observers in order to assess an algorithm’s suitability for clinical translation.
This renders algorithm evaluation much more expensive in terms of time and effort, and
requires the engagement of clinical colleagues which is challenging in many computer
science and engineering contexts which may be located distant to clinical centres. There
is therefore potential value in future work designing and validating novel spatial error
metrics that are more accurately predictive of required editing time. The data set
generated as part of our study in Chapter 4 could provide initial validation of novel
metrics for this purpose.
Since PCa tumours are most likely to be found within the peripheral zone of the
prostate gland, in some the clinical applications the segmentation of the prostate gland
into its zones could be helpful. Therefore, zonal segmentation of the prostate gland could
be taken into account as another step forward. According to the appearance of the
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peripheral zone in T2w MRI (i.e. usually a brighter region compared to the surrounding
tissues) the same local appearance-based segmentation method we used for whole
prostate gland segmentation might be also applicable for zonal segmentation of the gland.
This segmentation method could also be utilized in segmentation of any other
organs or objects that have convex shapes and inter-patient local appearance consistency
withing different parts of the object boundary, despite of inter-patient appearance
differences inside or outside of the object.
Finally, The conclusions of this work are valid only in the context of our own
segmentation techniques, and the results might differ if the operator editing study were
conducted with different algorithms. Moreover, due to the small size of the data sets and
the number of operators involved, this should be considered to primarily be a set of
hypothesis-generating studies that point the way to potentially fruitful studies on larger
sample sizes with sufficient statistical power to draw firmer conclusions. We also did not
study the effect of MR pulse sequence parameters on the results.
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2007-2008
2005
2005

The University of Western Ontario
ENGSCI 1036A – Programming Fundamentals for Engineers – Teaching Assistant
Iranian Academic Center of Education, Culture and Research, Isfahan, Iran
Linear Control Systems – Course Lecturer
Iranian Academic Center of Education, Culture and Research, Isfahan, Iran
Linear Differential Equations – Course Lecturer
Iranian Academic Center of Education, Culture and Research, Isfahan, Iran
Electrical Circuit Laboratory – Laboratory Instruction
Isfahan University of Technology, Isfahan, Iran
Digital Image Processing – Teaching Assistant
Isfahan University of Technology, Isfahan, Iran
Electronic Circuits Design – Teaching Assistant
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